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abstract
The overall aim of this study was to evaluate the pathophysiology, risk factors, incidence and 
consequences of surgical wound infections (SWI) after lower limb vascular surgery, and to 
assess preventive measures in the SWI prophylaxis. 
Study I was conducted to determine the incidence of SWI, to evaluate the risk factors and 
consequences of SWI, and to calculate the additional cost of services caused by SWI. The 
study cohort comprised of 184 consecutive adult patients undergoing lower limb vascular or 
infrarenal aorto-iliacal surgery. The incidence of SWI was 27% and the independent predic-
tors for SWI were infrainguinal surgery, body mass index over 25 kg/m2 and puncture site of 
arteriography on the operated area. The average costs attributable to SWI was €3,320. 
Study II was conducted to examine quantitative and qualitative analysis of surgical wound 
bacterial colonization and its correlation with the development of SWI. Study cohort com-
prised 94 consecutive patients with 100 surgical wounds. Swabs for microbiological analyses 
were taken from surgical wounds at four different time intervals: just before surgical area had 
been scrubbed, at the end of surgery and, at the first and the second postoperative day. The in-
cidence of SWI was 21%. Multivariate analysis revealed that high bacterial load at the second 
postoperative day and diabetes independently increased the risk of SWI. 
Study III was a multicenter, double-blinded study designed to test whether triclosan-coated 
sutures are effective in the prevention of SWI after lower limb vascular surgery. The study 
cohort comprised of 276 consecutive adult patients who were randomised to either the study 
or the control group. In the study group the arterial exposure and vein harvest incisions were 
closed using triclosan-coated sutures for subcutaneous and intracutaneous closure. The over-
all incidence of SWI was 22%. There was no difference between the triclosan group and the 
control group in the incidence of SWI. Obesity and the use of corticosteroids were independ-
ent predictors of SWI in the multivariate analysis.
Study IV was aimed to test whether postoperative supplemental inspired oxygen is effec-
tive in the prevention of SWI.  In this multicenter, investigator-blinded study, consecutive 
adult patients undergoing lower limb vascular surgery were randomised to either the study 
group (n=137) or the control group (n=137). The patients in the study group received 30% sup-
plemental oxygen via mask in the recovery room after the operation and on the first postoper-
ative day in the surgical ward. On the second postoperative day, patients inspired supplemen-
tal oxygen via a nasal cannula. The patients in the control group received usual postoperative 
care. There was a trend that the incidence of SWI was lower in the study group compared 
with the control group (18% and 25%, respectively, p=0.07). Asthma, coronary artery disease 
and infrainguinal incision were independent predictors of SWI in the multivariate analysis. 
In 103 patients with inguinal incision only, the use of supplemental oxygen significantly de-
creased the risk of SWI with odds ratio (OR) of 0.20. 
VI
In conclusion, surgical wound infection after lower limb vascular surgery is a remarkable 
problem with an incidence of 22-27%. Obesity, infrainguinal surgery, puncture site of arteri-
ography on the operated area, asthma, coronary artery disease, use of corticosteroids, diabe-
tes, and the high bacterial load of the surgical site at the second postoperative day increase the 
risk of the development of SWI after lower limb vascular surgery. 
National Library of Medicine Classification:
Medical Subject Headings: peripheral vascular surgery, surgical wound infection, supplemental oxygen, tri-
closan-coated sutures, bacterial load
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tIIVIstELMÄ
Alaraajavaltimoiden verisuonikirurgisia leikkauksia tehdään joko parantamaan valtimove-
renkiertoa tai korjaamaan valtimopullistumia. Lähtökohtana on potilaan alaraajan pelas-
taminen, liikuntakyvyn parantaminen tai valtimopullistuma komplikaatioiden estäminen. 
Näiden toimenpiteiden jälkeinen leikkaushaavatulehdus on tavallinen ongelma, joka pahim-
millaan voi johtaa alaraajan menettämiseen.
Tässä väitöskirjatyössä selvitettiin alaraajojen verisuonikirurgisten leikkausten jälkeisten 
haavatulehdusten syntymekanismia, riskitekijöitä sekä ilmaantuvuutta. Lisäksi arvioitiin haa-
vatulehduksista aiheutuvia kustannuksia ja testattiin menetelmiä tulehdusten ehkäisemiseksi. 
Ensimmäinen, kolmas ja neljäs osatyö toteutettiin monikeskustutkimuksena. Ensimmäisen tut-
kimuksen aineiston muodosti 184 verisuonikirurgista potilasta. Leikkaushaavatulehdusten il-
maantuvuus oli 27% ja itsenäiset riskitekijät leikkaushaavatulehduksen synnylle olivat ylipaino, 
leikkausalue alaraajassa nivustaipeen alapuolelle ja valtimoiden varjoainekuvauksen pistopaikka 
leikkausalueella. Yhden leikkaushaavatulehduksen hoito maksoi keskimäärin 3 320 euroa.
Toisessa osatyössä 95 verisuonikirurgisen potilaan 100 leikkaushaavalta otettiin bakteeri-
viljelynäytteitä laadullista ja määrällistä analalyysiä varten. Näytteet otettiin leikkaushaavalta 
leikkaussalissa juuri ennen leikkausalueen pesua, leikkauksen lopussa sekä ensimmäisenä ja 
toisena leikkauksen jälkeisenä päivänä. Leikkaushaavatulehduksen ilmaantuvuus oli 21% ja 
korkea bakteereiden määrä leikkausalueella toisena leikkauksen jälkeisenä päivänä oli itse-
näinen riskitekijä tulehduksen synnylle. Myös diabetes lisäsi infektioriskiä. 
Kolmannessa osatyössä testasimme vähentääkö triklosaanilla päällystettyjen ommelainei-
den käyttö leikkaushaavatulehdusten ilmaantumisen riskiä. Yhteensä 276 verisuonikirurgis-
ta potilasta satunnaistettiin kahteen ryhmään. Tutkimusryhmän potilaiden leikkaushaavat 
suljettiin triklosaanilla päällystetyllä ommelaineella ja kontrolliryhmän tavallisella ommelai-
neella. Leikkaushaavatulehduksen ilmaantuvuus tässä tutkimuksessa oli 22%, ryhmien välil-
lä ei ollut eroa. Tulehduksen riskiä lisäsi ylipaino sekä kortikosteroidien käyttö.
Neljännen osatyön tarkoituksena oli selvittää vähentääkö hengitettävän lisähapen anto leik-
kauksen jälkeen leikkaushaavatulehdusten määrää. Tutkimusaineiston muodosti 274 verisuo-
nikirurgista potilasta, jotka satunnaistettiin tutkimus- ja kontrolliryhmään. Tutkimusryhmän 
potilaat hengittivät lisähappea happimaskin ja happiviiksien kautta kahden leikkauksen jäl-
keisen vuorokauden ajan. Leikkaushaavatulehduksen ilmaantuvuus oli 18% lisähappiryh-
mässä ja 25% kontrolliryhmässä. Leikkaushaavatulehduksen itsenäisiä riskitekijöitä olivat 
astma, koronaaritauti sekä leikkaushaava alaraajassa nivustaipeen alapuolella. Potilaita, joilla 
oli leikkaushaava ainoastaan nivustaipeen alueella, oli 103. Tässä ryhmässä lisähapen anto 
vähensi merkitsevästi leikkaushaavatulehduksen ilmaantuvuutta.
Luokitus:
Yleinen Suomalainen asiasanasto: haavat; jalat; leikkaushoito; tulehdus; verisuonikirurgia
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1 Introduction
Until the late 19th century, surgical patients commonly developed postoperative surgical 
wound infection often followed by sepsis and death. The mortality associated with ovari-
otomy and other types of major abdominal surgery, repair of open fractures, and limb ampu-
tation was 50% or higher owing to infection (Wangensteen and Wangensteen 1978). The first 
one who radically changed surgery from an activity associated with sepsis and high mortality 
to procedures that could prolong life was Joseph Lister, an English surgeon. In his landmark 
series of articles Lister systematically and scientifically described the effectiveness of new sys-
tem of antisepsis with the use of carbolic acid (Lister 1867, Gawande 2012). 
The father of the modern infection control is generally considered to be Professor Ignaz 
Semmelweis (1818-1865), who showed that puerperal sepsis was contagious and could be 
prevented with adequate hand hygiene. Semmelweis studied and worked in the Maternity 
Hospital in Vienna. He noticed that maternal mortality was 10% in Ward 1, where medi-
cal students came directly from post-mortem room, and 3% in Ward 2, where midwives de-
voted much attention to cleanliness. Semmelweis established a hand-washing program and 
the death rate in Ward 1 dropped to the same level as in Ward 2 (Rutkow 1993). These ideas, 
however, had been brought out for decades before Semmelweis´ work. Alexander Gordon had 
published his observations in 1795 and showed the contagiousness of puerperal fever and ad-
vised disinfection of the hands and clothes of doctors and midwives (Dunn 1998, Gould 2010).
Research of Louis Pasteur (1822-1895) and Robert Koch (1843-1910) improved the understand-
ing of bacteria and antisepsis. By 1861 Pasteur demonstrated that putrefaction is caused by the 
presence of bacteria. Until that time, infection was believed to be owing to spontaneous gen-
eration. In 1875 Pasteur discovered the first anaerobic pathogen, Clostridium septicum. Robert 
Koch improved methods of fixing, staining and photographing bacteria. He also postulated 
that animal inoculation from the culture reproduces the disease and that the organism can be 
recovered from inoculated animals and again be grown in pure culture (Rutkow 1993). 
Sir Alexander Fleming (1881-1955), a Scottish biologist and pharmacologist, while investi-
gating the properties of staphylococci isolated penicillin in September 1928, and finally, there 
was an agent that could inhibit the bacterial growth, and even cure bacterial infections.
 In Fleming’s laboratory one culture of staphylococci had been accidently contaminated with 
a fungus and he noticed that the colonies of staphylococci that had immediately surrounded 
fungus had been destroyed, whereas other colonies farther away were normal (Hare 1970). 
Although antibiotic therapy, antibiotic prophylaxis and antiseptic techniques have been 
in general use in surgery for almost a century, surgical wound infections (SWIs) are still a 
remarkable problem. And in fact, the incidence of SWI has remained at the same level for the 
past 40 years (Olson et al 1983, Gil-Egea et al 1987, Moro et al 1996, Geubels et al 2000, Gaynes 
et al 2001, Coello et al 2005, Kasatpibal et al 2005, Kaya et al 2006, Roumbelaki et al 2008, 
Suljagic et al 2010).
Today the volume of surgical procedures is high – with at least 45 million inpatient pro-
cedures being performed annually in the United States (Hall et al 2012), which means, while 
the incidence of SWI is approximately 2.6% (Gaynes et al 2001), that there are 1.2 million SWIs 
each year in the US. Accordingly, the number of SWIs ranges between 450,000 and 6,000,000 
per year in Europe (Leaper et al 2004). In Finnland, the overall prevalence of SWI has reported 
to be 2.6% (Lyytikäinen et al 2008).
2Surgical wound infection is the most common complication after lower limb revascularisa-
tion surgery, which is considered “clean surgery”. In prospective studies, the incidence of SWI 
in patients undergoing peripheral vascular surgery ranges from 3.5% to 32% (Richet et al 1991, 
Chester et al 1992, Josephs et al 1993, Murphy et al 1995, Kent et al 1996, Childress et al 2007, 
Ploeg et al 2009, Virkkunen et al 2009, Linni et al 2012). Surgical wound infection increases the 
affected patient’s risk of major amputation as well as mortality (Pounds et al 2005, Nguyen et 
al 2007). Furthermore, SWI increases the cost of vascular surgery (Kent et al 1996).  
Prospective studies have revealed that independent predictors for SWI after peripheral 
vascular surgery are higher age, obesity, infrainguinal surgery, diabetes and redo vascular 
surgery (Richet et al 1991, Kent et al 1996). Furthermore, diabetes significantly prolongs the 
tissue healing time in patients operated due to critical ischaemia and tissue loss (Söderström 
et al 2008).  Staphylococcus aureus, a microorganism of the skin’s normal flora, is the most fre-
quently isolated pathogen occurring in 40-60% of SWIs after arterial reconstructions (Calligaro 
et al 1994, Lee et al 2000, Pounds et al 2005).  
Since postoperative infections mainly occur at or around the suture lines, the role of suture 
material in the development of SWI may be important. In order to avoid microbial colonisa-
tion of suture material, triclosan-coated polyglactin 910 (Vicryl Plus; Ethicon, GmbH) and 
triclosan-coated poliglecaprone 25 (Monocryl Plus; Ethicon, GmbH) with antibacterial activity 
were developed. To date, nine prospective studies have been published in which the efficacy 
of triclosan-coated sutures for prevention of surgical site infection is assessed. However, there 
is no concordance between the results of these studies (Ford et al 2005, Rozelle et al 2008, 
Deliaert et al 2009, Mingmalairak et al 2009, Baracs et al 2011, Chen 2011, Galal et al 2011, 
Williams et al 2011, Zhang et al 2011).
Oxygen is vital for the healing of wounds and avoidance of infection. Supplemental in-
spired oxygen during surgery and postoperatively for 2-6 hours has been demonstrated to 
reduce the risk of SWI after colorectal resection (Grief et al 2000, Belda et al 2005, Bickel et al 
2011). In contrast, there are studies with heterogeneous surgical patient populations that have 
not found supplemental perioperative oxygen to be protective against SWI (Pryor et al 2004, 
Mayzler et al 2005, Gardella et al 2008, Meyhoff et al 2009, Scifres et al 2011).
The overall aim of this study was to evaluate the risk factors, incidence and consequences 
of SWI after lower limb vascular surgery, and to assess preventive measures in SWI prophy-
laxis. Furthermore, in this study we try to define if there is a connection between bacterial 
contamination of operative wound and development of SWI in vascular surgery patients.
   
     
      
32 Review of litterature
2.1 sUrGIcaL WOUND
2.1.1 Classification of wounds
Wounds are generally classified as acute or chronic. Acute wounds, either surgical or traumat-
ic, are those that have been induced by external injury and that heal through an orderly and 
timely reparative process (Lazarus et al 1994, Bowler 2002). If wound-healing fails, wound is 
defined as being chronic. Chronic wounds are associated with pathophysiological abnormali-
ties, for example venous leg ulcers or diabetic foot ulcers. To predict the risk of surgical wound 
infection (SWI), surgical sites are traditionally classified preoperatively into four categories 
(Stone et al 1976, Mangram et al 1999):
Class I/Clean: An uninfected operative wound which no inflammation is encountered and 
respiratory, alimentary, genital, or urinary tracts are not violated. Clean wounds are primarily 
closed and if necessary, drained with closed drainage. Operative incisional wounds that follow 
nonpenetrating (blunt) trauma should be included in this category if they meet the criteria.
Class II /Clean-Contaminated: An operative wound in which the respiratory, alimentary, or uri-
nary tract is being operated on under controlled conditions and without unusual contamination. 
Specifically, operations involving the biliary tract, appendix, vagina, and oropharynx included in 
this category, provided no evidence of infection or major aberration in technique is encountered. 
Class III /Contaminated: Open, fresh, accidental wounds. In addition, operations with major 
breaks in sterile technique (e.g., open cardiac massage) or gross spillage from the gastrointestinal 
tract, and incisions in which acute, nonpurulent inflammation is encountered are included in 
this category.
Class IV /Dirty/Infected: Old traumatic wounds with retained devitalised tissue and those that 
involve existing clinical infection or perforated viscera. This definition suggests that the orga-
nisms causing postoperative infection were present in the operative field before the operation.
2.1.2 Risk Index
The surgical wound classification has been widely used to predict SWI risk. However, inci-
dence of SWI varies largely within categories, for example 1-16% in the clean wound category 
(Haley et al 1985). Therefore, reporting SWI rates stratified by wound class alone is not recom-
mended (Mangram et al 1999). The US-based NNSI risk index system was created in order to 
have improved predictor of risk for patient to develop SWI.
The NNSI SWI risk index system includes the conventional wound classification system, 
the American Society of Anesthesiologists (ASA) score, and duration of an operation. The 
patient’s fitness before surgery is assessed with the ASA score. Patients are given scores from 
1 to 5: 1 indicates a healthy patient; 2 is a patient with mild systemic disease; 3, a patient with 
severe systemic disease; 4, a patient with severe systemic disease that is a constant threat to 
life; and 5, a patient not expected to survive (Am S Anesthes 1963).
The simplified risk index has range of 0 to 3 points. Each operation is scored by counting 
4the number of following factors: 1 point if an operation is classified as contaminated or dirty-
infected; 1 point if a patient has an ASA preoperative assessment score of 3, 4 or 5, and 1 point 
if the operation has a duration of over ‘T’ hours, where ‘T’ depends on the operative procedure 
being performed (Culver et al 1991). The NNSI risk index is found to be significantly better 
predictor for SWI than the traditional wound classification system alone. The surgical wound 
infection rates range from 0.5-1.5% with none of the risk factors, to 5-13% for patients with all 
three of the risk assessment points (Culver et al 1991, Gaynes et al 2001). 
      
2.1.3 Healing of surgical wound
Acute wounds normally heal in order of four distinct, but overlapping phases: haemostasis, 
inflammation, proliferation and remodelling. The healing process begins at the moment tis-
sue is injured. 
In the haemostasis phase, the platelets, after they come into contact with collagen and oth-
er components of extracellular matrix, release clotting factors, growth factors and cytokines 
such as platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-β). 
Then neutrophils enter the wound site and begin phagocytosis to remove foreign materi-
als, bacteria and damaged tissue. During this inflammatory phase, macrophages continue 
the phagocytosis as well as releasing PDGF and TGF-β. Once the wound is cleaned out the 
proliferative phase begins: fibroblasts migrate to the site to deposit new extracellular matrix 
(Diegelmann and Evans 2004). Epithelisation is stimulated by presence of epidermal growth 
factor (EGF) and transforming growth factor alpha (TGF-α) that are synthesised by activated 
macrophages, platelets and keratinocytes (Schultz et al 1991). A new blood supply is provided 
during the process of angiogenesis which is stimulated by vascular endothelial cell growth 
factor (VEGF), basic fibroblast growth factor (bFGF) and TGF-β (Tonnesen et al 2000). The new 
collagen matrix then becomes cross-linked and organized during the remodelling phase.
Collagen accounts for 30 % of human body protein (Prockop and Kivirikko 1995). In normal 
tissues collagen provides strength, integrity and structure. When tissues are disrupted, col-
lagen is needed to repair the defect and restore anatomic structure and function (Diegelmann 
and Evans 2004).  
2.1.4 The role of oxygen in wound healing
The vital parameter for the healing of wounds is oxygen that is required in almost every step 
of the healing process (Schreml et al 2010). The oxygenation level of tissue, including wound 
tissue, is most often assessed by partial oxygen pressure (PO2) and described in millimetres 
of mercury (mmHg). The oxygenation of wound tissue is based on three following factors: (1) 
delivery of oxygen from lungs to the tissue, (2) transport of oxygen from blood to tissue, and 
(3) oxygen consumption in tissue (Gottrup 1994). 
Collagen production and deposition, which provides the strength of the wound, is directly 
correlated with PO2 (Jonsson et al 1991). Molecular oxygen is required for the hydroxylation of 
proline and lysine during collagen synthesis and without it only functionally deficient proto-
collagen is produced (Hunt et al 1969).
During the epithelisation a layer of epithelium covers the wound surface. The process, 
based on the differentiation, proliferation and migration of epidermal keratinocytes, is stim-
ulated by EGF and TGF-α. The epithelisation is highly metabolic and oxygen dependent 
(Diegelmann and Evans 2004). 
 Low oxygen tension stimulates the expression of hypoxia-inducible factor (HIF) that regu-
lates the expression of VEGF and thus stimulates angiogenesis (Gerber et al 1997). However, 
5it has been shown that also increased oxygenation increases the amount of angiogenesis-
stimulating VEGF in wound fluid (Sheikh et al 2000).
Oxidative killing is a critical defence against wound pathogens. Bacteria in wounds are 
destroyed inside a leukocyte, and molecular oxygen is necessary for the production of bacte-
ricidal oxygen radicals (Babior 1978). Bacterial killing capacity of leucocytes is reduced at low 
oxygen tension (Jönsson et al 1988, Allen et al 1997). On the other hand, hyperoxia increases 
the production of reactive oxygen species which destroy pathogens (Qadan et al 2010).
2.2 sUrGIcaL WOUND INfEctION
2.2.1 Definition and diagnosis
The US National Nosocomial Infections Surveillance (NNIS) of The Centers for Disease 
Control and Prevention (CDC) has developed standardised and commonly used criteria for 
defining postoperative SWI (Horan et al 1992). These criteria are presented in Table 1. SWIs 
are classified as superficial or deep infections, or infections involving organs or body spaces. 
Infection is classified to be SWI if it occurs within 30 days of the operation if no implant is 
placed in the surgical site or within one year if implant is in place and the infection appears 
to be related to the operation (Horan et al 1992).
A surgical wound can be considered uninfected if it heals primarily without discharge. 
The diagnosis of SWI is based on clinical and laboratory findings. However, SWI can occur 
without any haematologic or serologic laboratory abnormalities. 
Table 1. CDC Criteria for Defining a Surgical Wound Infection (SWI)
sUPErfIcIaL INcIsIONaL sWI
Infection occurs within 30 of the operative procedure and involves only skin or subcutaneous tissue of the 
incision, and at least one of the following is present
1. Purulent drainage from superficial incision
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision.
3. At least one of the following signs or symptoms of infection: pain or tenderness, localized swelling, 
redness, or heat- and superficial incision is deliberately opened by surgeon, unless culture of incision 
is negative. 
4. Diagnosis of superficial incisional SWI by the surgeon or attending physician
DEEP INcIsIONaL sWI
Infection occurs within 30 days of the operative procedure if no implant is left in place or within 1 year if 
implant is in place and the infection appears to be related to the operative procedure and the infection 
involves deep soft tissues (e.g. fascial and muscular layers) of the incision, and at least one of the follo-
wing is present 
1. Purulent drainage from the deep incision but not from the organ/space component of surgical site.
2. A deep incision spontaneously dehisces or is deliberately opened by surgeon when the patient has at 
least one of the following signs or symptoms: fever (›38⁰C), localized pain, or tenderness, unless cul-
ture of incision is negative.
3. An abscess or other evidence of infection involving the deep incision is found on direct examination, 
during reoperation, or by histopathologic or radiologic examination.
4. Diagnosis of deep incisional SWI by a surgeon or attending physician.
OrGaN/sPacE sWI
Infection occurs within 30 days of the operative procedure if no implant in in place, or within 1 year if 
implant is in place and the infection appears to be related to the operative procedure and if infection in-
volves any part of anatomy (e.g., organs or spaces) other than the incision opened or manipulated during 
the operative procedure, and at least one of the following is present
1. Purulent drainage from a drain that is placed through a stab wound into the organ/space.
2. Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/space.
3. An abscess or other evidence of infection involving the organ/space on direct examination, during 
reoperation, or by histopathologic or radiologic examination.
4. Diagnosis of an organ/space SWI by a surgeon or attending physician.  
Adapted from Horan et al 1992
62.2.2 Epidemiology and outcome
In the United States SWI is the second most common type nosocomial infection, also known 
hospital acquired infection or health care-associated infection. Approximately 5-10% of pa-
tients admitted to US acute care hospitals develop nosocomial infection and 25% of these 
infections are SWIs (Wenzel 2007). Comparatively, in Finnish acute care hospitals nosoco-
mial infection occurs in 8.5% of patients and SWI comprises 29% of all nocosomial infections. 
(Lyytikäinen et al 2008).   
Nosocomial infections cause extra costs because of prolonged hospitalisation, additional 
diagnostic tests, therapeutic use of antibiotics and sometimes additional surgery (Urban 2006, 
Broex et al 2009). SWI increases the hospital costs of surgical procedures by approximately 
115%. In other words, a treatment of one surgical patient with SWI costs as much as a treat-
ment of two surgical patients without SWI (Broex et al 2009).
A review with 48 European studies reported 1.5-20% postoperative SWI, and the rate de-
pends on the type of surgery and wound classification. The authors considered that there are 
an estimated 30 million surgical procedures conducted in Europe each year, which leads to 
number of SWI to range between 450,000 and 6,000,000. An average cost per day in hospital 
is €325 and an average extended hospital stay is 10 days, this means that SWI could be cost-
ing European health care systems between €1.47 billion and €19.1 billion (Leaper et al 2004). 
A study with 140 English hospitals participating found the extra postoperative length of stay 
(LOS) because of SWI ranging from 3.3 days for abdominal hysterectomy to 21 days for lower 
limb amputation. The additional costs attributable to SWI ranged from £959 to £6,103 (€1,154-
7,342).  Patients with SWI following hip prosthesis replacement, vascular surgery or large 
bowel surgery have a mortality rate significantly higher than those without SWI (Coello et 
al 2005). In US hospitals 1,737,125 nosocomial infections and 290,485 SWIs were reported in 
2007. And mortality related to nosocomial infection and SWI was 5.7% and 2.8%, respectively 
(Umscheid et al 2011). Furthermore, a long-term study conducted in France reported that 38% 
of the deaths that occurred in patients with SWI were directly attributable to the infection, and 
SWI increases mortality with an odds ratio (OR) of 1.6 [95% confidence interval (CI) 1.3-2.2] 
(Astagneau et al 2001). A case-control study estimated that median cost of a single coronary 
artery bypass surgery (CABG) followed by sternal infection is $49,500 (€36,300) compared to 
$18,200 (€13,400) in patients with no infection (Graf et al 2011).
A cross-sectional and retrospective study that covers all surgical wound infection injury 
claims made in Finland during 1988-1990 was conducted by using the records of the Patients 
Injury Act. The study revealed that 0.23% of all surgical procedures led to a compensation 
claim and about 70% of them led to a grant of compensation. The mean extra hospital stay per 
infection was 33.2 days (Hyrylä et Sintonen 1994).
2.2.3 Pathogenesis
The likelihood that SWI occurs is a relationship among (1) microbial characteristics and 
contamination, (2) patients characteristics and (3) surgical characteristics (Anderson 2011). 
Contamination of the surgical site with bacteria and other microorganisms occurs during 
surgery. In a prospective study with 201 cardiac surgery procedures 98% of patients showed 
bacterial growth on the skin surrounding the surgical wound at the end of the operation 
(Kühme et al 2007). Although nearly all surgical wounds become contaminated (Robson 1979, 
Saleh et al 2011), only a small number of patients develop a clinical infection (Olson et al 1984, 
Santos et al 2010).
7Intraoperatively microbial contamination of the surgical wound remains one of the most 
accepted risk factors for SWI. The greater the degree of bacterial load in the surgical wound, 
the higher is the risk of postoperative SWI (Anderson 2011, Saleh et al 2011). The risk of SWI is 
markedly increased when the contamination level of tissue exceeds 105 microorganisms per 
gram of tissue (Bendy et al 1964). However, a lower dose of contaminating microorganisms 
may be sufficient when foreign material is present at the surgical wound (Mangram et al 1999).
For most SWIs, the source of pathogens is the patient’s endogenous flora on skin, mucous 
membranes or in hollow viscera (Altemeier et al 1968). Endogenous organisms are usually aer-
obic gram-positive cocci, but may include anaerobic bacteria and gram-negative aerobes when 
incisions are made near perineum or groin. The microbes that most commonly contaminate 
the surgical wound by the end of the operation include the following bacteria of skin normal 
flora: coagulase-negative staphylococci, propionibacterium acnes and staphylococcus aureus 
(Saleh et al 2011, Kühme et al 2007). If the gastrointestinal organ is opened during surgical 
procedure, the organisms isolated from SWI are typically gram-negative bacilli, gram-positive 
organisms and anaerobes (Mangram et al 1999). Wound contamination occurs primarily near 
to the surgical site. However, patients with an infection somewhere in the body remote from 
the wound are in risk of endogenous bacterial contamination via bloodstream or lymphatic 
system (Robson 1997).
Exogenous sources of wound contamination include surgical personnel, the operating 
room environment and surgical instruments (Mangram et al 1999).  SWIs owing to exogenous 
sources most commonly occur sporadically (Anderson 2011).
      
2.2.4 Microbiology of surgical wound infection
Pathogens responsible for SWIs vary with the type and anatomic location of the procedure. 
Staphylococcus aureus, microorganism of the skin normal flora, is the most frequently isolat-
ed pathogen occurring in 8-36% of SWIs (Table 2).  Other endogenous bacteria responsible for 
SWI are coagulase-negative staphylococci, Enterococcus species and Escherichia coli. Typical 
SWI isolates after gastrointestinal procedures are gram-negative bacilli (e.g., Escherichia coli), 
gram-positive organisms (e.g. enterococci), and sometimes anaerobes (e.g. Bacteroides fragilis) 
(Mangram et al 1999). 
Methicillin-resistant Staphylococcus aureus (MRSA) as a causative agent of SWI is an in-
creasing problem in several countries. The proportions of MRSA of staphylococcus aureus 
isolated from SWI have reported as follows: The United States 47% (Kassavin et al 2011), 
Great Britain and Ireland 40% (Naylor et al 2001), Serbia 64% (Suljagic et al 2010), Greece 56% 
(Roumbelaki et al 2008), Switzerland 11% (Sax et al 2011) and Italy 11% (Di Leo et al 2009). At 
the present, MRSA is not a remarkable causative agent for SWI in Finland. 
Exogenous flora responsible for SWI are predominantly aerobes, especially gram-positive 
organisms such as staphylococci and streptococci (Mangram et al 1999). Unusual bacterial 
isolates from the hospital environment as well as fungi are occasionally found to be agents of 
SWI (Mangram et al 1999, Barie and Eachempati 2005, Anderson 2011). 
8Table 2. Pathogens isolated from surgical wound infections after various types of surgical pro-
cedures. Results of 12 prospective or prevalence studies that have been aimed to determine the 
etiology of SWI.
PatHOGEN PrEcENtaGE Of IsOLatEs
Staphylococcus aureus
Coagulase-negative staphylococci
Enterococcus sp. 
Escherichia coli
Pseudomonas aeruginosa
Enterobacter sp.
Proteus spp
Klebsiella sp.
Acinetobacter spp
Candida albicans
Streptococcus sp.
Bacteroides sp.
Clostridium
Culture negative 
7-36
12-29
3-16
5-20
2-21
1-21
2-11
1-14
3-13
2-6
6
2
6
8-30
Gil-Egea et al 1987, Twum-Danso et al 1992, Santos et al 1997, Murthy et al 1998, Kasatpibal et al 2005, 
Kaya et al 2006, Lyytikäinen et al 2008, Roumbelaki et al 2008, Suljagic et al 2010, Weigelt et al 2010, 
Kassavin et al 2011, Sax et al 2011 
     
According to the review of Rasnake and Dooley (2006), published studies of microbiology of 
SWIs suggest that 10-30 % of all cultures do not exhibit bacterial growth, even when clinical 
signs of infection are present. Reasons for culture-negative SWI are speculated to be antibiotic 
therapy prior to culture and lack of growth on routine culture. Some atypical pathogens do 
not grow on standard culture media or they grow so slowly that growth is not apparent at the 
time plates are discarded. Microbial pathogens that do not grow using routine culture meth-
ods include: rapidly growing mycobacteria, Mycoplasma, Ureaplasma, Legionella, “Small-
colony variant” Staphylococcus aureus and anaerobic pathogens (Rasnake and Dooley 2006).  
2.2.5 Risk factors 
2.2.5.1 Patients-related
2.2.5.1.1 Co-morbidities
It has been well established that diabetes mellitus (DM) is an independent risk factor for 
postoperative SWI (Nagachinta et al 1987, Harrington et al 2004, Drapeau et al 2007, Di Leo et 
al 2009, Ata et al 2010, Ahmed et al 2011, Mannien et al 2011). The increased infection risk in 
patients with DM is supposed to be associated with hyperglycaemia or with features in the 
DM state such as microvascular and immunologic changes. Some studies have revealed that 
perioperative hyperglycaemia increases the risk for SWI (Ambiru et al 2008, Olsen et al 2008, 
Ramos et al 2008, Serra-Aracil et al 2011), even in non-diabetic patients (Swenne et al 2005).
Body mass index (BMI), defined as weight in kilograms divided by height in meters squared 
(kg/m2), is the commonly used measure for obesity. According to the definition of the World 
Health Organisation (WHO) underweight, normal weight, overweight and obese people are 
those with a BMI under 20 kg/m2, 20-25 kg/m2, 25-30 kg/m2 and over 30 kg/m2, respectively. 
Obesity is a common medical condition in the Western world; 25-30% of adults in the US and 
the UK are obese (Baskin et al 2005, Rennie and Jebb 2005). In Finland the prevalence of obe-
sity is 22% among adults (Lahti-Koski et al 2010).
9Obesity, defined as an increased BMI, has been found to be an independent risk factor for 
SWI after various surgical procedures. A study with prospectively collected data of 4,476 coro-
nary artery bypass procedures (CABG) showed, that obesity is an independent risk factor of 
sternal wound infection (OR 1.8, 95% CI 1.4-2.3) (Harrington et al 2004). Another prospective 
study with 4,066 patients undergoing cardiothoracic procedures including CABG and valve 
surgery revealed that obesity increases the risk of SWI with an OR of 2.0 (Mannien et al 2011). 
Retrospective studies have also confirmed obesity to be an independent risk factor for SWI 
after cardiac surgery (Olsen et al 2002, Dietz et al 2007).
Obese patients are at significantly increased risk for SWI after colorectal surgery. 
Retrospective analysis with 7,020 colectomy patients revealed that obesity increases the risk 
of SWI with an OR of 1.59 (Wick et al 2011). Another study with 176 elective colorectal resec-
tion showed, that BMI 25-29 kg/m2 increases the risk of SWI with an OR of 2.9, and a BMI over 
30 kg/m2 with an OR of 3.0 (Smith et al 2004). 
Obesity is also an independent risk factor for SWI after spinal surgery with an OR vary-
ing between 2.2 and 2.4 (Olsen et al 2008b, Pull ter Gunne and Cohen 2009, Koutsoumbelis 
et al 2011). An Italian prospective multicenter study included 2,262 patients undergoing clean 
general surgery revealed that obesity increased the risk of SWI with an OR of 4.01 (Moro et 
al 1996).
While obesity is commonly defined as a BMI ≥ 30 kg/m2, percent body fat (%BF) might be 
an even more sensitive predictor for SWI risk. Obesity is then defined as a %BF of over 25 in 
men and over 31 in women. A study with 591 elective surgical patients revealed that obesity 
defined by %BF increased significantly the risk of SWI (OR 5.3, 95% CI 1.2-23.1) whereas a BMI 
of over 30 kg/m2 was not a risk factor for SWI even in univariate analysis (Waisbren et al 2010).
Chronic obstructive pulmonary disease (COPD) also increases the risk of SWI, especial-
ly in patients undergoing cardiovascular surgical procedures (Dietz et al 2007, Haridas and 
Malangoni 2008, Greenblatt et al 2011). 
A study using data from the Norwegian Arthroplasty Register with 108,786 primary total 
joint replacement revealed that after total knee replacement patients with rheumatoid arthri-
tis (RA) have a 1.6 times higher risk of revision for infection than patients with osteoarthritis 
(OA). There was no difference in incidence of SWI after total hip replacement (Schrama et al 
2010). A case control study at Mayo Clinic showed that RA compared with OA increases the 
risk prosthetic joint infections (HR 4.08, 95% CI 1.35-12.33) (Bongartz et al 2008).
A prospective observational study conducted in Italy revealed that the incidence of SWI 
in patients infected with human immunodeficiency virus (HIV) is 9.5% after various surgical 
procedures. The surgical wound infection rate was two-fold higher than rates reported earlier 
in Italian and European studies with general population (Drapeau et al 2009). Furthermore, 
a prospective cross-sectional study in Tanzania found HIV to be an independent risk factor 
for SWI with an OR of 11.0 (95% CI 2.6-64.2) (Mawalla et al 2011). The risk of SWI is higher in 
symptomatic HIV patients compared to asymptomatic (Abalo et al 2010).
      
2.2.5.1.2 Malnutrition
Malnutrition is often defined as hypoalbuminemia (serum albumin under 30g/l) or weight 
loss more than 10%. A nutrition risk index (NRI) is calculated as follows (Buzby et al 1988): 
NRI= 1.519 x serum albumin (g/l) + 41.7 x (current/usual bodyweight). Patients with an NRI of 
more than 97.5 are considered to be non-malnourished, those with an NRI of 83.5-97.5 mod-
erately malnourished and those with an NRI of under 83.5 severely malnourished (Schneider 
et al 2004).
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A French prospective study with 1,637 patients showed that malnutrition defined as NRI 
under 83.5 increases the risk of nosocomial infection among surgical patients with an OR of 
4.98 (95% CI 4.6-6.4) (Schneider et al 2004).
Hypoalbuminemia has been found to be risk factor for SWI in two retrospective analyses; 
a study of 524 gastrointestinal surgery patients revealed that hypoalbuminemia increases the 
risk of SWI development with RR of 5.68 (Hennessey et al 2010). In addition, a study of 10,253 
general surgery patients found hypoalbuminemia to be an independent risk factor for SWI 
with an OR of 1.8 (Haridas and Malangoni 2008).
In an analysis of prospectively collected data from 5,031 noncardiac surgical procedures, 
the incidence of SWI was 12.3% in patients with more than 10% weight loss 6 months prior to 
surgery and 7.1% in patients without weight loss, p=0.01. However, weight loss was not found 
to be an independent risk factor for SWI by logistic regression analysis (Malone et al 2002).
 
2.2.5.1.3 Smoking
Smoking impairs the process of wound healing by attenuating wound inflammation and fi-
broblast proliferation (Sørensen et al 2010a) and by affecting wound contraction and collagen 
metabolism (Sørensen et al 2010b), which may increase the risk for SWI. It has also been shown 
that smoking one cigarette decreases the tissue perfusion by more than 30% in more than 45 
minutes in specific areas of the body (Jensen et al 1991). Furthermore, it has been shown that 
four weeks of abstinence from smoking reduces the incidence of wound infection (Sørensen 
et al 2003).
Smoking has found to increase the risk of SWI in patients undergoing cardiac surgery with 
an OR of 1.8 (Nagachinta et al 1987), orthopaedic surgery with an OR of 1.19-1.41 (Veeravagu 
et al 2009, Singh et al 2011), general surgery with an OR of 3.1 (Arabshahi and Koohpayezade 
2006) and plastic surgery with an OR of 2.1 (Olsen et al 2008a).
2.2.5.1.4 Skin bacterial flora
Most of the SWIs are caused by the organisms of normal skin flora (see section 2.2.4). The 
relationship between bacterial load of surgical wound and development of SWI was studied 
in 18 patients undergoing dermatologic surgery. Quantitative and qualitative analysis of mi-
crobial composition were performed pre-, peri- and postoperatively. The study revealed that 
high postoperative bacterial load on surgical site was a significant risk factor for postopera-
tive complications including SWI (Saleh et al 2011). Correspondently, a study with 125 cases 
of flap reconstruction found that surgical sites with intraoperative positive bacterial culture 
compared with negative bacterial culture wound had a 47% and 7.8% flap complication rate, 
respectively (P<0.001) (Lineaweaver et al 2011).          
In contrast, a study with 609 neurosurgery patients did not find a relationship between 
prepreparation bacterial load and the incidence of SWI. There was, however, a light but not 
significant association between postpreparation bacterial load and the incidence of SWI (RR 
1.79 95% CI 0.72-4.44) (Cronquist et al 2001).    
2.2.5.1.5 Other patient-related risk factors
Age as a risk factor for SWI is not subject to modification. In a cohort study of 144,500 patients 
over 17 years of age, increasing age independently predicted an increased risk for SWI until 
age 65 years. At ages over 65 years, increasing age independently predicted a decreased risk 
of SWI (Kaye et al 2005).
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Prolonged preoperative hospital stay has been associated with SWI (Nagachinta et al 1987, 
Mannien et al 2011). However, the length of preoperative stay depends on the severity of illness 
and co-morbid conditions requiring inpatient therapy before operation (Mangram et al 1999).      
The data supporting the relationship between use of corticosteroid or other immunosup-
pressive medication is controversial: there are studies that have found that use of corticoster-
oids increases the risk of SWI (Gil-Egea et al 1987, Ismael et al 2011) and there are studies that 
do not support that finding (Eberhart et al 2011). 
The leading causative agent of SWI is Staphylococcus aureus (Table 2). A prospective co-
hort study among patients undergoing heart surgery showed that the rate of SWI is signifi-
cantly higher in patients who are nasal-carriers of Staphylococcus aureus compared with 
non-carriers (RR 3.1 95% CI 1.4-7.3) (Munoz et al 2008). Furthermore, a prospective observa-
tional study with 2400 orthopaedic patients showed that a patient with positive nasal MRSA 
culture is at an increased risk, with an OR of 11 to develop SWI compared with non-carriers 
(Yano et al 2009). 
2.2.5.2 Procedure-related
2.2.5.2.1 Hair removal
Traditionally, patients undergoing surgical procedures have their hair removed from the in-
tended surgical site preoperatively. Methods for hair removal are shaving, clipping and chem-
ical depilation. 
The Cochrane authors reviewed 14 trials to determine the influence of routine pre-oper-
ative hair removal (compared with no removal) and the timing or method of hair removal 
on SWI rate (Tanner et al 2011). In that analysis, there was no significant difference in inci-
dence of SWI when comparing hair removal with clipping and no hair removal. Neither did 
the analysis show any difference in incidence of SWI between shaving and no hair removal. 
Furthermore, there were no difference in risk of SWI between patients who had hair removed 
and patients who did not. When shaving was compared with clipping, the analysis showed 
that more patients developed SWI when shaved rather than clipped prior surgery (RR1.97, 
95% CI 1.08-3.58). There was no difference in incidence of SWI if hair was shaved or clipped 
on the day before surgery compared with the day of surgery (Tanner et al 2011).
Body hair removal does not seem to be required before surgical procedures in order to re-
duce SWI rate. If hair removal is necessary, the clippers are associated with fewer SWIs than 
shaving with razors.
2.2.5.2.2 Surgical procedures
The risk of SWI varies by the type of surgical procedures, being highest after lower limb am-
putation. Table 3 shows the incidence of SWI after different surgical procedures. Ten prospec-
tive studies, with 868,194 surgical procedures, that have been conducted with the intention to 
describe the incidence and risk factors of SWI in certain areas and over certain time periods 
are included in the Table 3. It is not difficult to notice that the incidence of SWI has remained 
stable for the last 35 years.
A prospective study with almost 4,500 patients undergoing different surgical procedures 
revealed that the incidence of SWI was higher after emergency procedures than after elec-
tive surgery; 5.1% and 3.2%, respectively (Gil-Egea et al 1987). Furthermore, in a study with 
5,031 noncardiac surgery patients emergency procedure compared with elective procedure 
increased the risk of SWI with an OR of 1.58 (Malone et al 2002).
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Open surgery compared with laparoscopic surgery is associated with higher incidence of 
SWI in various surgical procedures. A retrospective analysis with 11,662 patients from 22 
hospitals was performed to estimate nosocomial infection risks associated with laparoscopic 
as compared to open surgery in three procedures; cholecystectomy, appendectomy and hys-
terectomy. The analysis revealed that laparoscopic procedure decreased the risk of SWI after 
cholecystectomy and hysterectomy with an OR of 0.2 and 0.27, respectively (Brill et al 2008). 
In a study with almost 24,000 patients undergoing colorectal surgery the incidence of SWI 
was 9.4% after laparoscopy and 15.7% after laparotomy (p<0.0001) (Aimaq et al 2011). The risk 
of SWI is significantly reduced after laparoscopic versus open ventral or incisional hernia 
repair [risk ratio (RR) 0.26, 95% CI 0.15-0.46] according to a meta-analysis with 10 randomised 
prospective trials (Sauerland et al 2011). Another meta-analysis with 5,292 patients found that 
SWI rate is significantly lower after laparoscopic than after open appendectomy (OR 0.45, 95% 
CI 0.34-0.59) (Li et al 2010). 
Reoperation, not executed because of infection, increases the risk of SWI after cardiotho-
racic surgery (OR 5.2, 95% CI 2.5-10.6) (Mannien et al 2011).
Excellent surgical technique including effective haemostasis, gently handling of tissues 
and removing devitalised tissue, is widely believed to reduce the risk of SWI (Mangram et al 
1999), even though it has not been proved in randomised prospective trials. It is perhaps obvi-
ous that there is no need to conduct such studies.
Perioperative hypothermia, defined as a core body temperature below 36⁰C, is associated 
with increased SWI risk (Reynolds et al 2008). Hypothermia causes vasoconstriction that de-
creases the PO2 and leads to lowered resistance to infection (Kurz et al 1996).  
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Table 3. Surgical wound infection rate by procedures during different periods of time reported by 
National nosocomial infection surveillance system based studies
specialty group 1977-1985
2 studies with 24,661 
procedures 
(Olson et al 1984, 
Gil-Egea et al 1987)
1992-2001 
4 studies with 
826,133 procedures
(Moro et al 1996, 
Gaynes et al 2001, 
Geubbels et al 2000, 
coello et al 2005)
2001-2007 
4 studies with 17,400 
procedures
(Kasatpibal et al 
2005, Kaya et al 
2006, roumbelaki et 
al 2008, suljagic et al 
2010)
Limb amputation 12.4% 4.3-14.3% 16.7-25%
Small bowel surgery 8.0-10% 4.8-24%
Colon surgery 10.4% 8.6-12.9% 10.2-17%
Prostatectomy 8.9% 1.4% 16%
Transplantation 2.3% 6.6% 12%
Vascular surgery 5.3-12% 2.6-10.4% 3.6-11.1%
Gastric surgery 10.8% 3.5-11.6
Thoracic surgery 1.5% 1.5-7.4% 3.0-11%
Craniotomy 1.0% 1.5% 1.8-11.1%
Breast surgery 2.1-9.1% 1.2-11.1%
Appendicectomy 6.4% 4.0% 1.9-7.7%
Cholecystectomy 3.4% 3.6-5.3%
Open reduction of long 
bone fracture
6.8% 4.2-4.4% 4.0%
Hip prosthesis 2.2% 1.4-3.1% 2.3-4.3%
Knee prosthesis 3.1% 1.2-1.9% 0.9-4.1%
Nephrectomy 5.6% 1.2% 2.2%
Laminectomy 1.9% 1.2% 1.9-2.3%
Herniorrhaphy 1.4% 0-6.1% 0.9-2.1%
Coronary artery bypass 
graft
3.1% 3.0-4.2% 0.7%
Total 3.2-7% 2.6-12.3% 1.4-6.3%
Olson et al 1984,Gil-Egea et al 1987, Moro et al 1996, Geubbels et al 2000,Gaynes et al 2001, Coello et al 
2005, Kasatpibal et al 2005, Kaya et al 2006, Roumbelaki et al 2008, Suljagic et al 2010
2.2.5.2.3 Operation time
There are some studies that have shown an association between prolonged operation time 
and the risk of SWI (Moro et al 1996, Pessaux et al 2003, Peersman et al 2006). Duration of op-
eration might reflect other factors, such as blood loss, a patient s´ hypothermia and decreased 
concentration of prophylactic antibiotics that increase the risk of SWI.
2.2.5.2.4 Foreign material in the surgical site
Infections associated with permanent implants including suture material, prosthesis, shunts, 
grafts, stents and meshes are likely to occur. Most implants have a non-shedding surface 
to which bacteria can adhere, form biofilms and potentiate SWI. Biofilms form whenever 
micro-organisms attach to a surface. Once attached, bacteria undergo a phenotypic change 
and, within minutes, deposit a matrix of extracellular polymeric substance or biofilm matrix. 
Biofilms are the dominant mode of microbial growth and at least 60% of all human infections 
are thought to involve biofilms. The biofilm bacteria are difficult to treat because, shielded 
within the matrix, they are less susceptible to antibiotics and antiseptics (Leaper et al 2010). 
A prospectively collected data with 10,700 patients, found 0.5%-1% incidence of prosthetic 
joint infection after primary hip or knee replacement (Phillips et al 2006). The reported inci-
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dence of mesh-related infection following hernia repair has been 1-8% in different series, and this 
incidence is influenced by underlying co-morbidities, the type of mesh, the surgical technique 
and the strategy used to prevent infections (Falakas and Kasiakow 2005).
A retrospective study including 12,300 patients who underwent sternotomy for cardiac sur-
gery found the use of bone wax to be a risk factor for postoperative sternocutaneous fistulas 
(Steingrimsson et al 2009). Another retrospective study revealed that insertion of a breast im-
plant or tissue expander is an independent risk factor after major breast operation (Olsen et al 
2008a). Furthermore, foreign body implantation increases the risk of SWI after spinal surgery 
(Kanafani et al 2006).
      
2.2.5.2.5 Material for wound closure
Surgical wound closing devices can be divided into three main groups: absorbable and non-
absorbable sutures and, staples. It has been documented that bacteria adhere with different 
affinity to various types of suture materials (Katz et al 1981). A study with a bioluminescent 
in vitro model evaluated bacterial adherence to commonly used sutures: polyglecaprone, a 
synthetic absorbable monofilament suture (Monocryl; Ethicon, Inc. Somerville, New Jersey); 
polypropylene, a synthetic nonabsorbable monofilament suture (Prolene; Ethicon, Inc.); silk, 
nonabsorbable  suture composed of an organic protein (Ethicon, Inc.), polyglycolic, a synthet-
ic absorbable braided suture (Vicryl;.Ethicon, Inc.); and triclosan coated polyglycolic suture 
(Vicryl Plus; Ethicon, Inc). The study found that the Vicryl suture has the highest bacterial 
adherence compared with other examined sutures (Masini et al 2011). 
The risk of developing SWI after orthopedic procedures are found to be over three times 
greater after staple closure than suture closure in a meta-analysis including 683 wounds (Smith 
et al 2010). Likewise, staple closure has been shown to be an independent risk factor for SWI 
after major lower limb amputation (OR 1.69, 95%CI 1.04-2.75) (Coulston et al 2012). However, 
there is no difference in incidence of SWI after infrainguinal bypass surgery (Wolterbeek et al 
2002) or after vein harvesting for coronary artery bypass surgery (Biancari and Tiozzo 2010) 
when comparing staples with sutures for wound closure. 
    
2.2.5.2.6 Blood transfusion
It has been reported that perioperative transfusion of leucocyte-containing allogenic blood in-
creases the risk of SWI in comparison with transfusion of leucocyte-depleted red-cells (Jensen 
et al 1996). Furthermore, there seems to be a higher risk for SWI when transfusing homolo-
gous blood perioperatively compared with transfusing autologous blood (Heiss et al 1994). An 
observational study of cardiac surgery patients found that storage time of red blood cells over 
14 days is positively associated with severe postoperative infection (Andreasen et al 2011).
In a study of 125,000 patients undergoing general surgery procedures, intraoperative trans-
fusion of  packed  red blood cells was an independent risk factor of SWI (OR 1.25, p<0.05) 
(Bernard et al 2009). The findings are analogous to studies with smaller numbers of patients 
(Möhnle et al 2011, Karakida et al 2010). Blood transfusion for mildly anaemic surgical patients 
should be done after careful consideration because of the increased risk for SWI associated 
with transfusion.
2.2.5.2.7 Use of drainage
Drains are often required to remove excess fluid and blood from wound or body spaces. It has 
been clear for decades that to prevent infections drains should not exit through the working 
incision and that closed suction drainage is preferable to open drains (Alexander et al 2011).
15
Drain use after elective uncomplicated open or laparoscopic cholecystectomy and after 
lower limb major amputation increases wound infection rates (Gurusamy et al 2007, Gurusamy 
and Samraj 2007, Coulston et al 2012). However, the use of closed drainage is not shown to 
increase the risk of SWI after thyroid surgery (Gurusamy and Samraj 2007), orthopedic proce-
dures (Parker et al 2007), or colorectal surgery with anastomosis (Karliczek et al 2006).
2.2.6 Prevention
2.2.6.1 Antibiotic prophylaxis
2.2.6.1.1 Systemic antibiotic prophylaxis
A meta-analysis of meta-analyses involving 250 clinical trials strongly supported the hypoth-
esis that antibiotic prophylaxis is beneficial in preventing SWI in all 23 different types of 
surgery included in the study. The relative risk of developing SWI with antibiotic prophy-
laxis versus no prophylactic antibiotics varied from 0.19-0.82. Although the type of antibiotic 
and surgical procedure varied widely in this analysis, the use of prophylactic antibiotics as a 
whole decreased the incidence of SWI by one-half (Bowater et al 2009). 
Some problematic issues arise in the use of antibiotic prophylaxis: there are significant 
costs involved with antibiotic administration; they can have serious adverse effects; and there 
is a risk of the development of antibiotic resistance pathogens or Clostridium difficile colitis 
(Alexander et al 2011). Antibiotic prophylaxis is indicated clearly for most clean-contaminated 
and contaminated procedures. In particular, for procedures where bone is incised (e.g., cra-
niotomy, sternotomy), a prophylactic antibiotic is generally indicated (Barie and Eachempati 
2005). Controversy exists in soft tissue clean surgery procedures. Randomised prospective 
trials or meta-analyses have shown a benefit from antibiotic prophylaxis in breast surgery 
(Terijian et al 2006), varicose vein surgery (Mekako et al 2007), and lower limb arterial revas-
cularisation (Steward et al 2007). It has been found that antibiotic prophylaxis significantly re-
duces the rate of SWI after clean surgery in patients categorised as ASA 2 or ASA 3 risk groups, 
whereas ASA 1 patients undergoing clean surgery do not benefit from antibiotic prophylaxis 
(Iribarren and Araujo 2006). Table 4 lists meta-analyses of efficacy of antibiotic prophylaxis in 
different type of surgical procedures.
The antibiotics used for prophylaxis must be safe and effective against the expected bacte-
ria. The major sources of infection are bacteria form patient’s own skin and, less frequently, 
the alimentary or female genital tract.  The most common pathogens causing postoperative 
SWI are Staphylococcus aureus, followed by coagulase-negative Staphylococcus species and 
Enterococcus (Table 2). In clean and clean-contaminated cases the antibiotic chosen should 
be directed against staphylococci. Single-agent therapy is almost always effective except in 
colorectal operations, small-bowel procedures with stasis, emergency abdominal operations 
in the presence of polymicrobial flora, and penetrating trauma; in such cases, an antibiotic 
with anaerobic coverage is also required (Meakins and Masterson 2005).  First-generation and 
second-generation cephalosporins are preferred agents for most patients in several recom-
mendations (Barie and Eachempati 2005, Brazler and Houck 2005, Meaking and Masterson 
2005). However, a meta-analysis of 90 studies confirmed that prophylactic ceftriaxone, a third 
generation cephalosporin, is more effective than most other prophylactic antibiotics to reduce 
the risk of postoperative SWI, urinary tract infection and pneumonia in procedures with in-
creased risk of these infections (Woodfield et al 2009). 
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At the moment there is no intravenously administered first-generation cephalosporin in the 
market in Finland. Instead, the second- generation cephalosporin, cefuroxime, is the stand-
ard antibiotic used as prophylaxis in Finnish hospitals. Both ceftriaxone and cefuroxime are 
effective against Staphylococcus aureus, coagulase-negative Staphylococcus and Escherichia 
coli, the bacteria that are responsible for majority of the SWIs (Geroulanos et al 2001). In other 
words, ceftriaxone does not have any additional benefit compared with cefuroxime in pre-
venting SWIs. 
In case of β-lactam allergy the alternatives to cephalosporin are clindamycin and vanco-
mycin. Vancomycin or clindamycin may be the preferred antimicrobial prophylaxis in institu-
tions where SWIs caused by MRSA have been detected and for patients with MRSA colonisa-
tion (Mangram et al 1999, Muto et al 2003, Alexander et al 2011).  Vancomycin has also been 
recommended for operative procedures in which prosthetic material is placed and for patients 
undergoing sternotomy or craniotomy. This is, however, a recommendation without strong 
evidence (Alexander et al 2011).
In patients undergoing procedures where Bacteroides fragilis and other anaerobes must 
be covered, metronidazole is recommended with addition of cephalosporin or, in the case of 
β-lactam allergy, gentamicin or a quinolone is recommended with the addition of clindamy-
cin (Alexander et al 2011).
Effective use of prophylaxis in the prevention of SWI depends on correct timing of anti-
biotic administration. A study by Stone and colleagues demonstrated the importance of pre-
operative compared with postoperative antibiotic administration, in contrast to no antibiotic 
prophylaxis, in the prevention of SWI following gastric, biliary or colonic surgery (Stone et 
al 1976). The incidence of SWI was 3% among patients who received systemic cefazolin one 
hour before surgery and 14% among patient who received systemic cephazolin 1-4 hour after 
surgery (Stone et al 1976). Later study in patients undergoing elective clean or clean-contami-
nated surgical procedures confirmed the finding that administration of antibiotic prophylaxis 
within two hours before surgery reduces the risk of SWI (Classen et al 1992). 
The chosen antibiotic should be given at a time that allows for maximum tissue concen-
tration at the time of incision (Anderson 2011). When cefuroxime is used as a prophylactic 
antibiotic, administration 30-59 minutes before incision was found to be more effective than 
administration during the last half hour (Weber et al 2008). In general, antibiotic prophylaxis 
should be given 15-90 min before surgical incision and the timing of administration depends 
of the half-life of the drug (Esposito 1999).
According to a systematic review of 28 prospective randomised studies comparing single 
versus multiple doses of prophylactic antibiotic in major surgery procedures, there is no addi-
tional benefit of more than a single dose of antibiotic (McDonald et al 1998). Administration of 
a second dose of antibiotic prophylaxis is recommended only if the operation exceeds either 3 
hours, or twice the half-life of the antibiotic, or if a massive haemorrhage occurred (Meakins and 
Masterson 2005). However, a meta-analysis of 12 studies with 7,900 patients undergoing open 
heart surgery revealed that perioperative antibiotic prophylaxis of more than 24 hours may be 
more efficacious in preventing sternal wound infection compared to shorter regimens (Mertz et 
al 2011). Another meta-analysis with 59 trials concluded that antibiotic prophylaxis prolongation 
up to 48 hours after cardiac surgery might be beneficial (Lador et al 2012). In noncardiac thoracic 
surgery a single dose of antibiotic is recommended (Chang and Krupnick 2012). 
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Table 4. Efficacy of antibiotic prophylaxis against SWI.The most recent meta-analyses of different 
type surgical procedures.
study Procedure Number of 
studies/
patients
Incidence of 
sWI antibiotic/
placebo
Or / rr 95% cI
Barker 2002 Spinal surgery 6 / 843 2.2% / 5.9% OR 0.37 0.17-0.78
Andersen et al 
2005
Appendicectomy 47 / 8812 6.5% / 14.4% OR 0.33 0.29-0.38
Sanabria et al 
2006
Blunt or penetrating 
chest trauma with 
chest tube
5 /614
1.1% / 7.6% e
6.6% / 16% p
RR
0.19
0.44
0.07-0.5
0.27-0.73
Terijian et al 
2006
Breast surgery 5 / 1307 9.3% / 15.5% RR 0.54 0.32-0.91
Barker 2007 Craniotomy 6 / 1729 1.1% / 2.7% OR 0.43 0.2-0.92
Sanchez-
Manuel et al 
2007
Inguinal hernia repair 12 / 6705 2.9% / 3.9 % OR 0.64 0.48-0.85
Steward et al 
2007
Peripheral arterial 
reconstruction
10 / 1297 4.1% / 15.7% RR 0.25 0.17-0.38
AlBuhairan et 
al 2008
Total 
jointarthroplasty
7 / 3065 2.0% / 7.7% RR 0.19 0.12-0.31
Nelson et al 
2009
Colorectal surgery 10 / 813 10.2% / 38.6% RR 0.30 0.22-0.41
Smaill and 
Gyte 2010
Cesarean section 77 / 11961 3.6% / 9.5% RR 0.39 0.32-0.48
Gillespie 2010 Closed long 
bonefractures
7 / 3500 3.5% / 5.0% 
(sSWI)
1.1% / 2.5% 
(dSWI)
RR 0.69
RR 0.40
0.50-0.95
0.24-0.67
Yan et al 2011 Laparoscopic 
cholecystectomy
12 / 1990 3.5% / 3.3% OR  1.11 0.68-1.82
OR= odds ratio, RR=risk ratio, SWI=surgical wound infection, sSWI=superficial SWI, dSWI=deep SWI, 
e=empyema, p=pneumonia
2.2.6.1.2 Topical antibiotics
The local delivery of antibiotic at the surgical site has received very limited approval in any 
surgical prophylaxis consensus guidelines. Compared with systemic antibiotics delivery, the 
use of topical delivery of antibiotics has some advantages as well as disadvantages (Lipsky 
and Hoey 2009, McHugh et al 2011). The benefits of local application include high concentra-
tion, the limited potential for toxicity, reduced use of antibiotics, and, possibly, decreased de-
velopment of antibiotic resistance. The use of topical antibiotics may cause hypersensitivity, 
contact dermatitis or may disturb the wound healing (Lipsky and Hoey 2009).
In a randomised controlled trial with 972 minor dermatology surgery patients, the incidence of 
SWI was 6.6% in the group with a single topical dose of chloramphenicol and 11.0% in the control 
group, (p=0.01) (Heal et al 2009). The effectiveness of local antibiotics in prevention of SWI has also 
been studied in cardiac surgery patients. A prospective study with 416 patients showed that local 
application of vancomycin to the cut sternal edge independently reduces the risk of sternal wound 
infection (Vander et al 1989). Another study with 2,741 patients undergoing cardiac surgery re-
vealed that the use of local gentamicin reduces the risk of SWI with an RR of 0.47, 95% CI 0.33-0.69 
(Friberg et al 2005). In contrast, a study with 1,502 cardiac surgical patients at high risk for sternal 
wound infection (diabetes, body mass index >30, or both) did not find the use of local gentamicin 
to be effective in prevention of SWI (Bennet-Guerrero et al 2010a).
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A prospective study of 221 colorectal surgery patients tested whether the use of a local 
gentamicin-collagen sponge reduces the risk of SWI. In that study, the incidence of SWI was 
5.6% in the gentamicin-collagen group and 18.4% in the control group (p<0.01) (Rutten and Nijhus 
1997). However, a recent study with 602 colorectal surgery patients resulted in a higher inci-
dence of SWI in the local gentamicin group compared with the control group (30% and 20.9% 
respectively, p=0.01) (Bennet-Guerrero et al 2010b). Two prospective studies were conducted 
to reveal the effect of local gentamicin use in wound healing after sinus pilonidal surgery. A 
study with 80 patients found local gentamicin to decrease the rates of infection and recurrence, 
and shortened the hospital stay (Yetim et al 2010). Whereas, a study with 161 patients showed 
no significant differences in the rates of wound infection, wound healing, and recurrences when 
local gentamicin-collagen sponge was used (Andersson et al 2010).            
2.2.6.2 Triclosan-coated sutures 
2.2.6.2.1 Triclosan
Triclosan (2,4,4’-trichloro-2’hydroxy-diphenylether) is a synthetic, lipid-soluble, broad spec-
trum antimicrobial agent used in humans for 40 years, mainly in soaps, toothpaste and cos-
metics. The use of triclosan is controlled by the US Food and Drug Administration (FDA), the 
US Environmental Protection Agency (EPA) and the European Union’s Scientific Committee 
on Consumer Products (SCCP).
For many years, the mode of antibacterial action of triclosan was supposed to be through 
non-specific disruption of a cell membrane (Slater-Radosti et al 2001). Later studies, however, 
have revealed that triclosan targets fatty acid synthesis by inhibiting the enzyme enoyl reduc-
tase (enoyl-acyl carrier protein reductase [ENR], FabI) (McMurry et al 1998). At low concentra-
tions, triclosan is bacteriostatic by inhibiting the bacterial fatty acid synthesis.  At higher con-
centrations triclosan is bactericidal by attacking different structures in the bacterial cytoplasm 
and cell membrane (Russell 2004, Escalada et al 2005, Yazdankhah et al 2006). 
Triclosan is effective against numerous, but not all, types of gram-positive and gram-nega-
tive bacteria. It has also some antifungal, antiviral and anti-mycobacterial activity (Dellano et 
al 2009, Saleh et al 2010) and, it inhibits the growth of Plasmodium falciparum and Toxoplasma 
gondii (McLeod et al 2001).
2.2.6.2.2 Triclosan-coated sutures in prevention of surgical wound infection
All commonly used surgical sutures can become contaminated by various bacteria. It has 
been shown that braided sutures have greater inflammatory response than monofilament 
sutures (Masini et al 2011), and that the presence of contaminated suture materials increases 
the risk of SWI (Katz et al 1981).
To prevent microbial colonisation of suture material and surgical wound contamination, 
triclosan-coated polyglactin 910 (Vicryl Plus; Ethicon, GmbH) and triclosan-coated polygle-
caprone 25 (Monocryl Plus; Ethicon, GmbH) with antibacterial activity were developed.
 In studies based on in vitro models, triclosan-coated sutures have shown antibacterial 
efficacy against Staphylococcus aureus, Staphylococcus epidermidis, methicillin-resistant 
Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), 
Escherichia coli, Klebsiella pneumoniae, Staphylococcus hominis, Staphylococcus haemolyti-
cus, Staphylococcus auricularis, Enterococcus faecalis and Corynebacterium so (Rothenburger 
et al 2002, Edminston et al 2006, Gomez-Alonzo et al 2007, Ming et al 2008). The effect against 
Staphylococcus aureus, Staphylococcus epidermidis and E coli has also been demonstrated in 
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vivo in mouse, guinea pig and Sprague-Dawley rat models (Stroch et al 2004, Marco et al 2007, 
Ming et al 2008).
There is no evidence that long-term application of triclosan products to skin selects for tri-
closan-resistant populations. It is most unlikely that short-term exposure of triclosan within 
suture materials would cause development of resistance (Gilbert and McBain 2002). Animal 
model studies have not revealed triclosan to be carcinogenic, genotoxic or teratogenic. A le-
thal dose (LD) is an indication of the lethality of a given substance with the LD50 being the 
median lethal dose of toxin required to kill half of the members of tested population. Dermal 
exposure of triclosan in rabbits resulted in an LD50 value >9,300 mg/kg. It is considered that 
LD50 values of 2,000-5,000 mg/kg indicate that a material offers relatively safety.  The use of 
triclosan-coated sutures provides very low exposure levels of triclosan and does not result in 
any toxicity that would compromise safety (Barbolt 2002). One prospective randomised trial 
has shown an increased risk for surgical wound dehiscence related to use of triclosan-coated 
sutures (Deliaert et al 2009).
 Although there is no clear evidence that antibacterial sutures would be effective in reduc-
ing the risk of postoperative SWI, triclosan-coated sutures are being used in many hospitals 
for that particular reason. The randomised prospective trials of triclosan-coated sutures in 
prevention of SWI are presented in Table 5. In six studies with adult patients undergoing gas-
trointestinal surgery, breast surgery, or head and neck surgery, and, in one study, with paedi-
atric patients undergoing various surgical procedures, the use of triclosan-coated sutures did 
not have an effect on incidence of SWI (Ford et al 2005, Mingmalairak et al 2009, Zhang et al 
2011, Chen et al 2011, Baracs et al 2011, Williams et al 2011). Furthermore, a meta-analysis of 
seven randomised prospective trials did not find triclosan-impregnated sutures to reduce the 
incidence of SWI (OR 0.77, 95% CI 0.21-5.43) (Chang et al 2012).   
Wound closure with triclosan-coated polyglactin 910 sutures reduced significantly the risk 
of SWI after different surgical procedures in a trial involving 450 patients and conducted in 
Egypt at Cairo University Hospital. The results from a single hospital were reported although 
the trial was multicenter. The study included various surgical procedures from lipoma re-
moval to vascular surgery (Galal and El-Hindwy 2011). Wound closure with triclosan-coated 
sutures was associated with a reduced risk of infection in cerebrospinal fluid surgery (Rozelle 
et al 2008). 
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Table 5. Triclosan-coated sutures in prevention of surgical wound infections (SWI). Prospective 
randomised studies
study Number 
of 
patients
surgical 
procedures
blinding follow-
up 
period
sWI rate: stu-
dy vs. control 
goup
Univariate 
p
Ford  
et al 2005
147 Various pediatric 
surgery 
procedures
No 3% vs. 0% NS
Rozelle  
et al 2008
61 Implantation of 
cerebrospinal fluid 
shunting devices
Double 
blind
6 months 4.3% vs. 21% 0.038
Mingmalairak 
et al 2009
100 Appendicectomy Double 
blind
1 year 10% vs. 8% 0.05
Galal and 
El-Hindawy  
2011
450 Various different 
procedures
Double 
blind
7% vs. 15% 0.011
Zhang  
et al 2011
101 Mastectomy No 90 days 4.3% vs. 11.1% NS
Chen  
et al 2011
241 Head and neck 
cancer surgery
No 14.9% vs. 14.7% NS
Baracs  
et al 2011
485 Colorectal surgery No 12.2% vs. 12.2% NS
Williams  
et al 2011
150 Brest cancer sur-
gery
Double 
blind
6 weeks 15.2% vs 22.9% NS
NS=Non-significant SWI=surgical wound infection 
2.2.6.3 Supplemental oxygen in prevention of surgical wound infection
As discussed earlier in section 2.1.3., oxygen is vital for wound healing. The association be-
tween supplemental perioperative oxygen and the risk of SWI has been studied for different 
types of surgical procedures. The prospective randomised studies that have investigated the 
effect of supplemental inspired oxygen on incidence of SWI are listed on Table 6. In one study 
the patients were randomly assigned to receive either 2 litres (L) of oxygen by nasal cannula 
(standard care) or 10 L of oxygen by nonrebreather mask (intervention group) (Scifres et al 
2011). In the other 8 studies, patients were randomly assigned to receive either 80% oxygen or 
30-35% oxygen during surgery.  In one study supplemental oxygen delivery continued for 6 
postoperative hours (Belda et al 2005), and in another study supplemental 80 % oxygen was 
administered during the surgery only (Myles et al 2007). In the rest of the studies, the sup-
plemental 80 % oxygen delivery continued 2 hours postoperatively (Grief et al 2000, Pryor et 
al 2004, Mayzler et al 2005, Gardella et al 2008, Meyhoff et al 2009, Bickel et al 2011, Scifres et 
al 2011).
Four of the studies have shown that supplemental inspired oxygen reduces the risk of SWI. 
However, four studies did not find any difference in incidence of SWI between study and 
control groups, but another study found supplemental oxygen to be an independent risk fac-
tor for SWI. In a meta-analysis of 5 randomised controlled trials with 3001 patients the use of 
perioperative inspired supplemental oxygen was protective against SWI with risk ratio RR of 
0.556 (95% CI, 0.383-0.808, p=0.002) (Qadan et al 2009). Another meta-analysis did not reveal 
any significant effects of supplemental perioperative oxygen on risk of SWI after colorectal 
surgery. However, supplemental oxygen appeared to confer a mortality benefit with OR of 
0.18 (95% CI, 0.05-0.69, p=0.01) (Brar et al 2011).  
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Table 6. Supplemental oxygen in prevention of surgical wound infection
   
study Number of 
patients
surgical 
procedures
follow-up 
period
sWI rate:  study 
vs. control group
p value
Grief et al 
2000
500 Colorectal resection 15 days 5.2% vs. 11.2% p=0.01
Pryor et al 
2004
165 Major intra-
abdominal 
procedure
14 days 25% vs. 11.3% p‹0.001
Belda et al 
2005
291 Colorectal surgery 14 days 14.9% vs. 24.4% p=0.04
Mayzler et al 
2005
38 Colorectal surgery 30 days 12.5% vs. 17.6% p=0.54
Myles et al 
2007
2,050 Non-cardiothoracic 
surgery
30 days 7.7% vs. 10% p=0.03
Gardella et al 
2008
143 Cesarean delivery 14 days 25% vs. 10% p=0.13
Meyhoff et al 
2009
1,400 Abdominal surgery 14 days 19.1% vs. 20.1% p=0.64
Bickel et al 
2011
210 Open 
appendectomy
14 days 5.6% vs. 13.6 % p=0.04
Scifres et al 
2011
585 Cesarean delivery 30 days 11.5% vs. 8.8% p=0.28
SWI=surgical wound infection
Exposure to high-dose (100%) oxygen can cause pulmonary absorption atelectasis (Rothen 
et al 1995). In contrast, low-flow supplemental oxygen is regarded as quite safe (Benditt 2000) 
and a randomised prospective study showed that the incidence and severity of atelecta-
sis were comparable in patients given 30% and 80% perioperative oxygen (Akca et al 1999). 
Furthermore, none of the studies listed in Table 6 have reported increased pulmonary compli-
cations associated with supplemental perioperative oxygen administration.
It seems plausible, that supplemental inspired oxygen is safe and it could be advantageous 
in preventing SWI. In addition, supplemental perioperative oxygen is a low-cost intervention.
2.2.6.4 Other methods for preventing surgical wound infection 
Most SWIs are caused by skin organisms and, consequently, the number of bacteria colonising 
the skin should be decreased preoperatively. Preoperative bathing with chlorhexidine reduces 
pathogenic organisms on the skin but has a non-significant reduction in SWIs (Alexander et al 
2011, Anderson 2011, Webster and Osborne 2011). 
To decrease bacterial colonisation and prevent SWI, the surgical site is preoperatively 
scrubbed with antiseptic agents.  There is clear evidence that preoperative cleansing with 
chlorhexidine-alcohol decreases the risk of SWI compared with preoperative cleansing with 
povidone-iodine (Darouiche et al 2010, Noorani et al 2010, Levin et al 2011).   
It has been showed earlier that local intraoperative warming improves tissue oxygenation 
and presumably decreases the risk of SWI (Ikeda et al 1998). Furthermore, the systemic warm-
ing perioperatively reduces the blood loss and complications in surgical patients (Wong et al 
2007). A meta-analysis of 25 studies with 3599 patients revealed that perioperative warming 
significantly reduces the risk of SWI and postoperative pain (Sajid et al 2009). There are sev-
eral techniques for the warming of surgical patient perioperatively: simple cotton blankets, 
carbon-fibre sheets, circulating hot water mattresses, forced air warming, warm fluid infu-
sion, and oesophageal heat exchange systems (Sajid et al 2009).
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Handling tissue gently, minimising devitalised tissue and eradicating dead space at the 
surgical site are recommended to avoid SWI (Mangram et al 1999). However, there are rela-
tively few large or rigorously well-conducted studies on surgical techniques and their impact 
on SWI (McHugh et al 2010). 
There are studies that have compared the effect of intraoperative antiseptic lavage on the 
SWI rate, but their results are controversial (Angelini et al 1990, Bausz et al 2006). Therefore, a 
meta-analysis of 24 randomised controlled trials with 5,004 abdominal surgery, general sur-
gery, gynaecological surgery and spinal surgery patients was conducted to assess effective-
ness of intraoperative povidone-iodine (PVI) in the reduction of SWI. The meta-analysis re-
vealed that intraoperative PVI application significantly reduces the rate of SWI (RR 0.58, 95% 
CI 0.4-0.83; p=0.003) (Fournel et al 2010).
Despite the fact that hyperglycaemia is associated with the development of SWI, it is not 
proven that tight glycaemic control would decrease the incidence of SWI (Kao et al 2009). 
Thus, current recommendations state that control of diabetes mellitus should be improved 
before surgery and postoperative serum glucose concentration should be maintained at less 
than 11 mmol/l (200mg/dl) for the first 48 hours after surgery (Anderson 2011).
Even though there is no clear evidence that malnutrition increases the risk of SWI, sup-
plemental immunomodulating enteral diet reduces the risk of postoperative infections and 
wound complications in high-risk patients undergoing major surgery (Marik and Zaloga 2010). 
Wound dressings, applied after wound closure, are widely used to provide physical sup-
port, protection from bacterial contamination and absorb exudate. The CDC guidelines rec-
ommend protecting incision with sterile dressing for 24 to 48 hours. However, a review of 16 
randomised controlled trials did not find evidence that covering surgical wounds with dress-
ing reduces the risk of SWI (Dumville et al 2011).
Staphylococcus aureus nasal carriage increases the risk of SWI (see section 2.2.5.1.5) and 
the eradication of those bacteria should be taken into consideration. Furthermore, a review of 
4 studies with 686 patients showed that treatment with mupirocin significantly decreases the 
incidence of SWI among surgical patients with Staphylococcus aureus nasal carriage (RR 0.55, 
95%CI 0.34-0.89) (van Rijen et al 2008).
2.3 sUrGIcaL WOUND INfEctION aftEr VascULar sUrGEry  
2.3.1 Incidence
The majority of arterial surgery procedures are classified as clean surgery by the National 
Research Council because the operative exposure and revascularisation is performed in un-
infected tissues without inflammation and, the alimentary, respiratory or urinary tract is not 
entered (Bandyk 2008). Lower limb revascularisation surgery has been widely proven to be ef-
fective for the management of both claudication and critical limb ischaemia. According to the 
NNIS report with almost 85,000 surgical procedures the incidence of SWI after clean surgery 
is 2.1% (Culver et al). However, the incidence of surgical wound complication, either infection 
or failure to heal, after lower limb revascularisation surgery remains high compared with 
other clean surgery procedures.
Infection involving a vascular surgical wound may be superficial or deep or, the infection 
may involve vascular graft or operated native artery. For autogenous arterial revascularisa-
tions, only infections occurring within 30 days are classified as SWI, but when prosthetic graft 
is implanted the incidence of SWI is calculated for one year (Bandyk 2008).
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There is an extensive variation in the reported incidence of SWI after lower limb vascular 
surgery. In prospective studies with the number of patients ranging from 69 to 561, the inci-
dence of SWI was found to be between 3.5% and 32% (Richet et al 1991, Chester et al 1992, 
Josephs et al 1993, Murphy et al 1995, Kent et al 1996, Ploeg et al 2009, Virkkunen et al 2009, 
Linni et al 2012).
The rate of SWI varies among different types of vascular surgery procedures. The inci-
dence of SWI, including patch infection after carotid surgery is 0.2-0.5% (Greenstein et al 
2007, Knight and Tait 2009). Open abdominal aortic surgery is associated with 2.4-6.3% risk of 
30-day SWI (Giles et al 2010), and 0.44-1.9% risk of graft infection (Vogel et al 2008, Prager et 
al 2001). In a retrospective analysis with 12,626 open abdominal aortic aneurysm reconstruc-
tions, the risk of developing graft infection was highest during first postoperative year: 32% of 
all graft infections developed during the first year after surgery (Vogel et al 2008). For vascular 
access, created for haemodialysis, infection risk depends on the access material. Infection risks 
related to arteriovenous fistula and arteriovenous prosthesis are 0.9% and 9.1%, respectively 
(Schild et al 2008). In prospective studies, the incidence of SWI after varicose vein surgery has 
been reported to vary between 5-14% (Defty et al 2008, Mekako et al 2010). It seems plausible 
to draw a conclusion that vascular surgery procedures including lower limbs are associated 
with a relatively high risk of SWI. SWI rates after vascular surgery procedures reported by 
various studies are presented in Table 7.
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Table 7. Reported rates of surgical wound infection after different type vascular surgery procedures
study/ Number 
of patients
type of revascularisation 
procedure
follow-up 
period
ssI rate
Greenstein et 
al 2007
Retrospective/
9308
Carotid endarterectomy 30 days 0.2%
Vogel et al 
2008
Retrospective / 
12,626
Open abdominal aortic 
aneurysm repair
2 years  0.19%
AGI: 0.5%
Murphy et al 
1995
Prospective / 114 Proximal  25%
Infrainguinal 75%
14 days 3%
Chester et al 
1992
Prospective ran-
domised / 149
Proximal 9%
Extra-anatomical 5%
Infrainguinal 71%
30 days 3.5%
Josephs et al 
1993
Prospective / 69 Proximal 35%
Extra-anatomical 17%
Infrainguinal 52%
4%
Schild et al 
2008
Retrospective / 
1,700
Haemodialysis access 4.5%
Wolterbeek et 
al 2002
Prospective ran-
domised / 170
Infrainguinal 100% 3 weeks 6%
Giles et al 2010 Retrospective / 
7,595
Proximal 21 %
Infrainguinal 79%
11%
Greenblatt et al 
2011
Retrospective / 
12,330
Extra-anatomical 11%
Femoral endarterectomy 15%
Infrainguinal 74%
30 days 11%
Kent et al 1996 Prospective / 119 Proximal 14%
Extra-anatomical 10%
Femoral endarterectomy 7%
Infrainguinal 58% 
6 weeks 15%
Virkkunen et al 
2004
Retrospective / 
5709
Proximal 10%
Extra-anatomic 16%
Femoral endarterectomy 9%
Infrainguinal 61%
30 days 12.8%
Lee et al 2000 Retrospective / 
978
Infrainguinal 100% 13%
Nguyen et al 
2007
Retrospective / 
1404
Infrainguinal 100 % 20%
Vriesendorp et 
al 2004
Retrospective / 
275
Femoral endarterectomy 8%
Infrainguinal 78%
23%
Linni et al 2012 Prospective ran-
domised / 103  
Infrainguinal 100% 12 months 30%
Ploeg et al 
2009
Prospective ran-
domized / 171
Proximal 15%
Extra-anatomical 15%
Infrainguinal 70%
6 weeks 32%
Proximal: aorto-iliacal, aorto-femoral or iliaco-femoral reconstruction; Extra-anatomical: femoro-femoral, 
axillo-femoral or iliacofemoral bypass; SSI: surgical site infection; AGI: aortic graft infection
2.3.2 Risk factors for surgical wound infection after lower limb vascular surgery
The greater likelihood of SWI occurrence in the peripheral vascular-surgery patients com-
pared with other clean-surgery patients is due to both procedure and patient-related factors. 
The risk of deep graft infection following vascular prosthesis implantation is 1-5% (Wilson 
2001). However, the use of a vein graft has remained to be associated with indreased risk 
of SWI compared with use of prosthetic graft or use of no graft (O’Brien et al 2011). That 
is most probably related to long exposures needed for vein harvesting. Furthermore, graft 
placed mainly in the subcutaneous location instead of subfascial location increases the risk of 
SWI, with RR of 11.6, in patients undergoing infrainguinal bypass surgery (Blankensteijn et 
al 1996). Prolonged operation time is associated with SWI (Chang et al 2003, Greenblatt et al 
2011), which is speculated to be due to patient hypothermia, inadequate redosing of antibiotic, 
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retractor-related tissue trauma and breaks in sterile technique (Greenblatt et al 2011). Previous 
arterial surgery in the groin, earlier arteriographic procedure performed via operation site, 
and the use of wound drainage, have also shown to increase the risk of SWI (Landreneau and 
Raju 1981, Derksen et al 2009).  
Incisions for vascular access at the groin may be either vertical crossing through the lym-
phatic tissue or oblique sparing all lyphatic tissue. Many surgeons prefer a vertical incision 
because it offers a direct approach and full exposure of femoral artery. However, the surgical 
thecnique used for vertical groin incision is associated with increased risk of wound compli-
cation and infection rate (Chester et al 1992, Beirne et al 2008, Swinnen et al 2012). 
Infection of vascular prosthetics implanted for arterial occlusive disease occurs in ap-
proximately 1-5% of patients. The incidence of infection depends on the anatomical site, with 
the highest rate occurring in vascular access grafts placed for haemodialysis and in inguinal 
and lower extremity incisions in patients undergoing bypass procedures for femoral, pop-
liteal or tibial occlusion (Wilson 2001).  No difference has been found in the incidence of SWI 
when using either Polyester (Dacron) or polytetrafluoroethylene (ePTFE) vascular prostheses 
(Davidovic et al 2010).
Factors that increase the risk of aortic graft infection are graft contamination from skin 
flora during surgery, groin incision, graft revision, superficial SWI, emergency operation and 
postoperative bacteraemia (Perera et al 2006). 
A study with 12,330 patients who underwent open surgery for lower limb peripheral vas-
cular disease found obesity to be an independent risk factor for SWI development (OR 2,1, 
95% CI 1.8-2.4) (Greenblatt et al 2011). Furthermore, obesity has increased the risk of SWI after 
peripheral artery surgery in other studies with smaller number of patients with an OR vary-
ing between 1.7 and 2.6 (Lee et al 2000, Giles et al 2010a, Patel et al 2007). In addition, morbid 
obesity (BMI≥40 kg/m2) has found to be an independent risk factor for SWI after open aortic 
aneurysm repair with an OR of 2.6 (Giles et al 2010b). 
The reasons for higher risk of SWI in obese patients may be tissue hypoxia and low anti-
biotic concentration. Wound and tissue oxygen tension has been found to be reduced during 
surgery among obese patients and this is associated with increased SWI risk (Kabon et al 
2004).  Pharmacokinetic analysis has revealed that Cephazolin, used as prophylactic antibi-
otic, has a reduced concentration within adipose tissue in obese patients compared to lean 
patients (Pevzner et al 2011).   
Critical limb ischaemia manifests as chronic rest pain, nonhealing ulcers and gangrene 
and, patients with contaminated ulcers remote from surgical wound may be in the risk of 
endogenous bacterial contamination via bloodstream or lymphatic system. A retrospective 
study with 756 patients has shown that critical ishaemia with rest pain, ischaemic ulcer or 
gangrene (Fontaine III-IV), independently increase the risk of SWI after lower limb vascular 
surgery (OR 4.195%CI 1.88-8.88) (Ott et al 2012). 
Other patient-specific risk factors for SWI in lower limb vascular surgery include diabetes 
mellitus, postoperative hyperglycaemia, COPD, female gender, and dialysis (Richet et al 1991, 
Josephs et al 1993, Lee et al 2000, Vriesendorp et al 2004, Patel et al 2007, Greenblatt et al 2011). 
COPD may be a risk factor to SWI owing a lowered oxygen delivery. An explanation of the as-
sociation between female gender and inguinal SWI is thought to be gender-related differences 
in the amount and distribution of body fat and native skin flora (Greenblatt et al 2011). Patients 
with chronic renal failure and uraemia have impaired host defences and wound healing that 
can lead to increased risk of SWI (Chang and Wong 2001). 
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2.3.3 Causative agents
The most common causative agent associated with SWI after lower limb arterial surgery is 
Staphylococcus aureus which has been isolated from 33-60 % of infected wounds (Calligaro 
et al 1994, Pounds et al 2005). Methicillin-resistant Staphylococcus aureus has been report-
ed to be responsible for 30-50% of Staphylococcus aureus wound infections in the United 
States (Calligaro et al 1994, Lee et al 2000, Pounds et al 2005). The other causative bacteria 
are as follows: Staphylococcus epidermidis 17-24%, Streptococcus 19%, Pseudomonas 12-20%, 
Enterococcus 6-12%, E coli 2-8% and Enterobacter 3- 9% (Himbeeck et al 1992, Calligaro et al 
1994, Lee et al 2000, Pounds et al 2005).
Early prosthetic vascular graft infections are usually owing to Staphylococcus aureus or, in 
the case of aortoenteric fistulae, gram-negative species (Legout et al 2011). Late infections often 
involve more indolent species such as Staphylococcus epidermidis (Perera et al 2006). 
2.3.4 Consequences of surgical wound infection after lower limb vascular surgery
2.3.4.1 Impact on patient outcome
Although most of the SWIs after vascular surgery procedures heal with treatment (Himbeeck 
et al 1992, Calligaro et al 1994), they may be a significant source of morbidity. Surgical wound 
infection increases the risk of graft failure requiring intervention (Giles et al 2010, Greenblatt 
et al 2011). Reported incidence of major amputation owing to SWI ranges from 2 to 25% being 
highest as a result of vascular graft infection (Pounds et al 2005, Nguyen et al 2007). Several 
studies have not found association between SWI and 30-day mortality (Himbeeck et al 1992, 
Stone et al 2010, Greenblatt et al 2011).
Especially problematic are epidemics of multiresistent bacteria; a matched case-control 
study revealed that an outbreak of multidrug-resistant Pseudomonas aeruginosa in vascu-
lar surgery ward was associated with decreased short-term amputation-free survival after 
infrainguinal bypass surgery in patients with critical limb ischaemia (Söderström et al 2009).
Mortality owing to prosthetic vascular graft infection has been variously reported to be 11-
20% and 6.5-11% owing to lower limb prosthetic vascular graft infection (Calligaro et al 1994, 
Pounds et al 2005, O’Brien et al 2011, Legout et al 2011).  Aortic graft infection increases the 
mortality with OR of 5.6 (95% CI 1.1-28.7) (Legout et al 2011). 
2.3.4.2 Impact on resource utilisation
Surgical wound infection causes additional costs of vascular surgery procedures by delaying 
recovery, increasing the length of stay (LOS), and necessitating the need for additional treat-
ment. Length of stay is increased by 2-14 days because of SWI (Giles et al 2010, O’Brien 2011), 
and it has been calculated, in 1996, that cost of one SWI is €405 per infected patient (Kent et al 
1996). A database register study, conducted in the United States, with 870,000 elective vascular 
surgical procedures, including aortic, endovascular and lower limb revascularisation proce-
dures, was performed to describe the infectious complications after elective vascular surgery. 
In that study, nosocomial infections increased the LOS from 4.2 to 13.8 days and the hospital 
costs from $12,000-38,000 (€9,000-29,000) (Vogel et al 2010).
      
2.3.5 Treatment of surgical wound infection after vascular surgery
The basic treatment of SWI is to open and drain the wound, and to remove the necrotic tissue. 
Culture should be performed to identify the source of infection and antimicrobial therapy 
should be adjusted. Superficial incisional infections can often be treated with oral antibiotics 
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only, without surgical debridement (Anderson 2011).
Treatment of vascular prosthetic graft infection remains a challenging problem. Traditional 
management of infected arterial grafts included total graft revision and complex extra-anatom-
ical or venous revascularisation procedures. Since such management is associated with high 
mortality (26-34%) and limb loss rate (23-36%) (Liekweg and Greenfeld 1977, Lorentzen et al 
1985), techniques for partial and total graft preservation have been developed. However, re-
moval of the entire infected graft is still essential in patients who present systemic sepsis or with 
infected disrupted anastomoses or anastomotic bleeding (Calligaro et al 1994, Rutherford 2000).
In a study of 120 patients with infected extracavitary prosthetic arterial grafts (95 PTFE 
and 25 Dacron), complete or partial graft preservation was attempted in 94 (78%) patients. The 
hospital mortality rate was 12% and the hospital amputation rate among survivors was 13 % 
(14/106). Patient treated by complete graft preservation, the long term complete graft preserva-
tion was successful in 71% (32/45) of cases. Partial graft preservation was successful in 85% 
(34/41) of surviving patients with occluded grafts (Calligaro et al 1994). Another study with 
40 grafts (24 prosthesis, 3 vein and 13 biological) and 9 native arteries, reported 91% complete 
wound healing rate when, after radical debridement and graft preservation, negative pressure 
wound therapy was applied directly on the infected graft/wound. There was no difference 
in outcome between the various graft types involved (Mayer et al 2011). Coverage of exposed 
prosthetic material in the groin with a muscle flap may be an effective option for decrease 
morbidity, and to increase limb and graft salvage (Morasch et al 2004, Herrera et al 2009).
2.3.6 Prevention
There is a clear evidence of the benefit of prophylactic broad-spectrum antibiotics for vascular 
reconstruction (Steward et al 2007). A meta-analysis of 34 studies was conducted to evaluate the 
evidence for effectiveness of interventions to prevent wound and graft infection in peripheral 
vascular reconstructions. Of these trials, 22 were trials of systemic antibiotics. The meta-analysis 
demonstrated that prophylactic treatment with systemic antibiotics administered immediately 
preoperatively reduces the risk of wound infection and early graft infection between two thirds 
and three quarters (Steward et al 2007). Broad-spectrum cephalosporins, penicillin/β-lactamase 
inhibitors, or aminoglycosides would appear to confer similar benefits, and a 24-hour regimen 
of antibiotics appears to be an effective prophylaxis (Steward et al 2007).
Suction drains are commonly used to prevent postoperative haematoma formation. 
However, the use of drainage has shown to increase the risk of SWI (Landreneau and Raju 
1981, Derksen et al 2009), and a meta-analysis of four trials revealed that the use of drainage 
confers no benefit following lower limb revascularisation (Karthikesalingam et al 2008). On 
the other hand, a postoperative incisional haematoma has been associated with SWI develop-
ment (Lee et al 2000). Thus it seems plausible that both meticulous haemostasis and avoidance 
of surgical drainage would decrease the risk of SWI. In addition, efforts to reduce operation 
time, for example by using a “double-team”, would be beneficial since prolonged operation 
time is associated to SWI (Chang et al 2003, Greenblatt et al 2011). 
Two retrospective studies (n=149, n=196) have revealed that oblique incision for vascular 
access at groin significantly decreases the incidence of SWI compared with vertical incision 
(Chester et al 1992, Beirne et al 2008).  But, a later study using prospective collected data 
(n=171) showed no difference in incidences of SWI between direct and oblique groin incisions 
(Ploeg AJ et al 2009). 
A study with dogs indicated that a gelatin-sealed graft pre-bonded with two antibiotics 
resists infection caused by S aureus graft contamination (Javerliat et al 2007).  Thus, the risk of 
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SWI could be reduced by using rifampicin-bonded vascular graft when vein is not available. 
A prospective randomised study with 216 patients evaluated that postoperative silver-eluting 
dressing system decreases the wound complication rate (Childress et al 2007).
A meta-analysis of 21 studies with 2,799 patients undergoing coronary artery bypass sur-
gery showed that open saphenous vein harvesting compared with minimally invasive vein 
harvesting increases the risk of SWI (OR 3.85 95%CI 2.53-5.86) (Markar et al 2010). Using the 
minimally invasive vein harvest technique for lower limb revascularisation surgery could 
also be beneficial in order to avoid SWI. A further study in the relationship between vein har-
vesting technique and SWI should be conducted.
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3 The aims of the study
The overall aim of this study was to evaluate the pathophysiology, risk factors, incidence and 
consequences of SWI after lower limb vascular surgery, and to assess preventive measures in 
the SWI prophylaxis.
The specific aims were:
1. To determine the incidence of SWI, to evaluate the risk factors and conse-
quences of SWI, and to calculate the additional cost of services caused by SWI
2. To investigate whether bacterial flora on surgical site peri- and postoperatively 
has an effect on the development of surgical wound infection after lower limb 
vascular surgery. 
3. To test whether triclosan-coated sutures are effective in the prevention of SWI 
after lower limb vascular surgery
4. To test whether postoperative supplemental inspired oxygen is effective in the 
prevention of SWI after lower limb vascular surgery
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4 Patients and methods
4.1 PatIENts
 
The present study included adult 803 patients who underwent nonemergency lower limb arte-
rial surgery and 25 patients who underwent nonemergency aortic surgery. The characteristics 
of the patients and procedures are presented in Table 8.
4.1.1 Study I
The multicentre prospective observational study included 184 adult patients who underwent 
non-emergency infrarenal aortic or lower limb arterial surgery. The exclusion criterion was 
patients’ refusal to participate. 
The study took place in the following four hospitals: Kuopio University Hospital in Kuopio, 
North Karelia Central Hospital in Joensuu, South Karelia Central Hospital in Lappeenranta, 
and Mikkeli Central hospital in Mikkeli. Ethics Committees of all participating hospitals ap-
proved the study. The data were collected between June 2007 and January 2008. The collection 
period varied between three and five months in each hospital. Every patient provided a writ-
ten informed-consent form.
4.1.2 Study II
The prospective descriptive study included consecutive adult patients undergoing non-emer-
gency lower limb revasculrization surgery. The exclusion criteria were patients’ refusal to 
participate,  patients’ inability to give informed consent, antibiotic treatment two weeks prior 
the surgery, or  patient’s cephalosporin allergy.  Aorto-iliac procedures were not included in 
the study.
The study was conducted at the Department of Vascular Surgery, North Karelia Central 
Hospital. The data were collected between January 2012 and October 2012. Swabs for micro-
biological analysis were taken from all surgical wounds peri- and postoperatively. Qualitative 
and quantitative analyses of various bacterial species were performed at Eastern Finland 
Laboratory Centre, Regional Laboratory of Joensuu. Blinded microbiological analyses were 
performed by an investigator who remained unaware of the origins of the coded bacterial 
samples. The study was approved by Ethics Committee of Kuopio University Hospital. Every 
patient provided a written informed consent form.
One hundred and nineteen patients underwent lower limb revascularization surgery dur-
ing the study period. Altogether 94 patients with 100 surgical procedures were included. 
Reasons for exclusion from the study were as follows; patient underwent surgery at night or 
during the weekend when it was not possible to analyze the bacterial samples (92%), patient 
was receiving an antibiotic treatment (4%), or patient was allergic to cephalosporin (4%).
4.1.3 Study III
Consecutive adult patients who underwent non-emergency lower limb arterial surgery were 
enrolled into this multicenter, prospective, double-blinded parallel-group study. Aortoiliac 
procedures were not included in the study.  The exclusion criterion was patient’s refusal to 
participate. The study took place in three tertiary referral hospitals and two secondary refer-
ral hospitals in Finland: Helsinki University Hospital, Tampere University Hospital, Kuopio 
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University Hospital, North Karelia Central Hospital and South Karelia Central Hospital. The 
study was approved by Ethics Committees in all participating hospitals. Every patient pro-
vided a written informed consent form.
The data were collected between July 2010 and January 2011 but the collection period var-
ied between 4 and 6 months among hospitals. There were 394 patients undergoing lower limb 
revascularisation during that time, and 276 of those patients were enrolled and randomised 
in the study. A total of 139 patients were assigned to the study group, and 137 patients were 
assigned to the control group. Ten patients died within 30 days following surgery. Nine of 
these patients had no SWI at the time of death, and we considered them to be uninfected in 
our analysis. The flow of participants is shown in Figure 1.
Figure 1. Flow chart
E
n
ro
lle
m
e
n
t
A
llo
ca
ti
o
n
Fo
llo
w
-u
p
A
n
al
ys
is
Allocated to triclosan group  
(n=139)
Analysed (n=139)
Excluded from analysis (n=0)
Lost to follow-up (n=0)
Death (n=6)
Underwent surgery  
for lower limb  
revascularization (n=394)
Allocated to control group  
(n=137)
Analysed (n=137)
Excluded from analysis (n=0)
Lost to follow-up (n=0)
Death (n=4)
  Excluded (n=118)
  Refused to participate (n=5)
  Unable to provide consent (n=24)
  Urgent surgery (n=46)
  Was not asked (n=42)
  Already allocated to another
  study (n=1)
Randomized (n=276)
32
4.1.4 Study IV
The prospective, multicenter, investigator-blinded study included consecutive adult patients 
who underwent non-emergency lower limb arterial surgery. Patients with hypercapnic COPD 
or oxygen saturation of less than 90%-measured by pulse oximeter when the patient was 
breathing room air-were not included in the study. The patient was classified as having COPD 
if the COPD had been diagnosed earlier by a pulmonologist. Patient’s refusal to participate 
was the additional exclusion criterion.      
The study took place in one tertiary referral hospital and five secondary referral hospitals 
in Finland: Kuopio University Hospital in Kuopio, North Karelia Central Hospital in Joensuu, 
South Karelia Central Hospital in Lappeenranta, Mikkeli Central Hospital in Mikkeli, Central 
Hospital of Central Finland in Jyväskylä and Lapland Central Hospital in Rovaniemi. Ethics 
Committees of all participating hospitals approved the study. Every patient provided a written 
informed-consent form.
The data collection took place between May 2009 and February 2010 but the collection 
period varied between three and six months amongst the hospitals. There were 343 patients 
undergoing lower limb revascularisation during that time, and 274 of those patients were 
enrolled and randomised in the study. A total of 137 patients were assigned to both the study 
and the control group. Four patients died within 30 days following surgery. Three of these 
patients had no SWI at the time of the deaths, and we considered them to be uninfected in our 
analysis. The flow of participants is shown in Figure 2.
Figure 2 Flow chart
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Table 8. Demographics of the study groups (I-IV)
Variable study I
N (%)
Mean (±sD)
study II
N (%)
Mean (±sD)
study III
N (%)
Mean (±sD)
study IV
N (%)
Mean (±sD)
study 
group
control 
group
study 
group
control 
group
Total 184 100 139 137 137 137
Age, years 71 (11) 72 (9) 72 (11) 72 (11) 73 (11) 72 (11)
Male gender 115 (63) 66 (66) 87 (62) 86 (63) 78 (57) 88 (64)
BMI (kg/m2) 26 (5) 26 (4) 26 (4) 27 (5)
BMI>25 kg/m2 99 (54) 65 (65)
CAD 87 (47) 47 (47) 63 (45) 72 (53) 65 (47) 63 (46)
Diabetes 75 (41) 35 (35) 43 (31) 44 (32) 50 (36) 52 (38)
Hypertension 116 (63) 58 (58) 86 (62) 93 (68) 89 (65) 84 (61)
COPD 15 (8) 4 (4) 16 (12) 23 (17) 13 (9) 10 (7)
Asthma 13 (7) 4 (4) 12 (9) 12 (9) 11 (8) 11 (8)
Dialysis 7 (4) 0 (0) 1 (1) 6 (4) 5 (4) 1 (1)
Current smoking 56 (31) 39 (39) 43 (31) 46 (34) 37 (27) 29 (22)
Indication for surgery
Claudication 68 (37) 47 (47) 44 (32) 27 (20) 43 (31) 51 (37)
Ischemic pain 33 (18) 25 (25) 48 (35) 42 (31) 38 (28) 30 (22)
Ischemic ulcer 51 (28) 22 (22) 34 (25) 39 (29) 49 (36) 51 (37)
Site of arteriography on 
operative field
72 (39) 46 (41) 46 (38)
Preop blood sample
Haemoglobin value, g/l 132 (20) 133 (19) 128 (19) 131 (20) 131 (19) 131 (17)
White blood cells, E9/l 8.0 (2.3) 7.8 (2.2) 9.4(10.3) 8.3 (2.7) 8.5 (5.4) 7.9 (2.9)
C-reactive protein, g/l 16 (31) 11 (18) 22 (40) 16 (39) 12 (18) 13 (23)
Creatinine value,
µmol/l
108 (94) 82 (28) 95 (82) 103 (106) 105 (121) 90 (35)
Type of reconstruction
Fem-fem bypass 15 (8) 5 (5) 5 (4) 7 (5) 7 (5) 5 (4)
Femoral ea 48 (26) 47 (47) 23 (17) 27 (20) 43 (31) 41 (30)
Fem-popliteal bypass 47 (26) 20 (20) 52 (37) 38 (28) 45 (33) 47 (34)
Distal bypass 34 (18) 13 (13) 25 (18) 25 (18) 34 (25) 31 (22)
Other 15 (8) 15 (15) 34 (24) 40 (29) 8 (6) 13 (10)
Use of prosthetic mate-
rial
64 (35) 18 (18) 39 (28) 25 (26) 31 (46) 37 (54)
Infrainguinal incision 88 (48) 47 (47) 92 (66) 79 (58) 84 (61) 85 (62)
Redo surgery 32 (17) 29 (29) 32 (23) 36 (27) 31 (23) 31 (23)
Operation time, min 157 (88) 168 (90) 158 (71) 152 (80) 146 (77) 152 (71)
Blood loss, ml 729 (1232) 396 (474) 370 (350) 380 (460) 341 (337) 407 
(408)
Blood transfusion peri-
operatively
12 (12) 31 (22) 30 (22) 30 (22) 36 (26)
BMI: body mass index, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, fem: 
femoral, ea: endarterectomy
34
4.2 MEtHODs
4.2.1 Data collection
Data including demographic characteristics and operative factors were collected prospective-
ly. Magnetic resonance imaging or intra-arterial digital subtraction angiography (DSA) by ex-
perienced angiographers was used for peripheral arterial evaluation. Angiographer selected 
the puncture site. Body hair shaving around the intended surgical incision site was executed 
in the operating room just before surgery. Saphenous vein harvesting was performed under 
direct vision; in-situ saphenous vein bypass or minimal invasive vein harvesting techniques 
were not being used. The term “distal bypass” was used if the distal anastomosis was placed 
in the crural or pedal arteries. The term “inguinal incision” was used when the surgical inci-
sion was located on a groin area. The term “infrainguinal surgery” was used when there was 
an operative incision made below the groin. 
In study I, a sample for bacterial culture was taken from the skin of the operation site af-
ter the patient had been scrubbed. In the case of critical ischaemia with ulcer or gangrene, a 
sample for bacterial culture was taken from the ischaemic area. The blood glucose level was 
measured twice daily, blood pressure, pulse and finger-tip oxygen saturation was measured 
three times a day, and the number of blood white cells, the C-reactive protein value, and the 
haemoglobin value was measured once a day for the first 3 postoperative days. In studies II, 
III and IV, the blood pressure, pulse, finger-tip oxygen saturation and blood glucose level were 
measured twice a day, and the number of blood white cells, the hemoglobin value and the 
C-reactive protein value once a day for 2 postoperative days. In study IV, the oxygen level of 
a toe on the operated lower limb was measured with a pulse oximeter six times a day for the 
first 2 postoperative days.
In study III, the arterial exposure and vein harvest incisions were closed using 2-0 Vicryl 
Plus for subcutaneous suture and 3-0 Monocryl Plus for continuous intracutaneous suture in 
the study group. In the control group incisions were closed with 2-0 Vicryl and 3-0 Monocryl 
sutures.
In study IV, the study group received supplemental oxygen postoperatively and the control 
group received usual postoperative care. The primary study design was to deliver supple-
mental oxygen via face mask for the first two postoperative days. However, patients in the 
study group found it uncomfortable to wear the face mask and thus the initial study design 
was changed 2 weeks after the data collection had started. The patients in the study group 
received 30% supplemental oxygen via a Venturi mask in the recovery room after the opera-
tion and on the first postoperative day in the surgical ward. On the second postoperative day, 
patients inspired supplemental oxygen via a nasal cannula. A constant oxygen flow rate of 5 
l/min was used. Supplemental oxygen delivery continued from the end of the surgical opera-
tion until 10 pm on the second postoperative day. The patients in the control group breathed 
room air.      
Any postoperative complications were recorded. Surgical wounds were examined at the 
1 month follow-up visit by a vascular surgeon. In study I, the patients who developed any 
wound complication were followed up until the wound had healed. In studies II, III and IV, 
the patients who developed surgical wound infection were followed up until the wound had 
healed.
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4.2.2 Antibiotic prophylaxis
In studies I, II and IV, a standardised antibiotic prophylaxis of 3 g of cefuroxime was admin-
istered within the hour before the incision. If the operation took more than 4h or if blood loss 
was over 1,500 ml a further dose of 1.5g of cefuroxime was administered. 
In study III, antibiotic prophylaxis was standardised to 3g of cefuroxime being adminis-
tered intravenously within the hour before the incision in three participating hospitals. In 
two participating hospitals antibiotic prophylaxis was standardised to 1.5g of cefuroxime be-
ing administered intravenously one hour prior to incision and in every 8 hours for the first 
24 hours after operation. In one hospital patients also received intravenous vancomycin if a 
prosthetic graft was used.
4.2.3 Sampling methods in study II
A modified swabbing technique according to Levine was used in our study (Levine et al 
1976). Here, the specimen for bacterial culture was collected with liquid-based Copan ESwab 
collection and transport system (Copan) by twirling the pre-wetted (0.9% sterile saline) nylon 
flocked swab applicator with a sufficient pressure on the surgical site area of 2-cm x 4-cm, for 
30 seconds. The swabs were collected from groin in most of the cases. If the revasularisation 
surgery did not include the groin area, the swab was taken from the most proximal incision 
site.  The applicator was placed on the ESwab transport tube containing 1 ml of modified liq-
uid Amies according to instructions from the manufacturer.
Bacterial samples were collected at four different time intervals. Before surgery, the first 
sample was taken from the operative field just before surgical area had been scrubbed. At the 
end of surgery, the second sample was taken after suturing the wound and before dressing 
was applied. OpsiteTM -Post-Op dressing were used to cover the surgical wounds in all patients 
in the study. The third and fourth samples were taken directly from the wound on the first 
and the second postoperative days. The first two samples were taken in the operating room 
and last two in the surgical ward. An additional bacterial sample was taken from those surgi-
cal wounds that developed SWI.
Initially the ESwab tube containing the applicator was briefly vortexed to elute efficiently 
the bacteria from the nylon swab into the medium and to thoroughly mix the sample. To 
ensure more reliable counting of heavier bacterial loads a dilution series (1:10 and 1:100) was 
made as follows: One hundred microlitre of original sample was diluted with 0.9% sterile 
saline to create 1:10 dilution and this was further diluted to ten-fold to achieve 1:100 dilution. 
One hundred microlitre of original sample as well as 1:10 and 1:100 dilutions were plated onto 
duplicate blood agar plates. Additionally, the original sample and 1:10 dilution were plated 
onto chocolate agar, cysteine lactose electrolyte deficient (CLED) agar and anaerobic agar with 
5-mcg metronidazole disc. All plates were incubated at deg 35 C for 48 hours. Blood agar and 
chocolate agar plates were incubated in 5% CO2, CLED agar plates in ambient air and anaero-
bic agar in anaerobic atmosphere. Bacterial growth was quantified by counting colony form-
ing units (CFU). Bacterial identification was conducted according to standard methods and 
using automated bacterial identification system Vitek2 (bioMérieux, Marcy I’Etoile, France). 
Some isolates were identified with DNA sequencing. Antibiotic susceptibility testing was per-
formed using EUCAST disk diffusion method (www.eucast.org) and Vitek2.
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4.2.4 Outcomes
The primary outcome was the occurrence of surgical wound complication or infection in 
study I and occurrence of SWI in studies II, III and IV. The secondary outcomes were cardiac 
complications, renal complications, pneumoniae, major amputations, strokes and graft throm-
boses.
Surgical wound complications were defined as follows: seroma: a pocket of clear serous 
fluid in the operated area; hematoma: a collection of blood outside the blood vessels in the 
operated area; wound necrosis: skin necrosis that does not reach the subcutaneous space; and 
wound dehiscence: spontaneous parting of the sutured layers of the surgical wound for more 
than 5mm from each other.
A surgical wound complication was considered to be an infection if it met the criteria set 
by the CDC (Horan et al 1992), i.e. if there are bacteria isolated from the wound or if there are 
areas of localised redness, heat, swelling and pain around the wound appearing within 30 
days after the operative procedure. A superficial wound infection involves only skin and sub-
cutaneous tissue, a deep wound infection involves both fascia and muscle layers, and finally a 
graft infection is defined as the involvement of an artery or a graft (vein or prosthetic) (Horan 
et al 1992).  
• The general complications were determined as follows:
• Cardiac complication: a new Q-wave in ECG or ischaemic ST changes in the ECG com-
bined with a Troponin-T value over 0.5 µg/l or a clinical diagnosis of cardiac insuffi-
ciency and correlative changes in a chest x-ray.
• Renal complication: Anuria or serum creatinin value elevation of more than 50 µmol/l/ day.
• Pneumonia: Clinical diagnosis and correlative changes in a chest x-ray. 
• Major amputation: Below or above knee amputation.
• Stroke: Rapidly-developing loss of brain functions owing to ischaemia with correlative 
changes at computed tomography.
• Graft thrombosis: Occlusion of graft or revascularised artery.
4.2.5 Additional costs related to postoperative surgical wound infection
In study I, the additional days of hospitalisation, surgical procedures, visits to the outpatients’ 
clinic and rehabilitation related to wound infection were recorded. The costs of these actions 
were estimated from each hospital’s cost-accounting system. These values were as follows: 
additional day of hospitalisation €397/day, operating department fees for re-exploration and 
revision €10/min, visits to outpatient clinic €127/visit, outpatient nursing €46/visit and reha-
bilitation €152/day. By summarizing the real expenses of these actions, the actual cost of each 
individual SWI was calculated. The cost of antibiotic treatment was not included in the cal-
culation.
4.2.6 Sample size calculation amd randomisation
Power analysis and sample size estimation were performed in Studies III and IV. Study I 
revealed the SWI rate of 27% after lower limb vascular surgery. Based on that expected inci-
dence of SWI of 27% in one month, we calculated that 137 patients in both the study and the 
control group would be required to provide 80% power for detecting a 50% reduction in the 
SWI rate at α=0.05.
North Karelia Central Hospital served as the coordinating center and performed a block 
randomisation with block size of four. Pieces of paper containing the randomisation allo-
cations were placed into sealed envelopes. Each randomisation envelope was opened by a 
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research secretary after the patient was enrolled to the study. The randomisation was per-
formed before the surgery.
In Study III, only the nurses in the operating theatre knew to which group each patient had 
been randomised.  The nurses took the suture out of the package and gave it to the operating 
vascular surgeon who was blinded because the triclosan-coated and non-coated sutures are 
indistinguishable. Neither the vascular surgeons, the nurses in the surgical ward nor the pa-
tients knew to which group each patient had been randomised. The randomisation code was 
kept separate from the trial data until the end of the study.
In Study IV, the nurses in the recovery room and in the surgical ward knew to which group 
each patient had been randomised. Nurses gave the face masks and nasal cannulas to the 
study group patients, and they also took care that the masks and cannulas were put out of 
sight of the surgeon during ward rounds and whenever the surgeon met the patient. Vascular 
surgeons remained blinded during the data collection.
4.2.7 Statistics
Descriptive and demographic data of the study population are presented using frequencies 
and percentages for categorical variables. Means and standard deviations are reported for 
continuous variables. Statistical analyses were made using the Statistical Package for the 
Social Sciences (SPSS) version 17.0 for Windows (SPSS, Chicago, IL). For categorical variables, 
we applied either Pearson’s χ2 -test or Fisher’s exact test and for numerical variables we used 
either an independent samples t-test or Mann-Whitney U-test. The risk factors for infection 
were assessed with binary logistic regression analysis. We performed tests and analyses for 
all the patients entering the study.  A priori criterion for variables entering the logistic regres-
sion analysis was a two-tailed P value of less than 0.10 in Study III and less than 0.20 in Study 
I, Study IV, and Study II in the single variable analysis. In addition, the variables that were 
suggested to have an effect on the infection probability in earlier studies were tested. The final 
model was evaluated with a backward-directed stepwise method (likelihood ratio), with the 
exception of the variables “supplemental oxygen” and “suture material” which were entered 
into all the models in Study III and Study IV, respectively. A P value of less than 0.05 was con-
sidered statistically significant. In study IV, a subgroup analysis of patients with only inguinal 
incision was performed. 
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5 Results
5.1 stUDy I
There were 184 patients included to the study. Sixty-three percent of the patients were men 
and the mean age was 71 years. Critical ischaemia was the indication for surgery in 46% of 
cases. Only 19 (10%) required urgent surgery. Femoropopliteal or femorodistal bypass was 
performed to 44% of the patients. In 64 (35%) patients the reconstruction was made using 
artificial graft or patch. All of the redo operations were lower limb not aortic procedures. 
Demographic and operative data of patients are presented in Table 8.  
One hundred and sixty-four (89%) patients received the standardised antibiotic prophylax-
is. The other 20 patients were receiving antibiotic treatment or some other antibiotic prophy-
laxis.
The incidence of surgical wound complication was 34%, and the incidence of SWI was 27%. 
Of those patients who did not receive the standardised antibiotic prophylaxis 20% developed 
SWI. The outcome of this group was not statistically different from the others. The wound 
infection was superficial in 37 (76%) of the 49 SWIs. Exposure of graft occurred in three cases, 
one was prosthetic and two were vein grafts. The infected femoropopliteal prosthesis was re-
moved and replaced with saphenous vein graft. There were no signs of infection and the graft 
remained patent at two years follow-up.
The number of positive bacterial culture of infected wound was 35 (71%). Staphylococcus 
aureus was the most commonly identified species (40%) followed by coagulase-negative staph-
ylococcal species (26%), and Escherichia coli (9%). There were 51 patients with ischaemic ulcer 
and nine (18%) of them developed SWI. The cultures from the ischaemic wound matched the 
cultures from the postoperative infected wound in four of these nine patients. In addition, 
there was a positive bacterial culture from the skin of the operative field in 18 patients. Four of 
them developed SWI and with two of these individuals the causative bacteria of SWI was the 
same that was found in the culture taken from the operative field prior to the incision.
Of the 49 patients who developed wound infection, 47 were healed with treatment with 
only two patients needing major amputation. In those two cases, SWI was the cause for one of 
the amputations and critical ischaemia for the other.
Graft occlusion was detected in eight (4%) patients at the end of the study. There were 
five (3%) major amputations in the whole study group. One month mortality was 6% and no 
deaths were attributed to SWI. The surgical wound complications and other complications are 
presented in Table 9.
The result of univariate analysis is presented in Table 10. Multivariate analysis identified 
four independent predictors for SWI. The factors which increased the risk of SWI were as 
follows: infrainguinal surgery, body mass index over 25 kg/m2 and puncture site of arteriog-
raphy on the operated area. Redo surgery was the only predictor which reduced the risk of 
postoperative wound infection. The result of multivariate analysis is presented in Table 11.
The average cost of SWI was €3,320. This sum does not include the costs of antibiotics or 
other extra medical treatment or sick leave.
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Table 9. Wound and other postoperative complications in 184 operative patients
complication N (%)
Wound complications all together  a 63 (34)
   Seroma 13 (7)
   Wound necrosis 4 (2)
   Haematoma 12(7)
   Dehiscence 10 (5)
   Surgical wound infection 49 (27)
Postoperative complications   b
   Graft thrombosis 8 (4)
   Cardiac complication 8 (4)
   Renal insufficiency 3 (4)
   Pneumonia 11 (6)
   Urinary tract infection 2 (1)
   Thirty-day mortality 11 (6)
   Major amputation 5 (3)
a Only the most serious wound complication in each patient is included 
b Forty-eight postoperative complications occurred in 28 (15%)  patients
Table 10. Univariate analysis of 184 patients
 
characteristics No Infection
 N=135
Infection 
N=49
Univariate p
Female gender, N (%) 47 (35%) 22 (45%) 0.21
Age, years 72.0 (10.5) 68.3 (10.6) 0.03
Critical Ischemia 62 (46%) 22 (45%) 0.90
Elective surgery 116 (86%) 49 (100%)  0.006
BMI over 25 kg/m2 63 (47%) 37 (75%) 0,001
Preoperative angiographic access site in area 
of surgical wound
46 (34%) 26 (53%) 0,02
CAD 68 (50%) 19 (40%) 0,16
Diabetes 49 (36%) 26 (53%) 0,04
Hypertension 78 (58%) 38 (77%) 0,01
COPD 13 (10%) 2 (4%) 0,22
Asthma 7 (5%) 6(12%) 0,10
Dialysis 5 (4%) 2 (4%) 0,91
Clopidogrel use 11 (8%) 3 (6%) 0,65
Warfarin use 29 (22%) 10 (20%) 0,88
Corticosteroids use 8 (6%) 5 (10%) 0,32
Current smoking 40 (30%) 16 (33%) 0,72
Prosthetic graft or patch 53 (39%) 11 (22%) 0,03
Infrainguinal surgery 56 (42%) 33 (67%) 0,002
Redo surgery 28 (21%) 4 (8%) 0,05
Use of drainage 80 (59%) 34 (69%) 0,21
Blood transfusion 31 (39%) 8 (38%) 0,94
Skin colonisation by bacterium 13 (10%) 5 (12%) 0,76
Preop. hemoglobin, g/l 132.3 (20.7) 133.0 (19.7) 0,84
Preop. white blood cells count, E9/l 7.9 (2.4) 8.2 (1.9) 0,40
Preop. CRP, mg/l 16,3 (30.7) 14.3 (33.3) 0,74
Preop. creatinine, μmol/l 110.3 (101.1) 102.3 (71.0) 0,62
Preop albumin, g/l 34.1 (6.4) 34.9 (5.2) 0,49
Operation time, min 159.6 (93.7) 147.8 (71.2) 0,43
Blood loss, ml 814.0 (1366.0) 485.7 (678.6) 0,12
Blood glucose on 1st po. day, mmol/l 9.2 (3.7) 10.3 (4.1) 0,08
Mean arterial pressure on 1st po. day, mmHg 88.1 (15.8) 92.0 (15.2) 0,72
1st po. day finger tip oxygenation 94.9 (3.8) 95.1 (3.1) 0,87
CRP on 1st po  day, mg/l 48.9 (36.8) 48.1 (38.0) 0,91
Hemoglobin on 1st po.  day, g/l 111.1 (17.4) 111.8 (18.0) 0,82
White blood cells count on 1st po. day, E9/l 8.8  (2.5) 9.2 (2.7) 0,43
Categorical variables are presented as number of the patients and percentages. Continuous variables are 
presented as means and standard deviations. BMI = body mass index, CAD = coronary artery disease, 
COPD = Chronic obstructive pulmonary disease, CRP = C-reactive protein, po = postoperative, Preop. = 
Preoperative 
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Table 11. Independent predictors of surgical wound infections in multivariate analysis of 184 patients
risk factor Or 95% cI P-value
Arteriographu puncture site on operation 
area
2.49 1.13-5.48 0.02
Infrainguinal surgery 7.18 2.92-17.65 <0.001
BMI over 25 kg/m2 6.08 2.44-15.16 <0.001
REDO surgery 0.27 0.08-0.96 0.04
Cl=Confidence interval, OR= Odds ratio, BMI= Body mass index
5.2 stUDy II
Sixty-six percent of the patients were men and the mean age was 72 years. Half of the patients 
had coronary artery disease and one-third had diabetes. The indication for surgery was criti-
cal ischemia in 47 % of the cases. Thirty-three percent of the procedures were either femoro-
popliteal or femoro-distal bypasses. Vascular prosthesis or a prosthetic patch was used in 18 
(18%) patients. 
The incidence of SWI was 21%. Of the 21 SWIs, 76% were superficial and 19% were deep. In 
our material, there was one complication considered as graft infection; a patient with femo-
ral endarterectomy developed a groin infection involving the femoral artery. The infection 
healed by wound radical revision and muscle flap covering. Four patients died during the 
study period, these patients had not developed SWI. Causes for death were myocardial infarc-
tion in three patients and cardiac insufficiency in one patient. Two patients needed a major 
amputation due to critical ischemia. In one patient with SWI due critical ischemia and graft 
thrombosis, SWI was the cause of major amputation.  Postoperative complications are pre-
sented in Table 12. Of the 21 patients who developed SWI 20 were healed with treatment by 
end of study period.  
Total microbial counts in the SWI group compared to the non-SWI group were statistically 
significantly higher only in samples taken on the second post-operative day (p=0.001). Thus 
this time-point was selected for further analysis. The dynamics of wound bacterial coloniza-
tion at different time intervals is shown in Figure 3. There were five cases in which the second 
post-operative day sample was not taken or the sample was missing. For univariate and mul-
tivariate analysis, we divided the study material into two different groups: surgical wounds 
with bacterial counts greater than 400,000 CFU/ml (n=12) at second postoperative day and sur-
gical wounds with bacterial counts less than 400 000 CFU/ml (n=88) at second postoperative 
day. In these groups, the SWI rate was 66.7% and 14.8% respectively (p<0.001). 
Coagulase-negative staphylococci were the most common bacteria growing in 80% of the cul-
tures. Other commonly isolated bacteria were Corynebacterium spp. (25%), Propionibacterium 
spp. (15%), Enterococcus faecalis (4%), Micrococcus spp. (3%) and Staphylococcus aureus (3%). 
Positive cultures of infected wounds were obtained in 20 (95%) of 21 patients. The most com-
monly identified species were Staphylococcus aureus (52%), Enterococcus faecalis (23%), 
Peptostreptococcus spp. (29%), Escherichia coli (24%) and Corynebacterium species (19%). No 
methicillin-resistant S. aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-
spectrum beta-lactamase producing (ESBL) E coli or Klebsiella species or multi-drug resistant 
(MDR) Pseudomonas aeruginosa or other MDR gram-negative rods were present in these 
samples. Polymicrobial flora were found in 71% of the infected wounds. In 13 (62%) of cases, 
same bacterial isolates were found from the perioperative study samples and from the infect-
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ed wounds. S. aureus was the causative agent in 5 (71%) of the 7 SWI cases with non matching 
bacterial samples.
The univariate analysis found the following factors to increase the risk of SWI: male gen-
der, body mass index (BMI) of over 25 kg/m2, diabetes, and a high bacterial colonization of 
the surgical site on the second postoperative day when using the cutpoint of 400,000 CFU/ml. 
The result of the univariate analysis is presented in Table 13. Multivariate analysis identified 
the high bacterial colonization of the surgical site at the second postoperative day to be an 
independent risk factor for SWI with an odds ratio (OR) of 1.61. The other factor that increased 
the risk of SWI was diabetes. Redo surgery was the only predictor that decreased the risk of 
postoperative wound infection. The result of multivariate analysis is presented in Table 14.
Table 12. Postoperative complications
complication N (%)
  Surgical wound infection 21 (21)
  Graft thrombisis 9   (9)
  Cardiac complication 3   (3)
  Stroke 1   (1)
  Sepsis 1   (1)
  Major amputation 3   (3)
  Hemorrhage from surgical area 3   (3)
  Thirty-day mortality 4   (4)
Figure 3. Total bacterial counts (median) in patients with and without surgical wound infection 
before surgery, at the end of surgery, and at 1st and 2nd post-operative day. P-value refers to 
Mann-Whitney U-test. 
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Table 13. Univariate analysis of 100 surgical wounds
characteristics No infection N=79 Infection N=21 Univariate p
Male gender, N (%) 48 (61%) 18 (86%) 0.03
Age 71.8 (8.8) 70.9 (8.2) 0.66
Ischemic ulcer 16 (20%) 6 (29%) 0.41
Claudication 36 (46%) 11 (52%) 0.59
BMI > 25kg/m2 48 (61%) 17 (81%) 0.09
Preop. haemoglobin, g/l 131.5 (18.8) 138.2 (19.8) 0.17
Preop. white blood cells count, 
E9/l
7.9 (2.3) 7.7 (1.6) 0.81
Preop. CRP g/l 11.8 (19.2) 8.2 (8.2) 0.21
Hypertension 43 (54%) 15 (71%) 0.16
Diabetes 22 (28%) 13 (62%) 0.004
Use of Asa 53 (67%) 15 (71 %) 0.71
Use of Warfarin 16 (20%) 4 (19%) 0.90
Use of Clopidogrel 7 (9%) 3 (14%) 0.46
Current smoking 30 (38%) 9 (43%) 0.68
Infrainguinal incision 36 (46%) 11 (52%) 0.59
Use of prosthetic material 18 (23%) 0 (0%) 0.016
Redo surgery 25 (32%) 4 (19%) 0.26
Operation time (min) 172.4 (91.3) 154.2 (85.0) 0.40
Blood loss during surgery (ml) 403.6 (453.5) 367,6 (554.3) 0.79
Use of drainage 66 (84%) 19 (91%) 0.43
Blood transfusion 11 (14%) 1 (4.8%) 0.25
CFU/Swab > 400 000 at the sec-
ond postoperative day
4 (5%) 8 (38%) <0.001
Categorical variables are presented as number of the surgical wounds and percentages. Continuous va-
riables are presented as means and standard deviations. Asa=acetylsalicylic acid, BMI=body mass index, 
CFU=colony forming unit, CRP=C-reactive protein, Preop=preoperative, Redo=reoperative
Table 14. Multivariate analysis of factors associated with surgical wound infection after lower limb 
vascular surgery
risk factor Or 95% cI P-value
Redo surgery 0.81 0.67-0.98 0.040
CFU/Swab > 400 000 at the 2. postop day 1.61 1.28-2.02 0.001
Diabetes 1.23 1.06-1.43 0.016
CFU=colony forming units, Postop= postoperative, Redo= reoperative, OR=odds ratio, CI=confidence in-
terval
5.3 stUDy III
Clinical characteristics, the type of antibiotic prophylaxis, indications for surgery, and the du-
ration of surgery were not statistically different between the groups. There were 152 bypass 
procedures and prosthetic graft was used in 67 (44%) cases. 
The overall incidence of SWI was 22%. There was no difference between the triclosan group 
and the control group in the incidence of SWI. There were 24 (77%) versus 22 (73%) superfi-
cial wound infections and 5 (16%) versus 5 (17%) deep wound infections in the study and the 
control groups, respectively. The incidence of graft infection was similar in both groups; two 
(6%) patients in the study group and 3 (10%) patients in the control group developed vascular 
graft infection.
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There were no difference in incidences of other postoperative complications, including 
graft thrombosis, cardiac complications, stroke, pneumonia, renal insufficiency, and major 
amputations between the triclosan group and the control group (Table 15). Ten (3.6%) patients 
died during the 1-month study period. Six of them belonged to the triclosan group and four 
to the control group. Two of the deaths were caused by pneumonia, three of the deaths were 
caused by a stroke and five of the deaths were the result of myocardial infarction. One patient 
who died during the 1- month postoperative period had SWI.
Obesity and the use of corticosteroids were independent predictors of SWI in the multivari-
ate analysis. The results of the multivariate analysis are presented in Table 16. According to 
the multivariate logistic regression analysis, the odds ratio (OR) for SWI in the triclosan group 
was 1.10 [95% confidence interval (CI), 0.61-2.01; P=0.75].
A total of 245 patients (89%) received antibiotic prophylaxis according to the one out of 
three protocol standards: cefuroxime 3g intravenously (60%), cefuroxime 1.5g intravenously in 
every 8 hours for the first 24 hours (24%) or cefuroxime 1.5g and vancomycin intravenously in 
every 8 hours for the first 24 hours (5%).  The other patients were treated as follows: 5 were al-
lergic to cefuroxime and received other antibiotic prophylaxis, 1 patient didn t´ get any antibi-
otic prophylaxis, 17 were treated for an infected ulcer, 1 was treated for urinary tract infection, 
1 was treated for gastrointestinal infection and 1 was treated for pneumonia. Four patients 
received antibiotic prophylaxis for prevention of bacterial endocarditis. The most common an-
tibiotics that were used to treat infections were meropenem, vancomycin, and ciprofloxacin. 
Whether the patient received any of the standardised antibiotic prophylaxis or received some 
other antibiotic prophylaxis or antibiotic treatment had no effect on the incidence of SWI.
Positive cultures of the infected wounds were obtained from 44 (72%) of the 61 patients 
with a clinically-diagnosed infection. A negative culture was obtained from 6 (10%) of the in-
fected wounds, and 11 (18%) wounds were not cultured. The most common bacterial species 
found in these 61 infected surgical wounds were Staphylococcus aureus (29%), Enterococcus 
faecalis (21%), coagulase-negative staphylococcal species (25%) and Pseudomonas aeruginosa 
(3%).  There was no difference in the type or prevalence of bacterial colonisation between the 
study and the control group.
Of the 61 patients who developed SWI, 57 (93%) were cured with treatment by the end of 
the study. Four (7%) patients died before their wound infections had healed, three of these 
four patients died after the 1-month postoperative period.  One patient in the control group 
died from myocardial infarction on the 27th postoperative day and one from pneumonia on 
the 86th postoperative day. Two patients died as a result of complicated vascular graft infec-
tion; in study group one patient with vein graft infection died on the 65th postoperative day, 
and in control group one patient with prosthetic graft infection died on the 125th postoperative 
day. There were no major amputations because of SWI in this study. 
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Table 15 Comparative outcomes between two study groups
Outcome study group control group Univariate P value
Surgical wound infection 31 (22.3) 30 (21.9) 0.94
Graft Thrombosis 7 (5.0) 6 (4.4) 0.80
Cardiac complication 3 (2.2) 6 (4.4) 0.30
Pneumonia 5 (3.6) 5 (3.6) 0.99
Stroke 4 (2.9) 1 (0.7) 0.18
Renal insufficiency 2 (1.4) 1 (0.7) 0.57
Major amputation 4 (2.9) 5 (3.6) 0.72
Thirty-day mortality 6 (4.3) 4 (2.9) 0.55
Post-operative hospital stay, days 5.5 (6.5) 5.2 (4.3) 0.68
Data are expressed as means (SD) or percentages.
Cardiac comlication: new Q-wave in ECG or ischaemic ST changes in ECG combined with a troponin value 
over 0.5 µg/l or clinical diagnosis of cardiac insufficiency and correlative changes on chest x-ray film
Renal insufficiency: anuria or serum creatinine value elevation of more than 50 µmol/l/ day
Table 16 Factors associated with surgical wound infections in multivariate analysis
Variable Or 95% cI P value
Use of triclosan coated sutures 1.10 0.61 - 2.01 0.75
BMI over 25 kg/m2 3.14 1.63 - 6.07 0.001
Current use of corticosteroids 3.13 1.35 - 7.22 0.008
5.4 stUDy IV
5.4.1 Results of the main analyses
The study and the control group were equal in terms of clinical characteristics, the type of 
antibiotic prophylaxis, indications for surgery and the duration of surgery. There were 173 
bypass procedures and prosthesis grafts were used in 44 (25%) cases. Toe oxygen saturation 
levels were different between the groups at two time points: 24 hours after surgery the mean 
saturation was 94.4% in the oxygen group and 91.9% in the control group, p = 0.034, and 28 
hours after surgery the mean saturation was 95.0% in the oxygen group and 92.4% in the 
control group, p = 0.025. However, the mean of all post-operative oxygen saturation measure-
ments was not different between the study and the control groups [mean (SD), 95.0 (4.9) vs. 
93.7 (3.5), respectively, p=0.082]. 
The overall incidence of SWI was 23% of which 75% was superficial. SWI occurred in 25 (18%) 
patients in the supplemental oxygen group and in 38 (28%) patients in the control group, p=0.06 
(Table 17). According to the multivariate logistic regression analysis, the odds ratio (OR) for SWI 
in the supplemental oxygen group compared with the control group was 0.56 (95% confidence 
interval (CI), 0.30-1.04, p=0.07). There were 18 (13%) vs. 29 (21%) superficial wound infections and 
7 (5%) vs. 7 (5%) deep wound infections in the study and the control groups, respectively. Two 
(3%) patients in the control group developed a vascular graft infection.
Asthma, coronary artery disease and infrainguinal incision were independent predictors 
of SWI in the multivariate analysis. In contrast, the use of prosthetic material reduced the risk 
of postoperative SWI. The results of the multivariate analysis are presented in Table 18.
The incidence of other postoperative complications including graft thrombosis, cardiac 
complication, stroke, pneumonia, renal insufficiency and major amputation were not differ-
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ent in the supplemental oxygen and the control groups (Table 17). Three patients in the study 
group and one patient in the control group died during the one-month study period. One of 
the deaths was caused by aspiration pneumonia and three by myocardial infarctions.
Two hundred and forty-four (89%) patients received the antibiotic prophylaxis according 
to the protocol standard. The other patients were treated as follows: 10 received Cefuroxime 
1.5 g as antibiotic prophylaxis, 4 patients didn’t receive any antibiotic prophylaxis, 11 were 
treated for an infected ulcer, 3 were treated for a urinary tract infection and 2 were treated for 
sepsis. The most common antibiotics that were used to treat different infections were merope-
nem, ciprofloxacin and clindamycin. Whether the patient received the standardised antibiotic 
prophylaxis or received some other antibiotic prophylaxis or antibiotic treatment or did not 
receive any antibiotic, had no effect on the incidence of SWI. 
Positive cultures of the infected wounds were obtained from 41 (65%) of the 63 patients 
with a clinically-diagnosed infection. A negative culture was obtained from 11 (17%) of the 
infected wounds, and 11 wounds were not cultured. The most commonly identified species 
were Staphylococcus aureus (29%), Enterococcus faecalis (11%), coagulase-negative staphylo-
coccal species (8%) and Pseudomonas aeruginosa (5%).  
Of the 63 patients who developed SWI, 58 (92%) were cured with treatment by the end of 
the study. Three (5%) patients required major amputations. SWI was the cause of two amputa-
tions, and critical ischaemia because of graft thrombosis was the reason for one amputation. 
Of the two patients who required major amputation owing to SWI, one belonged to the study 
group and the other to the control group. Two (3%) patients died before their wound infec-
tions had healed. One belonged to the study group and died from myocardial infarction on 
the 30th postoperative day and the other belonged to the control group and died from renal 
failure on the 64th postoperative day.
Table 17. Comparative outcomes between the two study groups
Outcome supplemental oxygen 
group N=137
control group 
N=137
Univariate p
Surgical wound infection 25 (18.2) 38 (27.7) 0.06
Graft thrombosis 5 (3.6) 8 (5.8) 0.39
Cardiac complication 6 (4.4) 5 (3.6) 0.81
Pneumonia 1 (0.7) 4 (2.9) 0.18
Stroke 3 (2.2) 0 (0) 0.08
Renal insufficiency 3 (2.2) 1 (0.7) 0.31
Major amputation 3 (2.2) 5 (3.6) 0.47
Thirty-day mortality 3 (2.2) 1 (0.7) 0.31
Data are expressed as means (SD) or numbers (%).
Cardiac complication: new Q-wave in ECG or ischaemic ST changes in ECG combined with a troponin value 
over 0.5 µg/l or clinical diagnosis of cardiac insufficiency and correlative changes in a chest x-ray.
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Table 18. Factors associated with surgical wound infections in multivariate analysis
 
Variable Or 95% cI p value
Use of prosthetic material 0.20 0.08-0.50 0.001
Asthma 4.83 1.72-13.53 0.003
Infrainguinal incision 2.24 1.07-4.67 0.03
Coronary artery disease 1.94 1.04-3.62 0.04
Supplemental  oxygen 0.56 0.30-1.04 0.07
CI = Confidence interval, OR = Odds ratio
5.4.2 Subgroup analysis for inguinal procedures
There were 103 (52 in the study group and 51 in the control group) patients who had an in-
guinal incision only. The incidence of SWI was 15% in this selected population. The follow-
ing surgical procedures were performed: 84 femoral endarterectomies, 9 femoro-femoral by-
passes, 2 embolectomies and 8 other procedures. Clinical characteristics, the type of antibiotic 
prophylaxis, indications for surgery and the duration of surgery were similar in these two 
groups. Surgical wound infection occurred in three (6%) patients of the study group and in 12 
(24%) patients of the control group. That difference was statistically significant (p=0.01). There 
were no differences in secondary outcomes between these two groups (Table 19). In multivari-
ate analysis a BMI over 25 kg/m2 was an independent risk factor for SWI in isolated inguinal 
incisions (OR 1.22, 95% CI, 1.03-1.45, p=0.02), whereas supplemental oxygen was associated 
with reduced risk of SWI (OR, 0.20, 95% CI, 0.04-0.95, p=0.04).
Table 19. Postoperative data of 103 patients with inguinal incision only
Outcome supplemental oxygen 
group N=52
control group 
N=51
Univariate p
Surgical wound infection 3 (6) 12 (24) 0.01
Cardiac complication 3 (6) 1 (2) 0.32
Stroke 1 (2) 0 (0) 0.32
Major amputation 0 (0) 1 (2) 0.31
Post-operative hospital stay, days 5 (5) 5 (5) 0.95
Data are expressed as means (SD) or numbers (%). Cardiac complication: new Q-wave in ECG or ischaemic 
ST changes in ECG combined with a troponin value over 0.5 µg/l or clinical diagnosis of cardiac insufficiency 
and correlative changes in a chest x-ray
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6 Discussion
6.1 LIMItatIONs Of tHE stUDy
The follow-up time was only one month meaning that we are not able to draw any conclusions 
about infections of vascular prosthesis. According to the CDC definition, wound complication 
is SWI if it appears within 30 days after operation or within one year if there is foreign mate-
rial in place. Infections of prostheses generally occur a few months, sometimes years, after the 
initial surgery. Furthermore, the incidence of prosthesis infection in vascular surgery is 1-5% 
(Wilson 2001). There were 214 procedures with prosthetic material in the study, which means 
that not more than 2-11 infections of vascular prosthesis would have been expected to occur. 
Study I included 25 (14%) aortic surgery patients althought the aim of all studies was to 
evaluate the factors associated with wound infections after peripheral vascular surgery. 
Furthermore, the results apply only to patients undergoing peripheral vascular surgery.  It is 
not clear if the result can be generalised to the other surgical procedures. 
 In Study I, we did not analyse whether the graft was placed in the subcutaneous or subfas-
cial location. It has been found that that the presence of a vascular conduit in the subcutane-
ous plane is associated with a higher risk for SWI as compared to the situation with deeply 
placed grafts (Chang et al 2003). In Studies I and IV, the type of suture material and technique 
were not recorded.
Because of relatively limited number of patients (184) in Study I, it is possible that there 
were some type 2 statistical errors with respect to some of the potential predictors of SWI. In 
study IV, the sample size calculation was based on the expectancy of a 50% risk reduction of 
SWI. It is probable that there is a type 2 error in our study owing to the small sample size (274), 
and with a bigger sample size the difference between the supplemental postoperative oxygen 
group and the control group might have been significant.
6.2 PatIENts
Consecutive patients intended to undergo lower limb revascularisation surgery were enrolled 
to these four studies on which this thesis is based. Study I also included aortic surgery pro-
cedures. Only 20-30% of the patients were excluded from the study. The main reasons for 
exclusion were as follows: patient was undergoing urgent surgery or patient was not asked 
to participate to the study. We believe that the high participation rate of consecutive patients 
ensures that the results of this study can be generalised. 
Patients undergoing aortic surgery procedures were not included to Studies II, III and IV. 
The rationale of excluding these patients was that the number of aortic surgery procedures 
was quite low in Study I and the incidence of SWI related to aortic surgery is lower than with 
lower limb revascularisation surgery. 
6.3 EVaLUatION Of MEtHODs
The surgical methods and procedures used in our studies are generally accepted and com-
monly used. Imaging technique changed during the study period; angiography was per-
formed mainly by using the conventional digital subtraction technique during Study I and by 
using magnetic resonance imaging during Studies II, III and IV.
Studies I and II were prospective studies and Studies III and IV were randomised con-
trolled trials. Studies I, III and IV were multicenter studies and Study II was single-center 
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study. Studies II and IV were investigator-blinded and Study III was double-blinded. The cal-
culating of sample size was performed when designing Studies III and IV in order to achieve 
adequately powered sample size to allow clear conclusions.
   
6.4 INcIDENcE aND rIsK factOrs fOr sUrGIcaL WOUND 
INfEctION aftEr LOWEr LIMb VascULar sUrGEry (I)
In our study, the incidence of SWI after abdominal aortic or lower limb vascular surgery was 
27 % which was high compared with most previous reports. The incidence of SWI has ranged 
between 3.5 % and 32 % according to prospective studies (Richet et al 1991, Chester et al 1992, 
Josephs et al 1993, Murphy et al 1995, Kent et al 1996, Childress et al 2007, Ploeg et al 2009, 
Virkkunen et al 2009, Linni et al 2012) The high wound infection rate in our study is probably 
owing to our determination of SWI.  Some studies (Himbeeck et al 1992, Josephs et al 1993) 
have defined a wound complication an infection only if there is a positive culture from the 
wound. We classified a wound complication as an infection if there were signs of infection 
even though the culture was negative. In fact, 29 % of infected surgical wounds in our study 
had a negative culture. On the other hand, an incidence of SWI as high as 43% after lower limb 
bypass surgery with graft placed subcutaneously has been reported (Blankensteijn et al 1996).
Accordance with earlier studies (Richet et al 1991, Pounds et al 2005) we found infraingui-
nal surgery to be an independent predictor of SWI. The explanation for this might be reduced 
peripheral tissue perfusion and decreased tissue oxygenation. 
Obesity was also the risk factor for SWI in our study. The predictive value of obesity has 
been demonstrated also in previous studies (Lee et al 2000, Patel et al 2007). It has been shown 
that surgical wound hypoxia and tissue hypoxia are both common in obese patients (Kabon 
et al 2004), and the presence of hypoxia could predispose the patient to SWI.  Another reason 
for the high incidence of SWI in obese patients could be their richer bacterial skin flora. 
The angiography puncture site within the operation area was the third independent pre-
dictor of SWI in our study. An elevated incidence of postoperative wound complications in the 
groin area has been demonstrated to be related to transfemoral arteriography in one previous 
study (Landrenau and Raju 1981), but this has not been confirmed in later studies (Himbeeck 
et al 1992, Josephs et al 1993).
Unexpectedly redo surgery was related to smaller number of SWI. One explanation for 
this surprising finding is that the upper arm vein or the opposite side lower extremity vein 
is used more often as a graft in the re-operation than in the primary operation. In this study, 
the ipsilateral saphenous vein was used as a graft in 34% of cases in redo surgery and in 92% 
of cases in the primary operation. In other words, there were no extensive surgical wounds in 
the ischaemic lower extremity if the vein graft had been taken from contralateral lower limb 
or upper arm. 
The presence of an open extremity lesion has revealed to be a significant risk factor for 
developing of SWI (Josephs et al 1993, Ott et al 2012). In our study, neither the presence of is-
chaemic ulcer nor skin bacterial colonisation was found to be a risk factor to SWI.
Thirty-day mortality rate was 6%. Our finding is in concordance with a previous popu-
lation-based study with 3.7 million surgical procedures which revealed that the mortality 
is highest (5.6%) after vascular surgery procedures compared to other surgical specialities 
(Noordzij et al 2010). The high mortality rate reflects the fact that most patients undergo-
ing vascular surgery today are elderly and suffer from various co-morbidities and thus have 
many risk factors for major surgery. 
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Post-operative hyperglycaemia was reported to be a risk factor for post-operative infec-
tions in patients who underwent coronary artery bypass grafting (McAlister et al 2003). In our 
study, no association was found between postoperative hyperglycaemia and SWI.
In agreement with earlier studies, the leading pathogen was Staphylococcus aureus, found 
in 14 (29%) of infected wounds (Himbeeck et al 1992, Josephs et al 1993, Lee et al 2000, Pounds 
et al 2005). Methicillin-resistant Staphylococcus aureus (MRSA) was not isolated from any of 
the infected surgical wounds in our study. Other reports have shown MRSA to be leading 
causative agent for SWI (Pounds et al 2005, Lee et al 2000). At present, MRSA is not a major 
causative agent in any of the SWI encountered in eastern Finland where this study took place. 
Overall, 96% of the surgical wound infections were healed. There was one major amputa-
tion but no deaths attributable to SWI. An earlier study with SWI rate of 11% found that 17% 
of SWI resulted to major amputation, and 7% of patients with SWI died as a consequence 
(Pounds et al 2005). In that study 66% of infections were graft infections whereas in our study 
only 6% of SWIs were graft infections.
SWI increased the cost of vascular surgery by €3,320 per infected patient. This amount does 
not include costs of the antibiotic treatment and, therefore, the final monetary value would be 
even greater. The postoperative use of antibiotics was very heterogeneous and thus difficult 
to estimate. One other study published around fifteen years ago calculated that the average 
cost for one surgical wound complication after vascular surgery procedure was €405 (Kent et 
al 1996).  
According to Cochrane Collaboration, it is evident that antibiotic prophylaxis can reduce 
the risk of SWI after arterial reconstruction (Steward et al 2007). There is no evidence that 
continuing the antibiotic prophylaxis for longer than 24 hours confers any benefit (Steward et 
al 2007). In this study, a single dose of 3g of cefuroxime was administered before incision. If 
the operation took more than 4 hours or blood loss was over 1,500 ml, another dose of 1.5g of 
cefuroxime was provided. When considering peripheral vascular surgery procedures, there 
is no scientific evidence that a 24-hour regimen of antibiotic prophylaxis would be any more 
effective than the type of prophylaxis we used. There is also little guidance concerning the 
appropriate dose of antibiotic prophylaxis for obese patients (Edminston et al 2008).
There are some strategies to prevent SWI: meticulous surgical technique, basic skin cleanli-
ness, and operating theater antisepsis procedures. Reduced operating time, placing the graft 
in the subfascial rather than subcutaneous position and applying silver-coated wound dress-
ing may also confer some advantages (Blankensteijn et al 1996, Chang et al 2003, Childress et 
al 2007).  Using MRI angiography and other non-invasive imaging techniques for an evalu-
ation of peripheral artery disease might decrease the incidence of SWI. Landreneau and col-
leagues stated that the incidence of wound complication was lower if surgery was carried out 
within 24 hours after an arteriography or if there was a delay of 7 days or more. However, pa-
tients with critical ischaemia are not able to await surgery for over a week. Therefore a hybrid 
treatment involving an open surgery and an endovascular procedure for the patients with 
critical ischaemia might decrease the risk of SWI.
We conclude that surgical wound infection after vascular surgery is a frequent complica-
tion associated with increased morbidity and significant additional costs. The independent 
risk factors for SWI after an abdominal aortic and a lower limb vascular surgery seem to be 
infrainguinal surgery, obesity and an angiography injection site within the operating area. 
In this study redo surgery seemed to be protective against SWI.  Further research will be re-
quired to identify if there are interventions that can reduce the risk of SWI.
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6.5 bactErIaL fLOra Of sUrGIcaL sItE IN PatIENts 
UNDErGOING LOWEr LIMb VascULar sUrGEry (II)
The incidence of SWI after lower limb vascular surgery was 21% in our study. The main result 
of this study is that perioperative bacterial load is a significant risk factor for development of 
SWI. Similar results have been observed in two earlier studies, which found peri- and post-
operative bacterial load to increase the risk of wound complications after dermatologic and 
plastic surgery (Lineaweaver et al 2011, Saleh et al 2011). The difference between those studies 
and ours is that instead of wound complication, we used wound infection as an outcome. 
In contrast, a study with 609 neurosurgical patients did not find any correlation between intraop-
erative bacterial load and postoperative infection (Cronquist et al 2001). In that study samples were 
taken only during surgery not postoperatively. However, we particularly found that the high bacte-
rial load at the second postoperative day increases the risk of SWI. In addition, there was no signifi-
cant relationship between high bacterial colonization perioperatively and the development of SWI.
Perioperative bacterial load independently increases the risk of SWI although only in 13 
(62%) of cases, the same bacterial isolates were found from the perioperative or postoperative 
study samples and from the infected wounds. In the wound healing process, bacteria and 
debris are phagocytosed and removed by neutrophils during the inflammatory phase, which 
begins within 24 hours after injury (Diegelmann and Evans 2004). Proliferative phase follows 
and overlaps with the inflammatory phase, and is characterized by epithelial cells’ migration 
across the new tissue to form a barrier between the wound and the environment (Diegelmann 
and Evans 2004). Until the complete epithelialisation has created the bacterial barrier, a wound 
may become colonized by bacteria. We suggest that if there is a large amount of any bacteria 
in surgical wound, the phagocytosis by neutrophils is not effective to prevent SWI during the 
period of wound healing when complete re-epithelialisation has not yet occurred. In other 
words, during the inflammatory and proliferative phase of wound healing the number of 
bacteria rather than bacterial species seems to be important in the development of SWI.
High bacterial growth of surgical wound predicts the development of SWI. Quantitative 
measurement of bacterial growth will not, however, be a screening method for infections, 
because by the time the bacterial samples analysis is performed the wound infection already 
exists. Instead in future, more prospective studies are warranted to test hypotheses about 
methods to decrease the bacterial load of the wound. One of such methods could be a wound 
washing with antiseptic agents postoperatively.
Diabetes and infrainguinal surgery were other independent risk factors for the development of 
SWI. The predictive values of diabetes and infrainguinal surgery have been demonstrated also in 
other studies (Richet et al 1991, Josephs et al 1993). Likewise in Study I, we found redo surgery to 
be protective against SWI. The explanation for this surprising result might be that vascular pros-
thesis was used more often as a graft at redo surgery, which means that there were no long vein 
harvesting incisions. In this study, prosthetic graft was used in 18 (62%) of 29 redo procedures.
In agreement with earlier studies coagulase-negative staphylococci were the predomi-
nant bacteria isolated from the study samples followed by Corynebacterium spp. and 
Propionibacterium spp. (Cronquist et al 2001, Lineaweaver et al 2011, Saleh et al 2011). And, 
the leading causative agent for SWI was Staphylococcus aureus found in 52% of the infected 
wounds (Calligaro et al 1994, Pounds et al 2005). 
We conclude that high bacterial load of surgical wound increases the risk of SWI after 
lower limb vascular surgery. Further research will be required to find methods to decrease 
the wound bacterial load postoperatively.
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6.6 EffEct Of trIcLOsaN-cOatED sUtUrEs IN PrEVENtION 
Of sUrGIcaL WOUND INfEctION aftEr LOWEr LIMb 
VascULar sUrGEry (III)
We report the result of a prospective, randomised, double-blinded, multicenter trial assessing 
the effect of triclosan-coated sutures on the incidence of SWI after lower limb vascular surgery. 
The surgical incisions were closed with the same technique in both groups. In the study group 
both subcutaneous and intracutaneous sutures were triclosan-coated. The main result of our 
trial is that wound closure with triclosan-coated sutures does not reduce the risk of SWI. In vitro 
preclinical studies have demonstrated that triclosan-coated polyglactin 910 antimicrobial su-
tures inhibit the growth of several bacteria including Staphylococcus aureus, Staphylococcus ep-
idermidis, methicillin-resistant Staphylococcus aureus, Enterococcus faecalis and Pseudomonas 
aeruginosa (Rothenburger et al 2002, Edminston et al 2006).  In our study the most common 
causative bacterial agents in the development of SWI were staphylococcal species, enterococcus 
and pseudomonas aeruginosa, with no difference between the study and control groups in the 
percentage of each causative bacteria. This demonstrates that in clinical use among vascular-
surgery patients triclosan-coated sutures do not inhibit the growth of these bacteria.  
Nine other prospective randomised trials have assessed the efficacy of triclosan-coated su-
tures in the prevention of SWI with divergent results.  In accordance with our result, three 
studies with patients undergoing breast surgery found the use of triclosan coated sutures not 
to reduce the risk of SWI (Deliaert et al 2007, Williams et al 2011, Zhang et al 2011). Furthermore, 
studies that compared triclosan-coated and non-triclosan coated subcutaneous or fascial su-
tures in the closure of abdominal wounds after appendicectomy and colorectal surgery, and 
after neck cancer reconstruction did not find any difference in the incidence of SWI between 
groups (Mingmalairak et al 2009, Baracs et al 2011, Chen et al 2011). The feasibility of triclosan-
coated sutures was tested in a study with pediatric patients undergoing various surgical proce-
dures. The authors found the incidence of postoperative pain to be statistically reduced when 
triclosan-coated sutures were used compared to non-triclosan-coated suture use. However, the 
use of triclosan coated suture did not have an affect to the incidence of SWI (Ford et al 2005).
In contrast, there are two prospective studies that have indicated that triclosan-coated su-
tures reduce the risk of SWI. The effect of triclosan-coated sutures in the prevention of SWI 
after implantation of cerebrospinal fluid shunting devices was tested in 61 patients. The in-
cidence of shunt infection was statistically lower in the triclosan group than in the control 
group (Rozelle et al 2008). However, the sample size in this study is far too small, and thus 
this study is underpowered to draw any conclusions on the effect of triclosan-coated sutures 
on the risk of SWI for this procedure.
Galal and colleagues reported a significant reduction of the incidence of SWI when surgical 
incisions were closed with triclosan-coated sutures. In contrast to our study, they had a hetero-
geneous study population of surgical patients: all patients undergoing different surgical proce-
dures were included in the study. The surgical categories varied from vascular surgery, plas-
tic surgery, gastrointestinal surgery and thyroidectomy to smaller lipoma extirpation. Neither 
the method of closing the surgical incision nor the antibiotic prophylaxis was standardised. 
Furthermore, they conducted a multicenter study but reported the results of a single center only 
(Galal et al 2010). In our study, only peripheral vascular surgery procedures were included and 
both antibiotic prophylaxis and method of closing surgical wound were standardised.
We conclude that wound closure with triclosan-coated sutures does not reduce the risk of 
SWI after lower limb vascular surgery.
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6.7 EffEct Of sUPPLEMENtaL POstOPEratIVE OxyGEN IN 
PrEVENtION Of sUrGIcaL WOUND INfEctION aftEr LOWEr 
LIMb VascULar sUrGEry (IV)
This randomised trial suggests that supplemental inspired oxygen after lower limb revascu-
larisation surgery might reduce the incidence of SWI. Furthermore, we found that supple-
mental inspired oxygen significantly reduces the risk of SWI when only an inguinal incision 
is performed.
The amount of oxygen available to the tissues, called oxygen delivery, is determined by car-
diac output and arterial blood oxygen content (Nichols and Nielsen 2010). The oxygen content 
of arterial blood is the sum of the oxygen carried by haemoglobin and the amount dissolved 
in the plasma. Under normal physiologic conditions, less than 2% of the arterial oxygen con-
tent is dissolved in the plasma (Harder and Boshkow 2010). Increasing the amount of oxygen 
in the inspiratory gas increases the partial pressure of oxygen in the blood (PO2). However, 
in normoxemic states this mainly increases the amount of oxygen dissolved into the plasma 
and leads only to a small increase in arterial oxygen content, because the haemoglobin oxygen 
saturation approaches 100% already at baseline. Thus it seems plausible that supplemental 
oxygen might be of no benefit for non-hypoxemic patients. On the other hand oxygen tension 
plays a major role in the transport of oxygen to the cells. The pressure gradient is responsible 
for the diffusion of oxygen from the capillary blood into the cells, from one cell to another, 
and within the cells into mitochondria (Loiacono and Shapiro 2010). Increasing PO2 with sup-
plemental oxygen increases this pressure gradient. This might improve the diffusion of oxy-
gen particularly when the diffusion distances are long or regional blood flow is suboptimal, 
which may be the case with patients suffering from severe arteriosclerosis.
Oxygen therapy can be associated with adverse effects. Long-term exposure to high-dose 
oxygen causes pulmonary oedema and interstitial fibrosis and may result in severe lung in-
jury (Deneke and Fanburg 1980, Aoki et al 2008).  On the other hand, low-flow supplemental 
oxygen is regarded as quite safe (Benditt 2000). In a recent study on guinea pigs, two-week 
exposure to 40% oxygen caused transient damage to some pulmonary epithelial functions 
and affected collagen metabolism, but these changes were successfully compensated for dur-
ing the following weeks, despite continuous exposure to 40% oxygen, and no permanent in-
jury was detected. On the other hand, exposure to 90% oxygen caused rapid and progressive 
destruction of the lungs (Aoki et al 2008). The amount of supplemental oxygen used in our 
study is well below the amounts that are regarded in the literature as potentially harmful to 
the lungs.
With patients suffering from COPD supplemental oxygen may depress ventilation and in-
duce hypercapnia (Robinson et al 2000). This effect is generally small in magnitude when 
low-flow oxygen is used (Benditt 2000). Nevertheless, to avoid this potentially detrimental 
effect, we excluded patients with COPD and a known tendency for hypercapnia. It is still 
possible that patients with severe COPD would also benefit from supplemental oxygen after 
lower limb vascular surgery. This question is unanswered so far and we want to stress that 
whenever oxygen is administered to a COPD patient, he/she should be carefully monitored 
with the risk of hyperoxia-induced hypercapnia in mind.
The average toe tip oxygen saturation, which was measured every four hours after surgery 
for the first two postoperative days, did not differ between the study and the control groups. 
However, the oxygen saturation was higher in the study group at two time points: 24 and 28 
hours after surgery. This confirms that supplemental postoperative oxygen is helpful in pre-
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venting transient hypoxemia, which is in accord with our suggestion that improving tissue 
oxygenation with supplemental oxygen might reduce the incidence of SWI.
Several randomised controlled trials with other types of surgery have been conducted to 
study the association between supplemental oxygen and the risk of SWI. Four randomised 
controlled trials have shown that supplemental perioperative oxygen reduces the risk of SWI. 
In two of these studies elective colorectal surgery patients were included, one study included 
major non-cardio-thoracic surgery patients and, one included patients undergoing surgery for 
acute appendicitis. (Grief et al 2000, Belda et al 2005, Myles et al 2007, Bickel et al 2011). In con-
trast, one trial with major intra-abdominal surgical patients found that supplemental oxygen 
perioperatively increases the risk of SWI (Pryor et al 2004). The main difference between our 
study and the study by Pryor and colleagues was that in our study the patients in the supple-
mental oxygen group received 30% oxygen for the first 24 hours after an operation and then 
oxygen via nasal cannula for the next 24 hours. In the study by Pryor and colleagues the study 
group received 80% oxygen and the control group received 30% oxygen perioperatively and 
for the first two postoperative hours. The study by Pryor and colleagues has been criticised 
because the study groups were not standardised, which led to the following significant differ-
ences: patients receiving 80% inspired oxygen had higher BMI, lost more blood and required 
more fluid replacement than patients receiving 30% inspired oxygen. 
Furthermore two studies with patients undergoing abdominal surgery and two studies 
with women undergoing caesarean delivery found no difference in the incidence of SWI in 
patients receiving supplemental oxygen during the perioperative time (Mayzler et al 2005, 
Gardella et al 2008, Meyhoff et al 2009, Scifres et al 2011). 
A meta-analysis of five randomised controlled trials with 3,001 patients studied the ef-
fect of perioperative inspired supplemental oxygen on the development of SWI. That meta-
analysis demonstrated that supplemental perioperative oxygen therapy resulted in a relative 
risk reduction of 25.3% (95% CI 8.1%-40.1%). The authors recommend the use of hyperoxia to 
reduce the rate of SWI (Qadan et al 2009). Another meta-analysis with five prospective ran-
domised studies with colorectal surgery patients showed that supplemental oxygen did not 
significantly reduce the rate of SWI (OR=0.69, 95% CI 0.43,1.10). However, a significant mortal-
ity benefit was observed among patients receiving supplemental oxygen (OR 0.18, 95% CI 0.05, 
0.69) (Brar et al 2011).
The incidence of SWI was 23%, which is in accordance with the result of Study I. Likewise 
in Study I, we classified a wound complication as an infection if there were signs of infection 
even though the culture was negative. In fact, 35% of infected surgical wounds in our study 
did not have a positive culture. The characteristics we used meet the criteria defined by the 
Centers for Disease Control and Prevention (CDC) (Horan et al 1992). 
We conclude that supplemental inspired oxygen reduces the risk of SWI in groin incisions 
after lower limb vascular surgery. Further studies with larger sample sizes are warranted to 
find out whether supplemental oxygen reduces the risk of SWI after a lower limb vascular 
surgery in general, and not only after groin incisions. 
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7 Summary and conclusions
Based on these studies, the following conclusions can be drawn:
The incidence of SWI after lower limb vascular surgery is 22-27%. The independent risk fac-
tors of SWI are obesity, infrainguinal surgery, asthma, coronary artery disease, diabetes, cur-
rent use of corticosteroids and, arteriography puncture site on the operation area. Moreover, 
high bacterial load of surgical wound on 2nd postoperative day independently predicts the 
increased risk of the development of SWI. 
The average additional hospital cost of SWI is €3,320. The costs included are additional days 
of hospitalisation, operating department fees for re-exploration and revision, visits to outpa-
tient clinic, outpatient nursing and rehabilitation.
The use of triclosan-coated sutures does not have an effect on incidence of SWI after lower 
limb vascular surgery.
The inspired supplemental postoperative oxygen does not significantly reduce the risk of 
SWI after lower limb vascular surgery. However, the subgroup analysis revealed that the 
postoperative inspired supplemental oxygen may decrease the risk of SWI after lower limb 
vascular surgery in patients with inguinal incision only.
55
8 References
Abalo A, Patassi A, James YE, Walla A, Sangare A, Dossim A. Risk factors for surgical wound 
infection in HIV-positive patients undergoing surgery for orthopaedic trauma. J Orthop 
Surg 2010;18:224-7.
Ahmed D, Cheema FH, Ahmed YI, Schaefle KJ, Azam SI, Sami SA, Sharif HM. Incidence and 
predictors of infection in patients undergoing primary isolated coronary artery bypass 
grafting: a report from a tertiary care hospital in a developing country. J Cardiovasc Surg 
2011;52:99-104.
Aimaq R, Akopian G, Kaufman HS. Surgical site infection rates in laparoscopic versus open 
colorectal surgery. Am Surg 2011;77:1290-4.
Akca O, Podolsky A, Eisenhuber E, Panzer O, Hetz H, Laml K, Lackner FX, Wittmann K, 
Grabenwoeger F, Kurz A, Schultz AM, Negishi C, Sessler DI. Comparable postoperative 
pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after 
colon resection. Anesthesology 1999;91:991-8.
AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total 
joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008;90:915-9.
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical 
site infections. Ann Surg 2011;253:1082-93.
Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marococci L, Scheuensthul H, Chang M, Le 
AX, Hopf HW, Hunt TK. Wound hypoxia and acidosis limit neutrophil bacterial killing 
mechanisms. Arch Surg 1997;132:991-6.
Ambiru S, Kato A, Kimura F, Shimizu H, Yoshidome H, Otsuka M, Miyazaki M. Poor posto-
perative blood glucose control increases surgical site infections after surgery for hepato-
biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. J Hosp 
Infect 2008;68:230-3.
American Society of Anesthesiologists. Inc. New classification of physical status. Anesthesiology 
1963;24:107-11.
Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of posto-
perative infection after appendicectomy. Cochrane Database Syst Rev 2005;20:CD001439.
Anderson DJ. Surgical site infections. Infect Dis Clin N Am 2011;25:135-53.
Andersson RE, Lukas G, Skullman S, Hugander A. Local administration of antibiotics by 
gentamicin-collagen sponge does not improve wound healing or reduce recurrence rate 
after pilonidal excision with primary suture: a prospective randomized controlled trial. 
World J Surg 2010;34:3042-8.
Andreasen JJ, Dethlefsen C, Modrau IS, Baech J, Schonheyder HC, Moeller JK, Johnsen SP. 
Storage time of allogenic red blood cells is associated with risk of severe postoperative 
infection after coronary artery bypass grafting. Eur J Cardiothorac Surg 2011;39:329-34.
Angelini GD, Lamarra M, Azzu AA, Bryan AJ. Wound infection following early repeat ster-
notomy for postoperative bleeding. An experience utilizing intraoperative irrigation 
with povidone iodine. J Cardiovasc Surg 1990;31:793-5.
Aoki T, Yamasawa F, Kawashiro T et al. Effects of long-term low-dose oxygen supplementa-
tion on the epithelial function, collagen metabolism and interstitial fibrogenesis in the 
guinea pig lung. Respir Res 2008;9:37.
56
Arabshahi KS and Koohpayezade J. Investigation of risk factors for surgical wound infection 
among teaching hospitals in Tehran. Int Wound J 2006;3:59-62.
Astagneau P, Rioux C, Golliot F, Brucker G for the INCISO Network Study Group. Morbidity 
and mortality associated with surgical site infections: results from the 1997-1999 INCISO 
surveillance. J Hosp Infect 2001;48:267-74.
Ata A, Valerin BT, Lee EC, Bestle SL, Elmdorf SL, Stain SC. The effect of diabetes mellitus 
on surgical site infections after colorectal and noncoloractel general surgical operations. 
Am Surg 2010;76:697-702.
Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978:298;659-68. 
Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc 
Surg 2008;21:119-23.
Baracs J, Huszar O, Saijadi SG, Horvath OP. Surgical site infections after closure in colorectal 
surgery using triclosan-coated absorbable suture (PDS Plus) vs uncoated sutures (PDS 
II): a randomized multicentre study. Surg Infect (Larchmt) 2011;12:1-7.
Barbolt T. Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated 
Vicryl plus antibacterial suture (coated polyglatin 910 suture with triclosan). Surg Inf 
2002;3:45-53.
Barie PS and Eachempati SR. Surgical site infections. Surg Clin N Am 2005;85:1115-35. 
Barker FG 2nd. Efficacy of prophylactic antibiotic therapy in spinal surgery: meta-analysis. 
Neurosurgery 2002;5:391-400.
Barker FG 2nd. Efficacy of prophylactic antibiotics against meningitis after craniotomy: a 
meta-analysis. Neurosurgery 2007;60:887-94.
Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes 
Rev 2005;6:5-7.
Bausz M, Fodor E, Resch MD, Kristof K. Bacterial contamination in the anterior chamber after 
povidone-iodine application and the effect of the lens implantation device. J Cataract 
Refract Surg 2006;32:1691-5.
Beirne C, Martin F, Hynes N, Sultan S. Five years’ experience of transverse groin incision for 
femoral artery access in arterial reconstructive surgery: parallel observational longitu-
dinal group comparison study. Vascular 2008;4:207-12.
Belda FJ, Aguilera L, da la Asuncion JG et al. Supplemental perioperative oxygen and the 
risk of surgical wound infection: a randomized controled trial. JAMA 2005;294: 2035-42.
Benditt JO. Adverse effects of low-flow oxygen therapy. Respir Care 2000;45:54-61.         
Bendy RH, Nuccio PA, Wolfe E, Collins B, Tamburro C, Glass W, Martin CM. Relationship of 
quantitative wound bacterial counts to healing of decubiti: effect of topical gentamicin. 
Antimicrob. Agents Chemother 1964;4:147-55.
Bennet-Guerrero E, Ferguson TB Jr, Lin M, Garg J, Mark DB, Scavo VA Jr, Kouchoukos N, 
Richardson JB Jr, Pridgen RL, Corey GR; SWIPE-1 Trial Group. Effect of an implantable 
gentamicin-collagen sponge on sternal infections following cardiac surgery: a randomi-
zed trial. JAMA 2010;18:755-6a.
Bennet-Guerrero E, Pappas TN, Koltun WA, Fleshman JW, Lin M, Garg J, Mark DB, Marcet JE, 
Remzi FH, George VV, Newland K, Corey GR; SWIPE 2 Trial Group. Gentamicin-collagen 
sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010;9:1038-49b.
Bernard AC, Davenport DL, Chang PK, Vaughn TB, Zwischenberger JB. Intraoperative trans-
fusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, 
surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll 
Surg 2009;208:931-9.
57
Biancari F and Tiozzo V. Staples versus sutures for closing leg wounds after vein graft har-
vesting for coronary artery bypass surgery. Cochrane Database Syst Rev 2010;12.
Bickel A, Gurevits M, Vamos R, Ivry S, Eitan A. Perioperative hyperoxia and wound site in-
fection following surgery for acute appendicitis. Arch Surg 2011;146:464-70.
Blankensteijn JD, Gertler JP, Peterson MJ, Brewster DC, Cambria RP, LaMuraglia GM, Abbott 
WM. Avoiding infrainguinal bypass wound complications in patients with chronic renal 
insufficiency: the role of the anatomic plane. Eur J Vasc Endovasc Surg 1996;11:98-104.
Bongartz T, Halligan CS, Osman DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, 
Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee 
replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008;15:1713-20.
Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effecti-
ve intervention?  Testing a generic hypothesis over a set of meta-analyses. Ann Surg 
2009;49:551-6. 
Bowler PG. Wound pathophysiology, infection and therapeutic options. Ann Med 2002;34:419-27.
Brar MS, Brar SS, Dixon E. Perioperative supplemental oxygen in colorectal patients: a meta-
analysis. J Surg Res 2011;166:227-35.
Brazler DW and Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement 
from the national surgical infection prevention project. Am J Surg 2005;189:395-404. 
Brill A, Ghosh K, Gunnarsson C, Rizzo J, Fullum T, Maxey C, Brossette S. The effects of lapa-
roscopic cholecystectomy, hysterectomy, and appendicectomy on nosocomial infection 
risks. Surg Endosc 2008;22:1112-8.
Broex ECJ, Asselt ADI, Bruggeman CA, van Tiel FH. Surgical site infections: how high are 
the costs? J Hospit Infect 2009;72:193-201. 
Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE, Page CP, Peterson 
OL, Reinhart GF, Williford WO. Study protocol: a randomized clinical trial of total pa-
renteral nutrition in malnourished surgical patients. Am J Clin Nutr 1988;47:366-81.
Calligaro KD, Veith FJ, Schwartz ML, Goldsom J, Savarese RP, Dougherty MJ, DeLaurentis DA. 
Selective preservation of infected prosthetic arterial grafts. Ann Surg 1994;220:461-71.
Chang JK, Calligaro KD, Ryan S, Runyan D, Dougherty MJ, Stern JJ. Risk factors associated 
with infection of lower extremity revascularization: analysis of 365 procedures perfor-
med at a teaching hospital. Ann Vasc Surg 2003;17:91-6.
Chang SH and Wong LM. Surgical infections in patients with chronic renal failure. Infect Dis 
Clin North Am 2001;15:775-96.
Chang SH and Krupnick AS. Perioerative antibiotics in thoracic surgery. Thorac Surg Clin 
2012;22:35-45.
Chang WK, Srinivasa S, Morton R, Hill AG. Triclosan-impregnated sutures to decrease sur-
gical site infections. Ann Surg 2012;00:1-6.
Chen SY, Chen TM, Dai NT, Fu JP, Chang SC, Deng SC, Chen SG. Do antimicrobial-coated su-
tures reduce wound infection in head and neck cancer reconstruction? EJSO 2011;37:300-4.
Chester JF, Butler CM, Taylor RS. Vascular reconstruction at the groin: oblique or vertical 
incision? Ann R C Surg Engl 1992;74:112-4.
Childress BB, Berceli SA, Nelson PR, Lee WA, Ozaki CK. Impact of an absorbent silver-eluting 
dressing system on lower extremity revascularization. Ann Vasc Surg 2007;21:598-602.
Classen CC, Evans RS, Pestotnik SL, Horn SD, Meniove RL, Burke JP. The timing of prophy-
lactic administration of antibiotics and the risk of surgical-wound infection. N Engl J 
Med 1992;326:281-6.
58
Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site 
infections in English hospitals. J Hosp Infect 2005;60:93-103.
Cronquist AB, Jakob K, Lai L, Della Latta P, Larson EL. Relationship between skin microbial 
counts and surgical site infection after neurosurgery. Clin Infect Dis 2001;15:1302-8.
Coulston J, Tuff V, Twine C, Chester J, Eyers P, Steward A. Surgical factors in the preventi-
on of infection following major lower limb amputation. Eur J Vasc Endovasc Surg 2012; 
43:556-60.
Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards 
JR, Tolson JS, Henderson TS, Hughes JM. Surgical wound infection rates by wound class, 
operative procedure, and patients risk index. Am J Med 1991;91:152-7. 
Darouiche RO, Wall MJ, Itani KMF, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, 
Crosby CT, Mosier MC, AlSharif A, Berger DH. Chlorhexidine-alcohol versus povidone-
iodine for surgical-site antisepsis. N Engl J Med 2010;362:18-26.
Davidovic L, Jakovljevic N, Radak D, Dragas M, Ilic N, Koncar I, Markovic D. Dacron or ePTFE 
graft for above-knee femoropopliteal bypass reconstruction. A bi-centre randomised 
study. VASA 2010;39:77-84.
Defty C, Eardley N, Taylor M, Jones DR, Mason PF. A comparison of the complication ra-
tes following ulilateral and bilateral varicose vein surgery. Eur J Vasc Endovasc Surg 
2008;35:745-9.
Deliaert AE, van den Kerckhove E, Tuinder S, Fieuws S, Sawor JH, Meesters-Caberg MA, van 
der Hulst RR. The effect of triclosan-coated sutures in wound healing. A double blind 
randomized prospective pilot study. JPRAS 2009;62:771-3.
Dellano C, Vega Q, Boesenberg D. The antiviral of common household disinfectants and an-
tiseptics against murine hepatis virus, a potential surrogate for SARS coronavirus. Am 
J Infect Control 2009;8:649-52.
Deneke SM and Fanburg BL. Normobaric oxygen toxicity of the lung. N Engl J Med 1980;303:76-86.
Derksen WJM, Verhoeven BAN, van de Mortel RHW, Moll FL, de Vries JPPM. Risk factors for 
surgical-site infection following common femoral artery endarterectomy. Vasc Endovasc 
Surg 2009;17:69-75. 
Di Leo A, Piffer S, Ricci F, Manzi A, Poggi E, Poretto V, Fambri P, Piccini G, Patrizia T, Fabri 
L, Busetti R. Surgical site infections in an Italian surgical ward: a prospective study. 
Surg Infect(Larchmt) 2009;10:533-8. 
Diegelmann RF and Evans MC. Wound healing: an overview of acute, fibrotic and delayed 
healing. Front Biosci 2004;9:283-9.
Diez C, Koch D, Kuss O, Silbert RE, Friedrich I, Boergermann J. Risk factors for mediastini-
tis after cardiac surgery - a retrospective analysis of 1700 patients. J Cardiovasc Surg 
2007;20:23.
Drapeau CM, D’Aniello C, Brafa A, Nicastri E, Silvestri A, Nisi G, Petrosillo N. Surgical site 
infections in plastic surgery: an Italian multicentre study. J Surg Res 2007;143:393-7.
Drapeau CM, Pan A, Bellacosa C, Cassola G, Crisalli MP, De Gennaro M, Di Cesare S, Dodi 
F, Gattuso G, Irato L, Maggi P, Pantaleoni M, Piselli P, Soavi L, Rastrelli E, Tacconelli 
E, Petrosillo N. Surgical site infections in HIV-infected patients: result from an Italian 
prospective multicentre observational study. Infection 2009;37:455-60.
Dumville JC, Walter CJ, Sharp CA, Page T. Dressings for the prevention of surgical site infec-
tion. The Cochrane Library 2011;7.
Dunn P. Dr Alexander Gordon (1752-99) and contagious puerperal fever. Arch Dis Child Fetal 
Neonatal Ed 1988;78:232-3.
59
Eberhart LH, Holdorf S, Albert US, Kalder M, Kerwat K, Kranke P, Morin AM. Impact of a 
single perioperative dose of dexamethasone on the incidence of surgical site infections: 
a case-control study. J Obstet Gynaecol Res 2011:37;1807-12.
Edminston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, Brown KR, 
Towne JB. Bacterial Adherence to surgical sutures: can antibacterial-coated sutures 
reduce the risk of microbial contamination? J Am Coll Surg 2006;203:481-9.
Edminston CE, Krepel CJ, Wilson PJ, et al. Reducing the risk of surgical site infections: embra-
cing basic and innovative risk reduction strategies. Healthcare Infection 2008;13:121-129
Escalada GM, Russell AD, Maillard JY, Ochs D. Triclosan-bacteria interactions: single or 
multiple target sites? Lett Appl Microbiol 2005;41:476-81. 
Esposito S. Is single-dose antibiotic prophylaxis sufficient for any surgical procedure? J 
Chemother 1999;11:556-64.
Falagas ME and Kasiakou SK. Mesh-related infections after hernia repair surgery. Clin 
Microbiol Infect 2005;11:33-8.   
Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL. Intraoperative handling and wound 
healing: Controlled clinical trial comparing coated VICRYL® plus antibacterial suture 
(coated polyglatin 910 suture with triclosan) with coated VICRYL® suture (coated polyg-
latin 910 suture). Surg Inf 2005;6:313-21.
Fournel I, Tiv M, Soulias M, Hua C, Astruc K, Aho Glele LS. Meta-analysis of intraoperative 
povidone-iodine application to prevent surgical-site infection. Br J Surg 2010;97:1603-13. 
Frieberg O, Svedjeholm R, Soderquist B. Local gentamicin reduces sternal wound infections 
after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2005;79:153-61.
Galal I and El-Hindawy K. Impact of using triclosan-antibacterial sutures on incidence of 
surgical site infection. Am J Surg 2011;202:133-8.
Gardella C, Goltra LB, Laschansky E, Drolette L, Chadwick HS, Eschenbach D. High-
concentration supplemental perioperative oxygen reduce the incidence of postcesarean 
surgical site infection: a randomized controlled trial. Obstet Gynecol 2008;112:545-52.
Gawande A. Two hundred years of surgery. N Engl J Med 2012;366:1716-23.
Gaynes PG, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS and the National 
Nosocomial Infections Surveillance System. Surgical site infection (SSI) rates in the 
United States, 1992-1998: the national nosocomial infections surveillance system basic 
SSI risk index. CID 2001;33:69-77. 
Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of two vas-
cular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated 
by hypoxia. J Biol Chem 1997;19:23659-67.
Geroulanos S, Mrathias K, Kriaras J, Kadas B. Cephalosporins in surgical prophylaxis. J 
Chemother 2001;13:23-6.
Geubbels ELPE, Mintjes-de Groot AJ, van den Berg JM, de Boer AS. An operating surveillance 
system of surgical site infections in the Netherlands: surveillance network. Infect Control 
Hosp Epidemiol 2000;21:311-8.
Gilbert P and McBain A. Literature-based evaluation of the potentioal risks associated with 
impregnation of medical devices and implants of triclosan. Surg Inf 2002;3:55-63.
Giles KA, Hamdan AH, Pomposelli FB, Wyers MC, Siracuse JJ, Schemerhorn ML. Body mass 
index: surgical site infections and mortality after lower extremity bypass from the na-
tional surgical quality improvement program 2005-2007. Ann Vasc Surg 2010;24:1-15.a
60
Giles KA, Wyers MC, Pomposelli FB, Hamdan AD, Ching YA, Schermerhorn ML. The impact 
of body mass index on perioperative outcomes of open and endovascular abdominal 
aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-
2007. J Vasc Surg 2010;52:1471-7.b
Gil-Egea MJ, Pi-Sunyer MT, Verdaguer A, Sanz F, Stiges-Serra A, Eleizegui LT. Surgical wound 
infections:prospective study of 4,468 clean wounds. Infect CONTROL 1987;8:277-80.
Gillespie WJ and Walenkamp GH. Antibiotic prophylaxis for surgery for proximal femoral 
and other closed long bone fractures. Cochrane Database Syst Rev 2010;17:CD00024.
Gomez-Alonso A, Garcia-Criado FJ, Parreno-Manchado FC, Garcia-Sanchez JE, Garcia-
Sanchez E, Parreno-Manchado A, Zambrano-Cuadrado Y. Study of efficacy of coated 
VICRYL plus® antibacterial suture (coated polyglatin 910 suture with triclosan) in two 
animal models of general surgery. J Inf 2007;54:82-8.
Gottrup F. Physiology and measurement of tissue perfusion. Ann Chir Gynaecol 1994;83:183-9.
Gould IM. Alexander Gordon, puerperal sepsis, and modern theories of infection control-
Semmelweis in perspective. Lancet Infect Dis 2010;10:275-78.
Graff K, Ott E, Vonberg R-P, Kuehn C, Schilling T, Haverich A, Chanberny IF. Surgical site 
infections-economic consequences for the health care system. Langbecks Arch Surg 
2011;396:453-459.
Greenblatt DY, Rajamanickam V, Mell MW. Predictors of surgical site infection after open 
lower extremity revascularization. J Vasc Surg 2011;54:433-9.
Greenstein AJ, Chassin MR, Wang J, Rockman CB, Riles TS, Tuhrim S, Halm EA. Association 
between minor and major surgical complications after carotid endarterectomy: results 
of the New York carotid artery surgery study. J Vasc Surg 2007;46:1138-44.
Grief R, Akca O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce 
the incidence of surgical-wound infection. N Engl J Med 2000;342:161-7.
Gurusamy KS and Samraj K. Routine abdominal drainage for uncomplicated open cholecys-
tectomy. Cochrane Database Syst Rev 2007;18.
Gurusamy KS, Samraj K, Mullerat P, Davidson BR. Routine abdominal drainage for uncomp-
licated laparoscopic cholecystectomy. Cochrane Database Syst Rev 2007;17.
Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients 
at high risk of surgical wound infection. A simple multivariate index of patient suscep-
tibility and wound contamination. Am J Epidemiol. 1985;121:206-15.
Hall MJ, DeFrances CJ, Williams SN, Golosinkiy A, Schwartzman A. National Hospital 
Discharge Survey: 2007 summary. Natl Health Stat Report 2012;26:1-20,24.
Harder L and Boshkow L. The optimal hematocrit. Crit Care Clin 2010;26:335-54.
Hare, R. The Birth of Penicillin, Allen & Unwin, London, 1970
Haridas M and Malagoni MA. Predictive factors for surgical site infection in general surgery. 
Surgery 2008;144:496-501.
Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, Martin R, Edmonds D, Cocks 
J, Greenbough J, Lowe J, Randle L, Castell J, Browne E, Bellis K, Aberline M. Surgical-
site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect 
Control Hosp Epidemiol 2004;25:472-6.
Heal CF, Buettner PG, Cruickshank R et al. Does single application of topical chloramphenicol 
to high risk sutured wounds reduce incidence of wound infection after minor surgery? 
Prospective randomized placebo controlled double blind trial. BMJ 2009;338:
61
Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ. Benefical ef-
fect of autologous blood transfusion on infectious complications after colorectal cancer 
surgery. Lancet 1994;27:1328-33.
Hennessey DB, Burke JP, Ni-Dhonochu T, Shields C, Winter DC, Mealy K. Preoperative hypo-
albuminemia is an independent risk factor for the development of surgical site infection 
following gastrointestinal surgery: a multi-institutional study. Ann Surg 2010;252:325-9.
Herrera FA, Kohanzadeh S, Nasseri Y, Kansal N, Owens EL, Bodor R. Management of vas-
cular graft infections with soft tissue flap coverage: improving limb salvage rates – a 
veterans affairs experience. Am Surg 2009;75:877-81.
Himbeeck FJG, van Knippenberg LAA, Niessen MCGH, van Griethuysen AJA. Wound infec-
tion after arterial surgical procedures. Eur J Vasc Surg 1992;6:494-8.
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial 
surgical site infections, 1992: A modification of CDC definitions of surgical wound in-
fections. Infect Control Hosp Epidemiol 1992;10:606-8.
Hunt TK, Zederfeldt B, Goldstick TK. Oxygen and healing. Am J Surg 1969;118;480-5.
Hyrylä M and Sintonen H. The use of health services in the management of wound infection. 
J Hosp Infect 1994;26:1-14.
Ikeda T, Tayafeh F, Sessler DI et al. Local radiant heating increases the subcutaneous oxygen 
tension. Am J Surg 1998;172:33-7.
Iribarren O and Araujo M. Effect of antimicrobial prophylaxis on the incidence of infec-
tions in clean surgical wounds in hospitals undergoing renovation. Infect Control Hosp 
Epidemiol 2006;27:1372-6.
Ismael H, Horst M, Faroog M, Jordon J, Patton JH, Rubinfeld IS. Adverse effects of preopera-
tive steroid use on surgical outcomes. Am J Surg 2011;201:305-8.
Javerliat I, Goeau-Brissonniere O, Sivadon-Tardy V, Coggia M, Gaillard JL. Prevention of 
Staphylococcus aureus graft infection by a new gelatin sealed vascular graft prebomded 
with antibiotics. J Vasc Surg 2007;46:1026-31.
Jensen JA, Goodson WH, Williams H, Hopf HW, Hunt TK. Cigarette smoking decreases tissue 
oxygen. Arch Surg 1991;126:1131-4.
Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-
depleted versus buffy-coat-poor blood transfusion and complications after colorectal 
surgery. Lancet 1996;28:841-5.
Jonsson K, Jensen JA, Goodson WH, Scheuensthul H, West J, Hopf HW, Hunt TK. Tissue 
oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. 
Ann Surg 1991;214:605-13.
Josephs LG, Cordts PR, DiEdwardo CL, LaMorte WW, Menzoian JO. Do infected inguinal 
lymph nodes increase the incidence of postoperative groin wound infection? J Vasc Surg 
1993;17:1077-82.
Jönsson K, Hunt TK, Mathes SJ. Oxygen as an isolated variable influences resistance to in-
fection. Ann Surg 1988;132:991-6.
Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI, Kurtz A. Obesity decreases 
perioperative tissue oxygenation. Anesthesiology 2004;100:274-80.
Kanafani ZA, Dakdouki GK, El-Dbouni, Bawwab T, Kanj SS. Surgical site infections spinal 
surgery at a tertiary care center in Libanon: Incidence, microbiology, and risk factors. 
Scand J Infect Dis 2006;38:589-92.
62
Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycemic control regimens for preven-
ting surgical site infections in adults. Cochrane Database Syst Rev 2009;8.
Karakida K, Aoki T, Ota Y, Yamazaki H, Otsuru M, Takahasni M, Sakamoto H, Miyasaka 
M. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with 
microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 
2010;16:334-9.
Karliczek A, Jesus EC, Matos D, Castro AA, Atallah AN, Wiggers T. Drainage or nondrainage 
in elective colorectal anastomosis: a systemic review and meta-analysis. Colorectal Dis 
2006;8:259-65.
Karthikesalingam A, Walsh SR, Sadat U, Tang TY, Koraen L, Varty K. Efficacy of closed suc-
tion drainage in lower limb arterial surgery: a meta-analysis of published clinical trials. 
Vasc Endovasc Surg 2008;42:243-8.
Kasatpibal N, Jamulitrat S, Chongsuvivatwong V. Standardized incidence rates of surgical site 
infection: A multicenter study in Thailand. Am J Infect Control 2005;33:587-94.
Kassavin DS, Pascarella L, Goldfarb MA. Surgical site infections: incidence and trends at a 
community teaching hospital. Am J Surg 2011;201:749-53.
Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures: a possible factor in 
suture induced infection. Ann Surg 1981;194:35-41.93:1627-33.
Kaya E, Yetim I, Dervisoglu A, Sunbul M, Bek Y. Risk factors for and effect of a one-year 
surveillance program on surgical site infection at a university hospital in Turkey. Surg 
Inf 2006;7:519-26.
Kaye KS, Schmit K, Pieper C, Sloane R, Caughlan KF, Sexton DJ, Schmander KE. The effect 
of increasing age on the risk of surgical site infection. JID 2005;191:1056-62.
Kent KC, Bartek S, Kuntz KM, Anninos E, Skillman JJ. Prospective study of wound compli-
cations in continuous infrainguinal incisions after lower limb arterial reconstruction: 
Incidence, risk factors, and cost. Surgery 1996;119:378-83.
Knight BC and Tait WF. Dacron patch infection following carotid endarterectomy: a syste-
matic review of the literature. Eur J Vasc Endovasc Surg 2009;37:140-8.
Koutsoumbelis S, Hughes AP, Girardi FP, Cammisa FP Jr, Finerty EA, Nguyen JT, Gausden 
E, Sama AA. Risk factors for postoperative infection following posterior lumbar instru-
mented arthrodesis. J Bone Joint Surg Am 2011; 
Kühme T, Isaksson B, Dahlin LG. Wound contamination in cardiac surgery. A systematic 
quantitative and qualitative study of bacterial growth in sternal wounds in cardiac sur-
gery patients. APMIS 2007;115:101-7.
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of 
surgical wound infection and shorten hospitalization. Study of Wound infection and 
Temperature Group. N Engl J Med 1996;334:1209-15.
Lador A, Nasir H, Mansur N, Biderman P, Leibovici L, Paul M. Antibiotic prophylaxis in car-
diac surgery: systemic review and meta-analysis. J Antimicrob Chemother 2012;67:541-50.
Lahti-Koski M, Seppänen-Nuijten E, Männistö S, Härkänen T, Rissanen H, Knekt P, Rissanen 
A, Heliövaara M. Twenty-year changes in the prevalence of obesity among Finnish 
adults. Obes Rev 2010;11:171-6. 
Landreneau MD and Raju S. Infections after elective bypass surgery for lower limb ischemia: 
the influence of preoperative transcutaneous arteriography. Surgery 1981;90:956-961.
Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Percoraro RE, Rodeheaver G, Robson MC. 
Definition and guidelines for assessment of wounds and evaluation of healing. Wound 
Rep and Reg 1994;2:165-70. 
63
Leaper DJ, van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, Berger A. Surgical site 
infection-a European perspective of incidence and economic burden. Int Wound J 
2004;1:247-73.
Leaper D, McBain AJ, Kramer A, Assadian O, Sanchez JLA, Lumio J, Kiernan M. Healthcare 
associated infections: novel strategies and antimicrobial implants to prevent surgical 
site infection. Ann R Coll Surg Engl 2010;92:453-8.
Lee ES, Santilli SM, Olson MM, Kuskowski MA, Lee JT. Wound infection after infrainguinal 
bypass operations: multivariate analysis of putative risk factors. Surg Infect (Larchmt) 
2000;1:257-63.
Legout L, Sarraz-Bournet B, D’Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah 
Y, Senneville E, Haulon S, Leroy O. Characteristic and prognosis in patients with prost-
hetic vascular graft infection: a prospective observational cohort study. Clin Microbiol 
Infect 2011.
Levin I, Amer-Alshiek J, Avni A, Lessing JB, Satel A, Almog B. Chlorhexidine and alcohol ver-
sus povidone-iodine for antisepsis in gynecological surgery. J Womens Health (Larchmt) 
2011;20:321-4.
Levine NS, Lindberg RB, Mason SD, Pruitt BA. The quantitative swab culture and smear: a 
quick, simple method for determining the number of viable aerobic bacteria on open 
wounds. J trauma 1976;16:89-94. 
Li X, Zhang J, Sang L, Zhang W, Chu Z, Li X, Liu Y. Laparoscopic versus conventional appen-
dectomy- a meta-analysis of randomized controlled trials. BMC Gastroenterol 2010;3:1-8.
Liekweg WG and Greenfield LJ. Vascular prosthetic infections: collected experience and re-
sults of treatment. Surgery 1977;81:335-342.
Lineaweaver WC, Jacob S, Yan H, Zhang F. Wound cultures as predictors of complications in 
reconstructive flap procedures. Ann Plast Surg 2011;66:572-4.
Linni K, Mader N, Aspalter M, Butturini E, Ugurluoglu A, Hitzl W, Hölzenbein TJ. Ultrasonic 
vein mapping prior to infrainguinal autogenous bypass grafting reduces postoperative 
infections and readmissions. J Vasc Surg 2012;56:126-32.
Lipsky BA and Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect 
Dis 2009;49:1541-9.
Lister J. Antiseptic principle in the practice of surgery. Lancet 1867;21:246-8.
Loiacono LA and Shapiro DS. Detection of hypoxia at the cellular level. Crit Care Clin 
2010;26:409-21.
Lorentzen JE, Nielsen OM, Arendrup H, Kimose HH, Bille S, Andersen J, Jensen CH, Jacobsen 
F, Røder OC. Vascular graft infection: an analysis of sixty-two graft inections in 2411 
consecutively implanted synthetic vascular grafts. Surgery 1985;98:81-6. 
Lyytikäinen O, Kanerva M, Aghte N, Möttönen T, Ruutu P. Healthcare-assosiated infections in 
Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Inf 2008;69:288-94.
Malone DL, Genuit T, Tracy K, Gannon C, Napolitano LM. Surgical site infections: reanalysis 
of risk factors. JSR 2002;103:89-95.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guidance for prevention of sur-
gical site infection, 1999. Centers for Disease Control and Prevention (CDC) hospital 
infection control practices advisory committee. Am J Infect Control 1999;27:97-132.
Mannien J, Willie JC, Kloek JJ, van Benthem BHB. Surveillance and epidemiology of surgi-
cal site infections after cardiothoracic surgery in The Netherlands, 2002-2007. J Thorac 
Cardiovasc Surg 2011:141;899-904.
64
Marco F, Vallez R, Gonzalez P, Ortega L, de la Lama J, Lopez-Duran L. Study of the efficacy of 
coated Vicryl plus antibacterial suture in an animal model of orthopaedic surgery. Surg 
Infect (Larchmt) 2007;3:359-65.
Marik PE and Zaloga GP. Immunonutrition in high-risk surgical patients: a systemic review 
and analysis of the literature. J Parenter Enteral Nutr 2010;34:378-86.
Markar SR, Kutty R, Edmonds L, Sadat U, Nair S. A meta-analysis of minimally invasive ver-
sus traditional open vein harvest technique for coronary artery bypass graft surgery. 
Interact CardioVasc Thorac Surg 2010;10:266-70.
Masini BD, Stinner DJ, Waterman SM, Wenke JC. Bacterial adherence to suture materials. J 
Surg 2011;68:101-4.
Mawalla B, Mshana SE, Chalya PL, Imirzalioglu C, Mahlulu W. Predictors of surgical site 
infections among patients undergoing major surgery at Bugando Medical Centre in 
Northwestern Tanzania. BMC Surgery 2011;11:1-7.
Mayer D, Hasse N, Koelliker J, Enzler M, Veith FJ, Rancic Z, Lachat M. Long-term results of 
vascular graft and artery preserving treatment with negative pressure wound therapy 
in Szilagyi grade III infections justify a paradigm shift. Ann Surg 2011;254:754-9.
Mayzler O, Weksler N, Domchik S, Klein M, Mizrahi S, Gurman GM. Does supplemental pe-
rioperative oxygen administration reduce the incidence of wound infection in elective 
colorectal surgery? Minerva Anestesiol 2005;71:21-5. 
McAlister FA, Man J, Bistritz L, et al. Diabetes and coronary artery bypass surgery: an exami-
nation of perioperative glycemic control and outcomes. Diabetes care 2003; 26: 1518-1524.
McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial 
prophylaxis for major surgery: a systematic review. Aust N Z J Surg 1998;68:388-96.
McHugh SM, Hill ADK, Humphreys H. Intraoperative technique as a factor in the prevention 
of surgical site infection. J Hosp Infect 2010;78:1-4.
McHugh SM, Collins CJ, Corrigan MA, Hill ADK, Humphreys H. The role of topical antibio-
tics used as prophylaxis in surgical site infection prevention. J Antimicrob Chemother 
2011;66:693-701.
McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, 
Samuel BU, Lyons RE, Dorris M, Millhous WK, Rice DW. Triclosan inhibits the growth 
of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. 
Int J Parasitol 2001;31:109-13.
McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998;394:531-2.
Meakins JL and Masterson BJ. Prevention of postoperative infection. 2005 WebMD.
Mekako AI, Chetter IC, Coughlin PA, Hatfield J, McCollum PT. Randomized clinical trial 
of co-amoxiclav versus no antibiotic prophylaxis in varicose vein surgery. Br J Surg 
2010;97:29-36
Mertz D, Johnstone J, Loeb M. Does duration of perioperative antibiotic prophylaxis matter 
in cardiac surgery? A systematic review and meta-analysis. Ann Surg 2011;254:48-54.
Meyhoff CS, Wetterslev J, Jorgensen LN et al. Effect of high perioperative oxygen fraction 
on surgical site infection and pulmonary complications after abdominal surgery: the 
PROXI randomized clinical trial. JAMA 2009;303:1543-9.
Ming X, Rothenburger  S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS plus 
(polidioxane with triclosan) suture. Surg Infect (Larchmt) 2008;9:451-7.
65
Mingmalairak C, Ungbhakorn P, Paochron V. Efficcacy of antimicrobial coating suture co-
ated polyglatin 910 with triclosan (Vicryl plus) compared with polyglatin 910 (Vicryl) in 
reduced surgical site infection of appendicitis, double blind randomized control trial, 
premilinary safety report. J Med Assoc Thai 2009;92:770-5.
Morach MD, Sam AD 2nd, Kibbe MR, Hijjawi J, Dumanian GA. Early results with use of gra-
cilis muscle flap coverage of infected groin wounds after vascular surgey. J Vasc Surg 
2004;39:1277-83. 
Moro ML, Carrieri MP, Tozzi AE, Lana S, Greco D. Risk factors for surgical wound infec-
tions in clean surgery: a multicenter study. Italian PRINOS study group. Ann Ital Chir 
1996;67:13-9.
Munoz P, Hortal J, Gianella M, Barrio JM, Rodriguez-Creixems M, Perez MJ, Rincon C, Bouza 
E. Nasal carriage of S aureus increases the risk of surgical site infection after major 
heart surgery. J Hosp Infect 2008;68:25-31.
Murphy PG, Tadros E, Cross S, Hehir D, Burke PE, Kent P, Sheehan SJ, Colgan MP, Moore 
DJ, Shanik GD. Skin closure and the incidence of groin wound infection: a prospective 
study. Ann Vasc Surg 1995;9:480-2.
Murthy R, Sengupta S, N M, Shivananda PG. Incidence of postoperative wound infection and 
their antibiogram in a teaching and referral hospital. Indian J Med Sci 1998;52:553-5. 
Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM. SHEA gui-
deline for preventing nosocomial transmission of multidrug-resistant strains of staphy-
lococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
Myles PS, Leslie K, Chan MTV, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E. Avoidance 
of nitrous oxide for patients undergoing major surgery. Anesthesiology 2007;107:221-31.
Möhnle P, Snyder-Ramos SA, Miao Y, Kulier A, Böttiger BW, Levin J, Mangano DT. 
Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac 
surgery patients. Intensive Care Med 2011;37:97-109.
Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound infection follo-
wing cardiac surgery. J Infect Dis 1987;156:967-73.
Naylor AR, Hayes PD, Darke S. A Prospective audit complex wound and graft infections in 
Great Britain and Ireland. Eur J Vasc Endovasc Surg 2001;21:289-94.
Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery. Cochrane 
Database Syst Rev 2009;21:CD001181.
Nguyen LL, Brahmanandam S, Bandyk DF, Belkin M, Clowes AW, Moneta GL, Conte MS. 
Female gender and oral anticoagulants are associated with wound complications in 
lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia. 
J Vasc Surg 2007;46:1191-7.
Nichols D and Nielsen ND. Oxygen delivery and consumption: a macrociculatory perspective. 
Crit Care Clin 2010;26:239-53.
Noorani A, Rabey N, Walsh SR, Davies RJ. Systemic review and meta-analysis of preoperative 
antisepsis with chlorhexidine versus povidone-iodine in clean-contamined surgery. Br 
J Surg 2010;97:1614-20.
Noordzij PG, Poldermans D, Schouten O, Bax JJ, Scheiner FA, Boersma E. Postoperative mor-
tality in The Netherlands: a population-based analysis of surgery-specific risk in adults. 
Anesthesiology 2010; 112:1105-15.
O’Brien R, Pocock N, Torella F. Wound infection after reconstructive arterial surgery of the 
lower limbs: risk factors and consequenses. Surgeon 2011;9:245-8.
66
Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk for deep and 
superficial chest surgical-site infections after coronary artery bypass graft surgery are 
different. J Thorac Cardiovasc Surg 2002;124:136-45.
Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VJ. Risk factors 
for surgical site infection after major breast operation. J Am Coll Surg 2008;207:326-35.a 
Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, Fraser VJ. Risk factors 
for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 
2008;90:62-9.b
Olson M, O’Connor M, Schwartz ML. Surgical wound infections: a 5-year prospective study 
of 20 193 wounds at the Minneapolis VA Medical Center. Ann Surg 1984;199:253-9.  
Ott E, Bange F-C, Sohr D, Teebken O, Mattner F. Risk factors associated with surgical site 
infections following vascular surgery at a German university hospital. Epidemiol Infect 
2012:1-7.
Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after 
orthopaedic surgery. Cochrane Database Syst Rev 2007;18.
Patel VI, Hamdan AD, Schermerhorn ML, Hile C, Dahlberg S, Campell DR, LoGerfo FW, 
Pomposelli FB. Lower extremity arterial revascularization in obese patients. J Vasc Surg 
2007;46:738-42. 
Peersman G, Laskin R, Peterson MG, Richart T. Prolonged operation time correlates with 
increased infection rate after total knee ahrtroplast. HSS J 2006;2:70-2.
Perera GB, Fujitani RM, Kubaska SM. Aortic graft infection: update on management and 
treatment options. Vasc Endovasc Surg 2006;40:1-10.
Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y. Risk factors for postoperative infectious 
complications in noncoloractal abdominal surgery: a multivariate analysis based on a 
prospective multicenter study of 4718 patients. Arch Surg 2003; 138:314-24.
Pevzner L, Swank M, Krepel C, Wing DA, Chan K, Edminston CE Jr. Effects of maternal obe-
sity on tissue concentrations of prophylactic cefazolin during caesarean delivery. Obstet 
Gynecol 2011;117:877-82.
Pharmaca Fennica 2010.
Phillips JE, Crane TP, Noy M, Elliot TS, Grimer RJ. The incidence of deep prosthetic infec-
tions in a specialist orthopaedic hospital: 15-year prospective survey. J Bone Joint Surg 
Br 2006;88:943-8.
Ploeg AJ, Lardenoye JWP, MPFM Vrancen Peeters, Hamming JF, Breslau PJ. Wound comp-
lications at the groin after peripheral arterial surgery sparing the lymphatic tissue: a 
double-blind randomized clinical trial. Am J Surg 2009;197:747-51. 
Pounds LL, Montes-Walters M, Mayhall CG, Falk PS, Sanderson E, Hunter GC, Killewich LA. 
A changing pattern of infection after major vascular reconstructions. Vasc Endovasc 
Surg 2005; 39: 511-17. 117.
Prager M, Polterauer P, Böhmig HJ, Wagner O, Fugl A, Kretschmer G, Plohner M, Nanobashvili 
J, Huk I. Collagen versus gelatin-coated Dacron versus stretch polytetrafluoroethylene 
in abdominal aortic bifurcation graft surgery: results of a seven-year prospective, ran-
domized multicenter trial. Surgery 2001;130:408-14.
Prockop D and Kivirikko K. Collagens:molecular biology, diseases, and potentials for therapy. 
Ann Rev Biochem 1995;64:XX
Pryor KO, Fahey J, Lien CA et al. Surgical site infection and the routine use of periopera-
tive hyperoxia in a general surgical population: a randomized controlled trial. JAMA 
2004;291:79-87.
67
Pull ter Gunne and Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical 
site infection following adult spinal surgery. Spine 2009;34:1422-8.
Qadan M, Akca O, Suhal SM, Hornung CA, Polk HC. Perioperative supplemental oxygen the-
rapy and surgical site infection. Arch Surg 2009;144:359-66.
Qadan M, Battisa C, Gardner SA et al. Oxygen and surgical site infection. Anesthesiology 
2010;113:369-77.
Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, Rogers SO. Relationship 
of perioperative hyperglycemia and postoperative infections in patients who undergo 
general and vascular surgery. Ann Surg 2008;248:585-91. 
Rasnake MS and Dooley DP. Culture-negative surgical site infections. Surg Inf 2006;7:555-65.
Rennie KL and Jebb SA. Prevalnce of obesity in Great Britain. Obes Rev 2005;6:11-12.
Reynolds L, Beckmann J, Kurtz A. Perioperative complications of hypothermia. Best Pract 
Res Anaesthesiol 2008;22:645-57.
Richet HM, Chidiac C, Prat A, Pol A, David M, Maccario M, Cormier P, Bernard E, Jarvis WR. 
Analysis of risk factors for surgical wound infections following vascular surgery. Am J 
Med 1991;91:170-2.
van Rijen MM, Bonten M, Wentzel RP, Kluytmans JA. Intranasal muciporin for reduction of 
Staphylococcus aureus infections in surgical patients with nasal carriage: a systemic 
review. J Antimicrob Chemother 2008;61:254-61
Robson MC. Infection in the surgical patients: an imbalance in the normal equilibrium. Clin 
Plast Surg 1979;6:493-503.
Robson MC. Wound Infection: A failure of wound healing caused by an imbalance of bacteria. 
Surg Clin North Am 1997;77:637-50.
Rothen HU, Sporre B, Enberrg G, Wegelius G, Reber A, Hedenstierna G. Prevention of ate-
lectasis during general anesthesia. Lancet 1995;345:1387-91.
Rothenburger S, Spangler D, Bhene S, Burkley D. In vitro antibacterial evaluation of coated 
VICRYL® plus antibacterial suture (coated polyglatin 910 with triclosan) using zone of 
inhibition assays. Surg Inf 2002;3:79-87.
Roumbelaki A, Kritsotakis EI, Tsioutis C, Tzilepi P, Gikas A. Surveillance of surgical site in-
fections at a tertiary care hospital in Greece: incidence, risk factors, microbiology, and 
impact. Am J Infect Control 2008;36:732-8.
Rozelle CJ, Leonardo J, Veetai L. Antimicrobial suture wound closure for cerebrospinal fluid 
shunt surgery: a prospective, double-blinded, randomized controlled trial.  J Neurosurg 
2008;2:111-7.
Russell AD. Whither triclosan? J Antimicrob Chemother 2004;53:693-5.
Rutkow IM. Surgery, an illustrated history. Mosby 1993.
Rutten HJ and Nijhuis PH. Prevention of wound infection in elective colorectal surgery by 
local application of a gentamicin-containing collagen sponge. Eur J Surg 1997;578:31-5.
Sajid MS, Shakir AJ, Khatri K, Baig MK. The role of perioperative warming in surgery: a 
systemic review. Sao Paulo Med J 2009;231-7. 
Saleh K, Sonesson A, Persson B, Riesberck K, Schmidtchen A. A Descriptive study of bacterial 
load of full-thickness surgical wounds in dermatologic surgery. Derm Surg 2011;37:1014-22.
Saleh S, Haddadin RNS, Baillie S, Collier PJ. Triclosan-an update. LAM 2010;52:87-95.
Sanabria A, Valdivieso E, Gomez G, Echeverry G. Prophylactic antibiotics in chest trauma: a 
meta-analysis of high-quality studies. World J Surg 2006;1843-7.
Sanchez-Manuel FJ, Lozano-Garcia J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. 
Cochrane Database Syst Rev 2007;18:CD003769.
68
Santos KRN, Fonseca LS, Neto GPN, Filho PPG. Surgical site infection: rates, etiology and 
resistance patterns to antimicrobials among strains isolated at Rio de Janeiro university 
hospital. Infection 1997;25:217-220.   
Santos MdeL, Teixeira RR, Diogo-Filho A. Surgical site infections in adult patients undergoing 
of clean and contaminated surgeries at a university Brazilian hospital. Arq Gastroenterol 
2010;47:383-7.
Sauerland S, Walgenbach M, Habermalz B, Seiler CM, Miserez M. Laparoscopic versus open 
surgical techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev 
2011;16.
Sax H, Uckay I, Balmelli C, Berneasconi E, Boubaker K, Muhlemann K, Ruef C, Troillet 
N, Widmer A, Zanetti G, Pittet D. Overall burden of healthcare-associated infections 
among surgical patients. Ann Surg 2011;253:365-70.
Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A. Arteriovenous fistu-
lae vs arteriovenous grafts: a retrospective review of 1 700 consecutive vascular access 
cases. J Vasc Access 2008;9:231-5.
Schneider SM, Veyres P, Pivot X, Soummer AM, Jambou P, Filippi J, van Obberghen E, 
Hebuterne X. Malnutrition is an independent factor associated with nosocomial infec-
tions. Br J Nutr 2004:92;105-11.
Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI, Fevang BT. Risk of 
revision for infection in primary total hip and knee arthroplasty in patients with rheu-
matoid arthritis compared with osteoarthritis: a prospective, population-based study 
on 108,786 hip and knee joint arthroplasties from Norweigian Arthroplasty register. 
Arthritis Care Res 2010;62:473-9.
Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Bapilas P. Oxygen in acute and 
chronic wound healing. Br J Derm 2010;163:257-68.
Schultz G, Rotari DS, Clark W. EGF and TGF-alpha in wound healing and repair. J Cell Biochem 
1991;45:346-52.
Scifres CM, Leighton BL, Fogertey PJ, Macones GA, Stamilo DM. Supplemental oxygen for 
the prevention of postcesarean infectious morbidity: a randomized controlled trial. Am 
J Obstet Gynecol 2011;205:267.e1-9. 
Serra-Aracil X, Garcia-Domingo MI, Pares D, Espin-Basany E, Biondo S, Guirao X, Orrego C, 
Sitges-Serra A. Surgical site infection in elective operations for colorectal cancer after 
the application of preventive measures. Arch Surg 2011;146:606-12.
Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. Effect of hypoxia on vas-
cular endothelial growth factor levels in a wound model. Arch Surg 2000;135:1293-7. 
Singh JA, Houston TK, Ponce BA, Maddox G, Bishop MJ, Richman J, Campagna EJ, Henderson 
WG, Hawn MT. Smoking as a risk factor for short-term outcomes following primary total 
hip and total knee replacement in veterans. Arthritis Care Res 2011;63:1365-74.
Slater-Radosti C, Van Aller G, Greenwood R, Nicholas R , Keller PM, DeWolf WE, Fan F, Payne 
DJ, Jaworski DD. Biochemical and genetic characterization of the action of triclosan on 
Staphylococcus aureus. JAC 2001;48:1-6.
Smaill FM, Gyte GM. Antibiotic prophylaxis versus no prophylaxis for preventing infection 
after caesarean section. Cochrane Database Syst Rev 2010;20:CD007482.
Smith RL, Bohl JK, McElearney ST, Friel CM, Barclay MM, Sawyer RG, Foley EF. Wound 
infection after elective colorectal resection. Ann Surg 2004;239:599-605.
Smith TO, Sexton D, Mann C, Donell S. Sutures versus staples for skin closure in orthopaedic 
surgery:meta-analysis. BMJ 2010;340:1-8.
69
Sørensen LT, Karlsmark T, Gottrupp F. Abstinence from smoking reduces incisional wound 
infection: a randomized controlled trial. Ann Surg 2003;238:1-5.
Sørensen LT, Toft BG, Rygaard J, Ladelund S, Paddon M, James T, Taylor R, Gottrup F. Effect 
of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and 
systemic markers of collagen metabolism. Surgery 2010;148:982-90.b 
Sørensen LT, Toft BG, Rygaard J, Ladelund S, Teisner B, Gottrup F. Smoking attenuates wound 
inflammation and proliferation while smoking cessation restores inflammation but not 
proliferation. Wound Repair Regen 2010;18:186-92.a
Steingrimsson S, Gustafsson R, Gudbjartsson T, Mokhtari A, Ingemansson R, Sjögren J. 
Sternocutaneous fistulas after cardiac surgery: incidence and late outcome during a 
ten-year follow-up. Ann Thorac Surg 2009;88:1910-5.
Steward AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruc-
tion: A systematic review and meta-analysis. J Vasc Surg 2007;46:148-55.
Stone AM, Tucci VJ, Isenberg HD, Wise L. Wound infection: a prospective study of 7519 ope-
rations. Am Surg 1976;42:849-52.
Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, 
biliary and colonic surgery. Ann Surg 1976;443-450.
Stone P, Campbell J, AbuRahma A, Safley L, Emmett M, Asmita M. Vascular surgical antibio-
tic prophylaxis study (VSAPS). Vasc Endovasc Surg 2010;44:520-8.
Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated Vicryl plus 
antibacterial suture in guinea pigs challenged with staphylococcus aureus. Surg Inf 
(Larchmt) 2004;3:281-8.
Suljagic V, Jevtic M, Djordjevic B, Jovelic A. Surgical site infections in a tertiary health care 
center: prospective cohort study. Surg Today 2010;40:763-71. 
Swenne CL, Lindholm C, Borowiec J, Schnell AE, Carlson M. Peri-operative glucose control 
and development of surgical wound infections in patients undergoing coronary artery 
bypass graft. J Hosp Inect 2005;61:201-12.
Swinnen J, Chao A, Tiwari A, Crozier J, Vicaretti M, Fletcher J. Vertical or transverse incisions 
for access to the femoral artery: a randomized control study. Ann Vasc Surg 2010;3:336-41
Söderström M, Arvela E, Albäck A, Aho P-S, Lepäntalo M. Healing of ischaemic tissue lesions 
after infrainguinal bypass surgey for critical leg ischaemia. Eur J Vasc Endovasc Surg 
2008;36:90-95.
Söderström M, Vikatmaa P, Lepäntalo M, Aho P-S, Kolho E, Ikonen T. The consequences of 
an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for 
critical leg ischemia. J Vasc Surg 2009;50:806-12.
Tanner J, Norrie P, Melen K. Preoperative hair removal to reduce surgical site infection. The 
Cochrane Library 2011;11.
Terijian T, DiFronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection af-
ter breast surgery: a systemic review and meta-analysis. J Am Coll Surg 2006;203:729-34.
Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp 
Proc 2000;5:40-6.
Twum-Danso K, Grant C, Al-Suleiman A, Abdel-Khader S, Al-Awami MS, Al-Breiki H, Tahas 
S, Ashoor A-A, Wosornu L. Microbiology of postoperative wound infection: a prospective 
study of 1770 wounds. J Hosp Inf 1992;29-37.
Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the 
proportion of healthcare-associated infections that are reasonably preventable and the 
related mortality and costs. Infect Control Hosp Epidemiol 2011;32:101-114.
70
Urban JA. Cost analysis of surgical site infections. Surg Infect (Larchmt) 2006;7:s19-22.
Vander Salm TJ, Okike ON, Pasque MK. Reduction of sternal wound infection by application 
of topical vancomycin. J Thorac Cardiovasc Surg 1989;98:618-22.
Vascular surgery. W.B. Saunders company 2000. Edited by Rutherford RB
Veeravagu A, Patil CG, Lad SP, Boakye M. Risk factors for postoperative spinal wound infec-
tions after spinal decompression and fusion surgeries. Spine 2009;34:1869-72.
Virkkunen J, Venermo M, Saarinen J, Salenius J. Predictors for immediate and long-term 
outcome of a vascular surgical procedure. Scand J Surg 2009;98:164-8.
Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after 
aortic aneurysm repair. J Vasc Surg 2008;47:264-9.
Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Lowry SF, Graham AM. Infectious compli-
cations after elective vascular surgical procedures. J Vasc Surg 2010;51:122-30.
Vriesendorp TM, Morelis QJ, DeVries JH, Legemate DA, Hoekstra JBL. Early post-operative 
glucose levels are an independent risk factor for infection after peripheral vascular 
surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004;28:520-5.
Wangensteen OH and Wangensteen SD. The rise of surgery: from empiric craft to scientific 
discipline. Minneapolis: University of Minnesota Press, 1978.
Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers SO, Eriksson E. Percent body fat and 
predicton of surgical site infection. J Am Coll Surg 2010;381-9.
Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V. Surgical site infections: causa-
tive pathogens and associated outcomes. Am J Infect Control 2010;38:112-20.
Wenzel RP. Health care-associated infections: major issues in the early years of the 21st cen-
tury. Clin Infect Dis 2007;45:85-8.
Weber WP, Marti WR, Zwahlen M, Misteli H, Rosenthal R, Reck S, Fueglistaler P, Bolli M, 
Trampuz A, Oertli D, Widmer AF. The timing of surgical antimicrobial prophylaxis. Ann 
Surg 2008;247:918-26.
Webster J and Osborne S. Preoperative bathing or showering with skin antiseptics to prevent 
surgical site infection. The Cochrane Library 2011;1.
Wick EC, Hirose K, Shore AD, Clark JM, Gearhart SL, Efron J, Makary MA. Surgical site infec-
tions and cost in obese patients undergoing colorectal surgery. Arch Surg 2011;146:1068-72.
Williams N, Sweetland H, Goyal S, Ivins N, Leaper DJ. Randomized trial of antimicrobial-
coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect 
(Larchmt) 2011;12:469-74.
Wilson SE. New alternatives in management of the infected vascular prosthesis. Surg Infect 
(Larchmt) 2001;2:171-5.
Wolterbeek JH, van Leeuwen AAM, Breslau PJ. Skin closure after infrainguinal bypass sur-
gery: a prospective randomized study. Eur J Vasc Endovasc Surg 2002;23:321-4.
Wong PF, Kumar S, Bohra A, Whetter D, Leaper DJ. Randomized clinical trial of perioperative 
systemic warming in major elective abdominal surgery. Br J Surg 2007;94:421-6.
Woodfield JC, Beshay N, van Rij AM. A meta-analysis of randomized, controlled trials asses-
sing the prophylactic use of ceftriaxone. A study of wound, chest and urinary infections. 
World J Surg 2009;33:2538-50.
Yan RC, Shen SQ, Chen ZB, Lin FS, Riley J. The role of prophylactic antibiotics in laparoscopic 
cholecystectomy in preventing postoperative infection: a meta-analysis. J Laparoendosc 
Adv Surg Tech 2011;21:301-6.
71
Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W, Tada K. Positive culture 
of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site 
infection in orthopedics. Acta Orthop 2009;80:486-90.
Yazdankhaha SP, Sceheie AA, Hoiby EA, Lunestad BT, Heir E, Fotland TO, Naterstad K, 
Kruise H. Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug 
Resist 2006;12:83-90.
Yetim I, Ozkan OV, Dervişoglu A, Erzurumlu K, Canbolant E. Effect of gentamicin-absorbed 
collagen in wound healing in pilonidal sinus surgery: a prospective randomized study. 
J Int Med Res 2010;38:1029-33.
Zhang Z, Zhang H, Fang X, Wang L, Li X, Li Y, Sun X, Carver J, Simpkins D, Shen J, Weisberg 
M. Cosmetic outcome and surgical site infection rates of antibacterial absorbable (polyg-
latin 901) suture compared to Chinese silk suture in brest cancer surgery: a randomized 
pilot research. Chin Med J 2011;124:719-24.

Publications of the University of Eastern Finland
Dissertations in Health Sciences
isbn 978-952-61-1082-0
issn 1798-5706
Johanna Turtiainen
Surgical Wound 
Infections after Lower 
Limb Vascular Surgery
Peripheral vascular surgery procedures  
are usually performed in order to im-
prove blood supply to extremities. Pa-
tients undergoing these procedures suffer  
from critical ischaemia or claudication.  
Surgical wound infection (SWI) is the  
most common complication after lower  
limb vascular surgery increasing the  
affected patient’s risk of major amputa-
tion as well as mortality. In this study,  
the incidence of SWI was 22-27% and,  
the average cost attributable to SWI was  
€3,320. Obesity, infrainguinal surgery,  
puncture site of arteriography on the  
operated area, asthma, coronary artery  
disease, use of corticosteroids, diabetes,  
and the high bacterial load of the surgi-
cal site at the second postoperative day  
increased the risk of the development of  
SWI after lower limb vascular surgery. 
